Opendata, web and dolomites
H2020 projects about "cancer"
The page lists 1643 projects related to the topic "cancer".
| # | |||
|---|---|---|---|
| 1 | APERIM | APERIM: Advanced bioinformatics platform for PERsonalised cancer IMmunotherapy | 2015 |
| 2 | B-CAST | Breast CAncer STratification: understanding the determinants of risk and prognosis of molecular subtypes | 2015 |
| 3 | SPENmr | Ultrafast Spatiotemporally-Encoding: A Superior Approach to Cancer Diagnosis by Non-Invasive Diffusion-Weighted MRI | 2015 |
| 4 | ULTRAPLACAD | ULTRAsensitive PLAsmonic devices for early CAncer Diagnosis | 2015 |
| 5 | MULTIMOT | Capture, dissemination and analysis of multiscale cell migration data for biological and clinical applications (MULTIMOT) | 2015 |
| 6 | MedBioinformatics | Creating medically-driven integrative bioinformatics applications focused on oncology, CNS disorders and their comorbidities (MedBioinformatics) | 2015 |
| 7 | EPoS | Elucidating Pathways of Steatohepatitis | 2015 |
| 8 | FORECEE | Female cancer prediction using cervical omics to individualise screening and prevention | 2015 |
| 9 | EU-TOPIA | EU-TOPIA: TOWARDS IMPROVED SCREENING FOR BREAST, CERVICAL AND COLORECTAL CANCER IN ALL OF EUROPE | 2015 |
| 10 | BeyondSeq | Genomic diagnostics beyond the sequence | 2015 |
| 11 | GLAM | Laser Multiplexed Biosensor | 2015 |
| 12 | BRIDGES | Breast Cancer Risk after Diagnostic Gene Sequencing (BRIDGES) | 2015 |
| 13 | PROCROP | Professional cross-priming for ovary and prostate cancer | 2015 |
| 14 | PanCanRisk | Personalized bioinformatics for global cancer susceptibility identification and clinical management | 2015 |
| 15 | MoTriColor | Molecularly guided trials with specific treatment strategies in patients with advanced newly molecular defined subtypes of colorectal cancer (MoTriColor) | 2015 |
| 16 | LuMaSense | A Non-Invasive Test for Guiding Follow–up of Patients with CT-Detected Lung Nodules | 2015 |
| 17 | LOWBRASYS | a LOW environmental impact BRAke SYStem | 2015 |
| 18 | GlioVac | Validation of a conceptually new treatment for glioblastoma multiforme with an IP protected small molecule | 2015 |
| 19 | CSUMECH | Cholesterol and Sugar Uptake Mechanisms | 2015 |
| 20 | RevMito | Deciphering and reversing the consequences of mitochondrial DNA damage | 2015 |
| 21 | CrIC | Molecular basis of the cross-talk between chronic inflammation and cancer | 2015 |
| 22 | MetDNASecStr | Metabolism of DNA secondary structures and their impact on genome stability | 2015 |
| 23 | INTRAHETEROSEQ | Molecular characterization of the role of intra-tumor heterogeneity in cancer progression and metastasis | 2015 |
| 24 | AngioGenesHD | Epistasis analysis of angiogenes with high cellular definition | 2015 |
| 25 | CRCStemCellDynamics | Molecular Subtype Specific Stem Cell Dynamics in Developing and Established Colorectal Cancers | 2015 |
| 26 | SM-IMPORT | Substrate import at work: single-molecule studies of ABC transporters | 2015 |
| 27 | SILENCE | Mechanisms of Gene Silencing by the Glucocorticoid Receptor | 2015 |
| 28 | Autophagy in vitro | Reconstituting Autophagosome Biogenesis in vitro | 2015 |
| 29 | DNAendProtection | DNA end protection in Immunity and Cancer | 2015 |
| 30 | LimitMDR | Utilizing evolutionary interactions to limit multidrug resistance | 2015 |
| 31 | G4DSB | G-quadruplex DNA Structures and Genome Stability | 2015 |
| 32 | Crosstag | Unravelling cross-presentation pathways using a chemical biology approach | 2015 |
| 33 | PRCTOERC | Novel Regulatory Principles of Polycomb Repressive Complex 2 | 2015 |
| 34 | FLDcure | A potent Micro-RNA therapeutic for nonalcoholic fatty liver disease (NAFLD) | 2015 |
| 35 | Rethyming | Rebuilding the human thymus to create a tolerising system for allogeneic tissue and organ transplantation | 2015 |
| 36 | Medulloblastoma | Molecularly defined models of human childhood brain tumors | 2015 |
| 37 | SQUALAC | Preclinical development of squalenic acid and gemcitabine squalene nanomedicine | 2015 |
| 38 | NDI | Nano-diamond tracers for MRI molecular imaging | 2014 |
| 39 | VASCFLAP | A new reconstructing technique using tissue engineering methods to create an engineered autologous vascularized tissue flap | 2015 |
| 40 | EPICUP | Development of a ncRNA DNA Methylation Kit for the Diagnosis of Cancer of Unknown Primary | 2015 |
| 41 | COLOStage | COLOStage : A new prognosis test for the prediction of metastasis in Colorectal Cancer and Hepatocellular Carcinoma | 2015 |
| 42 | SIMDEQ | SIngle Molecule DEtection and Quantification (SIMDEQ): A new platform for genetic and epigenetic analysis | 2014 |
| 43 | A CACTUS | Antibody-free method for Counting All Circulating TUmour cellS while maintaining them alive and intact | 2015 |
| 44 | Cancer-Targeted PolyIC | Treatment of EGFR over-expressing cancers by targeted non-viral delivery of PolyIC | 2015 |
| 45 | BALaNCE | BreAking the Link betweeN myo10 and CancEr | 2015 |
| 46 | SENSEI | Sequence-Enabled Single cEll Identification device | 2015 |
| 47 | ONCORNET | ONCOgenic Receptor Network of Excellence and Training | 2015 |
| 48 | MAGICBULLET | Peptide-Drug Conjugates for Targeted Delivery in Tumor Therapy | 2015 |
| 49 | CLOSPORE | UNDERSTANDING THE CLOSTRIDIUM SPORE, A PREREQUISTE FOR DISEASE INTERVENTIONS AND EXPLOITATION | 2015 |
| 50 | TOLLerant | Toll-Like Receptor 4 activation and function in diseases: an integrated chemical-biology approach. | 2015 |
| 51 | MEL-PLEX | Exploiting MELanoma disease comPLEXity to address European research training needs in translational cancer systems biology and cancer systems medicine | 2014 |
| 52 | RADIATE | Radiation Innovations for Therapy and Education | 2015 |
| 53 | Mid-TECH | Infrared sensing made visible: Combining infrared light sources and upconversion sensors for improved sensitivity in medical applications and gas analysis | 2015 |
| 54 | EpiPredict | Epigenetic regulation of endocrine therapy resistance in breast cancer: A systems medicine approach to predict treatment outcome | 2015 |
| 55 | BonePain | European Training Network on Bone Pain | 2015 |
| 56 | InCeM | Research Training Network on Integrated Component Cycling in Epithelial Cell Motility | 2015 |
| 57 | IMMUNOSHAPE | Development of Selective Carbohydrate Immunomodulators Targeting C-type Lectin Receptors on Antigen Presenting Cells | 2015 |
| 58 | Chromatin3D | Chromatin Dynamics in Development and Disease | 2015 |
| 59 | iManageCancer | iManageCancer - Empowering patients and strengthening self-management in cancer diseases | 2015 |
| 60 | TRANSCAN-2 | ERA-NET: Aligning national/regional translational cancer research programmes and activities | 2015 |
| 61 | MATRIXASSAY | Novel Cell Migration Assay Based on Microtissue Technology and Tissue-Specific Matrices | 2015 |
| 62 | SAGE-CARE | SemAntically integrating Genomics with Electronic health records for Cancer CARE | 2014 |
| 63 | SAPHELY | Self-amplified photonic biosensing platform for microRNA-based early diagnosis of diseases | 2015 |
| 64 | PRISAR | Preclinical Intra-Operative Image-Guided Surgery and Post-Operative Radiotherapy of Tumours | 2015 |
| 65 | INEXCA | Excellent research and expertise of quality of cancer care by internationally trained staff | 2015 |
| 66 | Immuno-NanoDecoder | Nanostructured molecular decoders for the quantitative, multiplexed, layer-by-layer detection of disease-associated proteins | 2015 |
| 67 | HYMADE | Hybrid Drug Delivery Systems upon Mesoporous Materials, Self Assembled Therapeutics and Virosomes | 2015 |
| 68 | GLYCANC | Matrix glycans as multifunctional pathogenesis factors and therapeutic targets in cancer | 2015 |
| 69 | LYMPHORG | Organ-specific mechanisms of lymphatic vascular development and specialisation | 2015 |
| 70 | NChIP | Chromatin dynamics during DNA replication | 2015 |
| 71 | GLYCO-TOOLS | Bio-Inspired Tools for Glycoscience | 2015 |
| 72 | CVDTEU | Clinical validation of the DiviTum assay in key European markets | 2014 |
| 73 | PRECEDE | PRECEDE: PancREatic Cancer Early DEtection | 2014 |
| 74 | BioGuidePCa | Biomarker Guided Prostate Cancer Management | 2014 |
| 75 | COMBPDCHEMOTHERAPY | Rational design of combined PDT photosensitizers and chemotherapeutic agent as new approach in cancer therapy: a computational approach | 2015 |
| 76 | OTULINVIVO | The role of OTULIN and Met1-linked ubiquitin in immune signaling and host defense in vivo | 2015 |
| 77 | EVOPRIMPOL | Artificial evolution of a novel multifunctional human polymerase | 2015 |
| 78 | Cancer-Drug-Screen | High-throughput drug screening for identifying personalized cancer treatments tailored to the particular mutations of the patient’s tumor | 2015 |
| 79 | Egg-Juvenate | Deciphering the roles of chromatin modifiers in germline aging | 2015 |
| 80 | Pharmcophore-DOS | Pharmacophore guided diversity-oriented synthesis and its application in discovering inhibitors of protein-protein interactions between RAD51 and BRCA2 | 2015 |
| 81 | Brain Metastases | The Role of Circulating Monocytes in the Development of Brain Metastases | 2015 |
| 82 | CONSORT | Controlled Singlet Oxygen Release Photosensitizers in Photodynamic Therapy | 2015 |
| 83 | BlaC E-assay | Portable electrochemical assay system for on-chip quantitative estimation of bladder cancer biomarkers in real samples | 2015 |
| 84 | CANCER-TECH | Cervical cancer detection platform based on novel laser processing | 2016 |
| 85 | STOPAPCG1IMP | Spatial-temporal regulation of APC/C, its role on G1 arrest and impact on terminal differentiation | 2015 |
| 86 | LARP4MOT | Structural and functional studies of LARP4, a new RNA binding protein involved in mRNA stabilisation and cell migration | 2016 |
| 87 | Leucophyl | Total Synthesis of Leucophyllidine | 2015 |
| 88 | GutILC3 | Cell-cell interactions critical to ILC3 function in the human gut | 2015 |
| 89 | miROMeS | miRNA biomarkers of Osseous Metastases in Serum from breast cancer patients | 2015 |
| 90 | EMCOP9CRL | Structural basis of Cullin-RING ligase regulation by the COP9 signalosome | 2015 |
| 91 | Cdc42Adhere | Role of Cdc42 in cancer cell adhesion to endothelial cells and platelets | 2015 |
| 92 | SingMet | Development of MRI contrast agents based on long-lived singlet states | 2015 |
| 93 | mini-liver SCCS | Human “mini-liver” stem cell culture systems: from mechanisms behind liver cancer origin and recurrence to new therapeutic treatments | 2016 |
| 94 | RADIOGENFF | RADIOGENOMICS: Finding Genetic Functional Variants Through Fine Mapping | 2016 |
| 95 | BaCTher | Bacteria for Cancer Therapy | 2015 |
| 96 | NPL | Synthesis of Natural Product Like Compounds for Drug Discovery | 2016 |
| 97 | Tolltum | Role, regulation and targeting of nucleic acid-sensing TLRs within the tumour microenvironment | 2015 |
| 98 | Class II PI3K | Characterization of the signalling and physiological roles of the class II PI3Ks | 2016 |
| 99 | Oncoworm | ONCOWORM: Using functional genomics in highly regenerative flatworms to find novel cancer genes | 2016 |
| 100 | HspAdhesion | Role of cell membrane associated Hsp70 in cancer cell adhesion and metastasis | 2015 |
| 101 | INAME | Imaging nucleic acid metabolism in cells | 2016 |
| 102 | SmartMammaCAD | Intelligent Automated System for detecting Diagnostically Challenging Breast Cancers | 2015 |
| 103 | NIMBLIS | Laser Induced Synthesis of Biocompatible Multifunctional Inorganic Nanoparticles: A Novel Route to Produce Multifunctional Contrast Agents for Early Diagnosis of Breast Cancer | 2016 |
| 104 | MINDFLY | Mid-IR ultrabroadbaNd thulium-doped Fiber Laser sYstems | 2016 |
| 105 | NextGen RiBiomics | Next Generation Proteomic Analysis of Pre-Ribosomal Proteome Dynamics Coupled to Glucose Metabolism in Caner Cells | 2016 |
| 106 | MRTGS | Mechanical regulation of tissue growth and signalling | 2016 |
| 107 | TARGEPILIVER | Characterization of Key Epigenetic Targets in Hepatic Fibrosis and Hepatocellular Carcinoma Development. Generation of New Antifibrotic and Antitumoral Drugs. | 2015 |
| 108 | STROMAMECH | Targeting stromal cells to modify tumor mechanical microenvironment and optimize drug delivery | 2015 |
| 109 | DC cancer | Development and immunological control of dendritic cell cancer | 2015 |
| 110 | SilentFACT | Functional networks and cancer roles of the essential histone chaperone FACT | 2015 |
| 111 | ICSIS | The interaction and clearance of senescent vascular cells by the innate immune system | 2015 |
| 112 | InVivo_DDR_ADPR | Decoding the DNA damage signalling in C. elegans by proteomic analyses of ADP-ribosylation | 2016 |
| 113 | WORMTUMORS | Worm power: Can helminths modify the development of colorectal cancer? | 2015 |
| 114 | SCARtool | Scattered radiation reduction tool to improve computer-aided diagnosis performance in digital breast tomosynthesis | 2015 |
| 115 | RNA-SHAPE | Structure and function of repeat-derived non-coding RNAs in epigenetic regulation of mammalian pericentric heterochromatin | 2015 |
| 116 | breast cancer dormancy | Molecular characterisation of a clinical model of estrogen receptor-positive breast cancer dormancy | 2015 |
| 117 | MHAtriCell | Hyaluronan-rich matrices crosslinked with collagen-like peptides for 3D culture of ovarian cancer cells | 2015 |
| 118 | MSMART | Margination of Microcapsules in Small Arteries | 2015 |
| 119 | CARiPSCTcells | Generation of safe and efficient, off-the-shelf, chimeric antigen receptor (CAR)-engineered T cells for broad application | 2015 |
| 120 | PATOX | Development of pyrrolizidine alkaloid detection methods for the assessment of food contamination and impact on human and animal health | 2016 |
| 121 | N-SHEAD | Nanoarrays: Self-assembled Hotspots for Enhanced Analyte Detection | 2015 |
| 122 | HAT-MOZ-sphere | Identification of genes and pathways regulated by the HAT activity of MOZ | 2015 |
| 123 | ChemoBOOM | Development of Palladium-Labile Prodrugs for Bioorthogonally-Activated Chemotherapy | 2016 |
| 124 | MYO-DESMOPLASIA | Modulating the behaviour of cancer myofibroblasts to control tumour desmoplasia | 2015 |
| 125 | jamclay | Chemical Tools to Probe the Role of Bromodomains in the Parasite Trypanosoma cruzi | 2016 |
| 126 | HGSOC | A novel approach into modeling origin and development of ovarian cancer | 2015 |
| 127 | RISH | Imaging of multiple mRNA targets using SERS nanoparticle labels and in situ hybridization in human cancer tissue sections | 2015 |
| 128 | GENMETASTEM | GENOMIC AND METABOLIC REGULATION OF METASTATIC CANCER STEM CELLS | 2016 |
| 129 | MACROIMAGING | Specific Fluorogenic Peptides for Imaging Metastasis-associated Macrophages | 2015 |
| 130 | NovLeuReg | Identification and characterization of novel essential regulators of acute myeloid leukemia | 2016 |
| 131 | OLIGOBINPRO | Non-canonical nucleoside incorporation into synthetic RNA-oligonucleotides: investigations towards the discovery of selective RNA-binding proteins | 2015 |
| 132 | CR-PHAGOCYTOSIS | Complement-mediated phagocytosis in neutrophils | 2015 |
| 133 | CICCI | Characterization of Intestinal Cancer Cell Invasion | 2015 |
| 134 | FiBRO | Fibroblasts in the Biology of Rectal Cancer Progression | 2016 |
| 135 | MatrixMacrophages | Matrix degrading macrophages in cancer growth and invasion | 2015 |
| 136 | BRIDGES | Bioinformatic approaches to identify and detect both disease- and drug-related genomic alterations in breast cancer patients | 2015 |
| 137 | ORSETOSY | Organocatalysis at the service of total synthesis: Madangamine alkaloids | 2015 |
| 138 | ACM | Cholesterol metabolism as a driver of prostate cancer aggressiveness | 2015 |
| 139 | EpiLIVER | Characterization and implications of DNA damage response in liver cancer | 2016 |
| 140 | HyHeat | Profiling gene expression in Hydra vulgaris following Gold Nanoparticle-mediated hyperthermia | 2015 |
| 141 | NEDRATS | New Enantioselective Desymmetrization Reactions in Alkaloid Total Synthesis | 2015 |
| 142 | SFSASP | Structural and Functional Studies of ATRX- Syndrome Protein | 2015 |
| 143 | Lx Micelles | Coordination chemistry in doubly stabilized micelles for the tageted delivery of cytostatic drugs in cancer therapy | 2015 |
| 144 | APOBEC | Enzymatic DNA deamination and the immunity/cancer balance | 2015 |
| 145 | WntTraffic | Characterising the spatial organisation and regulation of the Wnt receptor complex in stem cells and cancer | 2016 |
| 146 | TransVivome | Microbial biogeography of the gastrointestinal tract: Towards a better understanding of the drivers of oral and colorectal cancer development. | 2015 |
| 147 | RLOOP-AS | Interconnection between R-loops and co-transcriptional alternative splicing | 2015 |
| 148 | LYMPHOSIGN | Integrated study of the role of B-cell receptor signaling in the development of Follicular Lymphoma | 2015 |
| 149 | STRETCHLENS | Deformable platform with thin-film based circuits and ultra-thin Si chips for smart contact lens applications | 2016 |
| 150 | TITLY | Inhibition of the T-cell receptor signalling pathway for treatment of T-cell lymphoma | 2015 |
| 151 | MetAccembly | Accelerating metal-directed assembly, recognition and catalysis with computational methods | 2015 |
| 152 | PROVIST | PROTEASES VISUALIZATION DURING TUMOR PROGRESSION | 2016 |
| 153 | BRCA2Interact | Structural and biochemical characterization of pre-recombination complexes | 2015 |
| 154 | CHAT | Control of the Homeostasis of Actin through Time: actin homeostasis during embryonic development by means of single-molecule imaging and simulation in C. elegans | 2015 |
| 155 | HepatoRiSK | A new tumor suppressor role for RSK2 in hepatocellular carcinoma | 2015 |
| 156 | CARDIOTOX | Predicting Cardiotoxicity Induced by Kinase Inhibitors: From Systems Biology to Systems Pharmacology | 2015 |
| 157 | CELLETEST | Liquid Biopsy blood test in lung cancer diagnosis and monitoring: a next generation noninvasive tumor tracker device | 2015 |
| 158 | SENSITIVITYMARKERS | Clinical validation of prognostic biomarkers of chemotherapy response in liquid biopsies | 2015 |
| 159 | GWAFH | Emulsar: give the world appetite for health. | 2015 |
| 160 | MIRCAB | Validation of diagnostic and/or prognostic miRNAs in triple-negative breast cancer | 2015 |
| 161 | SixthSense | Early diagnosis of cervical cancer through the validation of Human Papilloma Virus viral load and expression of oncogenic viral proteins E6/E7 as risk indicators | 2015 |
| 162 | Diricore | Exploiting vulnerabilities in protein synthesis for cancer diagnosis and therapy | 2015 |
| 163 | BLOBREC | A gene expression test in blood for breast cancer | 2015 |
| 164 | XMED | Medical Phase Contrast X-ray Imaging with Laser Plasma Accelerator | 2015 |
| 165 | HYMEDNA | Hypermethylated DNA detection using NanoGaps | 2015 |
| 166 | Bio4Med | International Doctoral Programme in Biological Bases of Human Diseases | 2015 |
| 167 | SUMOblock | Blocking SUMO conjugation as drug discovery strategy. | 2015 |
| 168 | HYscreen | A fast, cost-effective breath analysis technology for Helicobacter pYlori screening at both large and small scale. | 2015 |
| 169 | LOUISA-3D | Clinical validation of Laser Optoacoustic Ultrasonic 3D Imaging System Assembly for breast cancer detection and characterization through endogenous biomarkers. | 2015 |
| 170 | URO-BEST | UROthelial carcinoma Biomarker based diagnostic tEST | 2015 |
| 171 | MAP-Detector | Development of a novel low dose, high resolution, high contrast X-ray detector for medical applications to improve patient diagnoses and reduce the risk of X-radiation induced cancer | 2015 |
| 172 | FGFSTAB | Industrial Production of Stable Fibroblast Growth Factors for Broad Therapeutic, Research, and Personal Care Applications | 2015 |
| 173 | PCMPS | Precision Cancer Medicine Pipeline and Services | 2015 |
| 174 | MD | Rapid monitoring of biomarkers in postoperative care | 2015 |
| 175 | EDePDAC | Feasibility study for the validation and industrialization of two diagnostic kits in both ELISA and CLIA formats for the early detection of pancreatic cancer based on the novel biomarkers EZR and ENOA | 2015 |
| 176 | MyNano | Towards the design of Personalised Polymer-based Combination Nanomedicines for Advanced Stage Breast Cancer Patients | 2015 |
| 177 | Evolutionary Neurogenomics | The impact of recent retrotransposon invasions on the evolution of human neural gene expression | 2015 |
| 178 | MEDICIS-PROMED | MEDICIS-produced radioisotope beams for medicine | 2015 |
| 179 | INPACT | Innovative peptides against cancer and pathogenic bacteria, with advances in science, biopharmaceutical drug development, product market targeting, training , and communication. | 2015 |
| 180 | PCSP | Odour-GPCRs based technology for detection and stratification of cancer: Prostate Cancer Smell Print as first vertical market | 2015 |
| 181 | NANOTAM | Development and Evaluation of Nanomedicines for Cancer Treatment through Immunomodulation: Targeting Tumor-Associated Macrophages | 2015 |
| 182 | iTampon | Intimate, home-diagnostic tools for women | 2015 |
| 183 | ONCOMECHAML | Common Oncogenic Mechanisms in Multi-Partner Translocation Families in Acute Myeloid Leukemia | 2015 |
| 184 | FAtoUnFRAGILITY | Fanconi anemia : a disease model to understand causes and consequences of common fragile site instability. | 2015 |
| 185 | VIRION | Viruses, Immune stimulation and RNA Interference in Oncology Network | 2015 |
| 186 | Enhancer ID | Identification and functional characterization of mammalian enhancers and transcriptional co-factors during cellular signaling and cell fate transitions | 2015 |
| 187 | MANGO | The determinants of cross-seeding of protein aggregation: a Multiple TANGO | 2015 |
| 188 | BrightSens | Ultrabright Turn-on Fluorescent Organic Nanoparticles for Amplified Molecular Sensing in Living Cells | 2015 |
| 189 | IRIS | Infrared imaging and sensing: the single-photon frontier | 2015 |
| 190 | PREVENT | Prostate cancer extracellular vesicles as biomarkers for nanomedicine treatment | 2015 |
| 191 | IntraMEMS | Microfluidic platform for intra-operative tumor immunohistochemistry | 2015 |
| 192 | DDRNA | DDRNA-based cancer therapy targeted telomeres | 2015 |
| 193 | CHROMAVISION | Super-resolution visualisation and manipulation of metaphase chromosomes | 2015 |
| 194 | INCIPIT | INnovative Life sCIence Phd Programme in South ITaly | 2016 |
| 195 | CAPTURE-CTC | A Streptavidin Microarray Platform for Capturing of Circulating Tumor Cells from the Blood of Cancer Patients | 2015 |
| 196 | Dermtest | An empowering toolkit for general practitioners to prevent, detect and treat melanoma (Dermtest) | 2015 |
| 197 | RAIL | Radiomics of lung cancer (RAIL): non-invasive stratification of tumour heterogeneity for personalised cancer therapy | 2015 |
| 198 | NanoPoreFab | On-chip fabrication of solid state nanopores for high throughput single molecule analysis | 2015 |
| 199 | ProCanEx | Prostate cancer diagnostic assay based on protein kinase activity profiling in exosomes | 2015 |
| 200 | ARTEMIDA | Advanced Regional Translation of Excellence into Medical Innovations for Delayed Aging | 2015 |
| 201 | Symbiotic | INNOVATIVE AUTONOMOUS ELECTRICAL BIOSENSOR SYNERGISTICALLY ASSEMBLED INSIDE A PASSIVE DIRECT METHANOL FUEL CELL FOR SCREENING CANCER BIOMARKERS | 2015 |
| 202 | QUANTEXBIO | Quantitative and Experimental Biology | 2015 |
| 203 | ChemoPredict | Predictive in vitro diagnostics test for individualized tailoring of chemotherapy in primary breast cancer | 2015 |
| 204 | proLungPlasma | Validation of a Lung Cancer Plasma Reflex Test Using Epigenetic Biomarker for Cancer Detection | 2015 |
| 205 | NanoPaths | Identifying pathways of cellular nanoparticle uptake and early processing for novel nanomedicine applications | 2015 |
| 206 | EpiTALL | Dynamic interplay between DNA methylation, histone modifications and super enhancer activity in normal T cells and during malignant T cell transformation | 2015 |
| 207 | MELGEN | MELanoma GENetics - understanding and biomarking the genetic and immunological determinants of melanoma survival | 2015 |
| 208 | IMMUTRAIN | Training Network for the Immunotherapy of Cancer | 2015 |
| 209 | REGiREG | Regulating the immune regulators: targeting adaptive immune control | 2015 |
| 210 | CONCERT | Description of information transfer across macromolecules by concerted conformational changes | 2015 |
| 211 | ZF-MEL-CHEMBIO | Chemical Biology in Zebrafish: Drug-Leads and New Targets in the Melanocyte Lineage and Melanoma | 2015 |
| 212 | VALID-SCREEN | Validation of PreCursor-M for enhanced Cervical (Pre)Cancer detection | 2015 |
| 213 | FoReCaST | Forefront Research in 3D Disease Cancer Models as in vitro Screening Technologies | 2015 |
| 214 | TransGeno | The ERA Chair for Translational Genomics and Personalized Medicine | 2015 |
| 215 | FRESCO | Efficient, Flexible Synthesis of Molecules with Tailored Shapes: from Photo-switchable Helices to anti-Cancer Compounds | 2015 |
| 216 | MammaPrint | Improved breast cancer care by innovative diagnostic test MammaPrint | 2015 |
| 217 | BLACANDI | BLACANDI can improve life quality and cut cost of diagnosing and managing bladder cancer in half | 2015 |
| 218 | platinDx | A test for predicting the efficacy of common platinum drugs enabling personalized chemotherapy for bladder cancer patients. | 2015 |
| 219 | IRSkin | IRSkin provides dermatologists a new dermatoscope, equipped with a software for visual comparisons in the diagnostic phase, performing a content based Image Retrieval from an a-priori built database. | 2015 |
| 220 | CSC-IS | Development of a more effective and safer therapeutic antibody for cancer treatment with a dual mechanism of action to eliminate CSCs and reactivate the tumour’s immune system. | 2015 |
| 221 | NANOSHOCK | Manufacturing Shock Interactions for Innovative Nanoscale Processes | 2015 |
| 222 | LIFEOMEGA | Innovative highly concentrated Omega 3 food supplement | 2015 |
| 223 | TEC_Pro | Molecular control of self-renewal and lineage specification in thymic epithelial cell progenitors in vivo. | 2015 |
| 224 | PROTEOMICAN | Discovery of breast cancer aggressiveness markers using topo-proteomics mapping | 2015 |
| 225 | BIOMENDELIAN | Linking Cardiometabolic Disease and Cancer in the Level of Genetics, Circulating Biomarkers, Microbiota and Environmental Risk Factors | 2015 |
| 226 | WoundCure | Personalized Wound Dressings Based on Nanofiber Mats | 2015 |
| 227 | LAUREN | bLadder cAncer URine cEll aNalysis | 2015 |
| 228 | LEONID | Lung cancEr fusiOn geNes: a new dIagnostic Device | 2015 |
| 229 | MetCAF | Uncovering the Role of Cancer Associated Fibroblasts in Facilitating Breast Cancer Metastasis | 2015 |
| 230 | SPICE | Synthetic Lethal Phenotype Identification through Cancer Evolution Analysis | 2015 |
| 231 | PROMETHEUS | Novel Cells for Organ Repair | 2015 |
| 232 | STARS | Strategies Targeting Thyroid Hormone in Athrophy Related Syndromes | 2015 |
| 233 | AutoRecon | Molecular mechanisms of autophagosome formation during selective autophagy | 2016 |
| 234 | CilDyn | Molecular analysis of the Hedgehog signal transduction complex in the primary cilium | 2015 |
| 235 | LEGO | Multimodal glycoconjugates: a molecular Lego approach for antitumoral immunotherapy | 2015 |
| 236 | TARLOOP | R-loops as a major modulator of transcription-associated recombination and chromatin dynamics | 2015 |
| 237 | IMMPACT | Clinical validation of a serum protein biomarker signature for the early diagnosis of pancreatic cancer. | 2015 |
| 238 | CaSR Biomedicine | Calcium-Sensing Receptor (CaSR): Therapeutics for Non-Communicable Diseases | 2016 |
| 239 | spim4You | spim4You: customised solutions for light sheet microscopes and imaging data analysis. | 2015 |
| 240 | HAP-PHEN | From haplotype to phenotype: a systems integration of allelic variation, chromatin state and 3D genome data | 2015 |
| 241 | MeLiLoN | Metabolic Networks that Link Longevity to Reproduction in Response to Nutrition | 2015 |
| 242 | COMAL | COMAL:COhesin Mutations in Acute Leukemia: from modeling and mechanisms to novel therapeutics | 2015 |
| 243 | NANOBUBBLE | Laser-induced vapour nanobubbles for intracellular delivery of nanomaterials and treatment of biofilm infections | 2015 |
| 244 | UNEXPECTED | Uncovering targets for ex vivo expansion of hematopoietic stem cells to enhance cell therapies of blood disorders | 2015 |
| 245 | DNA2REPAIR | DNA strand break repair and links to human disease | 2015 |
| 246 | PHII | PTX3 in Humoral Innate Immunity | 2015 |
| 247 | TRIGGDRUG | Reactions That Translate mRNA into Drug-like Molecules | 2016 |
| 248 | LineageDiscovery | Laying the Biological, Computational and Architectural Foundations for Human Cell Lineage Discovery | 2015 |
| 249 | ZAUBERKUGEL | Fulfilling Paul Ehrlich’s Dream: therapeutics with activity on demand | 2015 |
| 250 | ProteinConjugates | A training network for the chemical site-selective modification of proteins: Preparation of the next-generation of therapeutic chemically-defined protein conjugates | 2015 |
| 251 | MASSTRPLAN | MASS Spectrometry TRaining network for Protein Lipid adduct ANalysis | 2015 |
| 252 | TASPPI | Targeted small-molecule Stabilisation of Protein-Protein Interactions | 2016 |
| 253 | OMA | Optimization of Medical Accelerators | 2016 |
| 254 | Phd | Deciphering PI3K biology in health and disease | 2015 |
| 255 | ISPIC | Image-Guided Surgery (IGS) and Personalised Postoperative Immunotherapy To Improving Cancer Outcome | 2016 |
| 256 | HaemMetabolome | Deciphering the Metabolism of Haematological Cancers | 2015 |
| 257 | GlyCoCan | Exploiting Glycosylation of Colorectal Cancer for the development of improved diagnostics and therapeutics | 2015 |
| 258 | p38Cure | New breast cancer therapies based on available p38 MAPK inhibitors | 2015 |
| 259 | INTESTINANOS | Intestinal Lipoidal Nanostructures - A Lipid Bridge to Increased Drug Delivery | 2015 |
| 260 | CholangioConcept | Functional in vivo analysis of cholangiocarcinoma development, progression and metastasis. | 2015 |
| 261 | PERIF | Perivascular cells at the crossroads of inflammation, regeneration and fibrosis | 2015 |
| 262 | IL7sigNETure | IL-7/IL-7R signaling networks in health and malignancy | 2015 |
| 263 | Cancer-Recurrence | Tumor cell death supports recurrence of cancer | 2015 |
| 264 | PROTEOMICS4D | Proteomics 4D: The proteome in context | 2015 |
| 265 | HEPCIR | Cell circuits as targets and biomarkers for liver disease and cancer prevention | 2016 |
| 266 | PolarNet | Principles of Polarity – Integrating genetic, biophysical and computational approaches to understand cell and tissue polarity | 2015 |
| 267 | TRAIN-ERS | Endoplasmic Reticulum Stress in Health and Disease | 2015 |
| 268 | ULTIMA | ULTrafast Imaging sensor for Medical Applications | 2015 |
| 269 | FrEBT | Improving diagnostics of respiratory diseases and boosting the COMAC MEDICAL Ltd. competitiveness and growth by validation of fractional EBT biomarker through new method of measurement and device | 2015 |
| 270 | NOVLASE | Novel light sources for biomedical-imaging applications | 2015 |
| 271 | EPIGEN | EPIGEN: A New Predictive Response Test for Non Small Cells Lung Cancer Treatment | 2015 |
| 272 | NutrientSensingVivo | The Physiology of Nutrient Sensing by mTOR | 2016 |
| 273 | DeFiNER | Nucleotide Excision Repair: Decoding its Functional Role in Mammals | 2016 |
| 274 | CRADLE | Cancer treatment during pregnancy: from fetal safety to maternal efficacy | 2015 |
| 275 | PLASMA | Running away and radiating | 2015 |
| 276 | TOPOmics | Global dynamics of topoisomerase-induced DNA breaks | 2015 |
| 277 | StemNicheOnWaveCrest | New therapies for myeloproliferative diseases based on multi-stage and -system analyses of the haematopoietic stem-cell niche | 2015 |
| 278 | RNAEDIT | RNA EDITING IN HEALTH AND DISEASE | 2016 |
| 279 | Colodetect | Development of a novel blood-based diagnostic test for colorectal cancer | 2015 |
| 280 | CELLPLASTICITY | New Frontiers in Cellular Reprogramming: Exploiting Cellular Plasticity | 2015 |
| 281 | MASCP | Mechanisms of alternative pre-mRNA splicing regulation in cancer and pluripotent cells | 2015 |
| 282 | uPET | Molecular imaging and targeted therapy of the aggressive phenotype: development of uPAR theranostics for cancer patients | 2015 |
| 283 | SENTINEL | HIV-1 sensing and signaling in dendritic cells | 2015 |
| 284 | AVATAR | Integrating Genomics and Avatar Mouse Models to Personalize Pancreatic Cancer Treatment | 2015 |
| 285 | COMbAT | Commercialization of a novel tool for designing personalized nOvel MelAnoma Therapies | 2015 |
| 286 | EPOCH28 | Epigenetic Profiling of Chemotherapy Efficacy | 2015 |
| 287 | SLACC | Supplying lung adenocarcinoma cell lines to the cancer research community. | 2015 |
| 288 | AcTafactors | AcTafactors: Tumor Necrosis Factor-based immuno-cytokines with superior therapeutic indexes | 2015 |
| 289 | CellScreenChip | All-in-One Cell Screening Chip: Device for Affordable High-Throughput Cell Screenings | 2015 |
| 290 | BioBarPro | A Hot-Spot Bio-Barcode Strategy for Prognostic Biomarkers In Colorectal Cancer | 2015 |
| 291 | TackSHS | Tackling secondhand tobacco smoke and e-cigarette emissions: exposure assessment, novel interventions, impact on lung diseases and economic burden in diverse European populations. The TackSHS Project. | 2015 |
| 292 | SmokeFreeBrain | Multidisciplinary tools for improving the efficacy of public prevention measures against smoking | 2015 |
| 293 | BIOVALID | Clinical validation of the DiviTum assay in two high profile clinical studies in Europe | 2015 |
| 294 | AM-SENSE | A Rapid Point-of-Care Breath Ammonia Sensor for Diagnosis of Helicobacter Pylori | 2015 |
| 295 | ONCOCHECK | A simple blood test to monitor disease progression in patients undergoing cancer therapy | 2015 |
| 296 | EPICHECK | Detection of Various Cancer Types for Screening and Diagnosis through Blood Samples with Epigenetic Biomarkers Panels | 2015 |
| 297 | CANDLE | Cancer Diagnosis by Multiplex Protein Epitope Profiling | 2015 |
| 298 | Tomo-FPS | Tomosynthesis is a low-dose alternate to has CT already transformed Breast Imaging, our vision is to reduce the costs, further enhance sensitivity and reduce dose, and transform portability. | 2015 |
| 299 | UNIBIO | TK210 ELISA – universal serum protein biomarker for cancer screening, diagnosis, treatment response monitoring and early detection of relapse (UNIBIO) | 2015 |
| 300 | CYTOPRO | Profiling of tumour cells in blood for personalized treatment of metastatic cancer | 2015 |
| 301 | VALPAS | VALidation of human PApilloma virus assays on Self-collected first void urine samples | 2015 |
| 302 | MARA | Molecular Analytical Robotics Assays | 2015 |
| 303 | ARVisS | Augmented Reality Vision for Surgery | 2015 |
| 304 | FAST SPECTRO | Spatially Multiplexed Spectrophotometry | 2015 |
| 305 | RCC-TEST | A breakthrough in Renal Cell Carcinoma: Personalized RCC-Test | 2016 |
| 306 | TRANSBIO | A BIOmarker-based assay for prognosis and monitoring in renal TRANSplantation | 2015 |
| 307 | LeukoPredict | LeukoPredict: an in vitro system predicting and monitoring the therapeutic response of patients in the cure of Chronic Myeloid Leukemia (CML). | 2016 |
| 308 | ThyroTrust | A novel reliable diagnostic device to avoid unnecessary thyroid surgery | 2016 |
| 309 | ClearPEMplus | Enhanced Silicon Photomultiplier-based detectors for high-resolution Positron Emission Mammography. | 2015 |
| 310 | iMPACT | innovative Medical Protons Achromatic Calorimeter and Tracker | 2016 |
| 311 | OCProDx | Strategic planning for commercialisation of a multiplexed protein diagnostic (Dx) blood test for Organ-Confined Prostate cancer: OCProDx | 2016 |
| 312 | CODIC | COmmercializing first-in-class dCTPase Inhibitors for treatment of hematological Cancers | 2016 |
| 313 | AcetyLys | Unravelling the role of lysine acetylation in the regulation of glycolysis in cancer cells through the development of synthetic biology-based tools | 2016 |
| 314 | ThDEFINE | Re(defining) CD4+ T Cell Identities One Cell at a Time | 2016 |
| 315 | INFANTLEUKEMIA | GENOMIC, CELLULAR AND DEVELOPMENTAL RECONSTRUCTION OFINFANT MLL-AF4+ ACUTE LYMPHOBLASTIC LEUKEMIA | 2016 |
| 316 | rEnDOx | REDOX SIGNALING AND METABOLIC STATES IN ANGIOGENESIS IN HEALTH AND DISEASE | 2016 |
| 317 | PanCaT | Next-generation in vivo models for improved pancreatic cancer therapies | 2016 |
| 318 | HYPERDIAMOND | The Diamond Revolution in Hyperpolarized MR Imaging – Novel Platform and Nanoparticle Targeted Probe | 2016 |
| 319 | HYPMED | Digital Hybrid Breast PET/MRI for Enhanced Diagnosis of Breast Cancer | 2016 |
| 320 | Angiolnc | Endothelial long non-coding RNAs | 2016 |
| 321 | HERCULES | Comprehensive characterization and effective combinatorial targeting of high-grade serous ovarian cancer via single-cell analysis | 2016 |
| 322 | GLINT | GlucoCEST Imaging of Neoplastic Tumours | 2016 |
| 323 | MIB | Multi-modal, Endoscopic Biophotonic Imaging of Bladder Cancer for Point-of-Care Diagnosis | 2016 |
| 324 | CARAT | Chimeric Antigen Receptors (CARs) for Advanced Therapies | 2016 |
| 325 | FORCE | Imaging the Force of Cancer | 2016 |
| 326 | IDentIFY | Improving Diagnosis by Fast Field-Cycling MRI | 2016 |
| 327 | ChiLTERN | Children’s Liver Tumour European Research Network | 2016 |
| 328 | Organoid | Dissecting microbiome and immune interactions in human intestinal (cancer) organoids | 2015 |
| 329 | ADOPT BBMRI-ERIC | implementAtion anD OPeration of the gateway for healTh into BBMRI-ERIC | 2015 |
| 330 | CFS modelling | Chromosomal Common Fragile Sites: Unravelling their biological functions and the basis of their instability | 2016 |
| 331 | Bcl-Inhib | Discovery of Bcl-3 inhibitors as Potential Chemopreventive Agent for skin cancer | 2015 |
| 332 | CONQUEST | Companion Nanodiagnostics for Quantifying EPR and Stratifying Patients to Targeted Nanotherapies | 2016 |
| 333 | MURAB | MRI and Ultrasound Robotic Assisted Biopsy | 2016 |
| 334 | LUCA | Laser and Ultrasound Co-Analyzer for thyroid nodules | 2016 |
| 335 | Endoo | Endoscopic versatile robotic guidance, diagnosis and therapy of magnetic-driven soft-tethered endoluminal robots | 2015 |
| 336 | NEVERMIND | NEurobehavioural predictiVE and peRsonalised Modelling of depressIve symptoms duriNg primary somatic Diseases with ICT-enabled self-management procedures | 2016 |
| 337 | DESIREE | Decision Support and Information Management System for Breast Cancer | 2016 |
| 338 | miRNA-DisEASY | microRNA biomarkers in an innovative biophotonic sensor kit for high-specific diagnosis | 2015 |
| 339 | EPIC | Exploiting Protein Complexes that Induce Cell-death | 2016 |
| 340 | CARTHER | Carbon-based nano-materials for theranostic application | 2016 |
| 341 | PELICO | Peptidomimetics with photocontrolled biological activity | 2016 |
| 342 | STREAM | Strategies towards Excellence in Immuno-Oncology | 2016 |
| 343 | VACTRAIN | TWINNING ON DNA-BASED CANCER VACCINES | 2016 |
| 344 | ReTuBi | Towards outstanding research and training in tumour biology at IMM | 2016 |
| 345 | CerISMA | Cerenkov Imaging for Surgical Margin Assessment | 2015 |
| 346 | OncoMasTR | OncoMasTR - Novel Prognostic Assay for Early Stage Breast Cancer | 2016 |
| 347 | GROWTHPATTERN | Coordination Of Patterning And Growth In The Spinal Cord | 2016 |
| 348 | REDOXCYCLE | The molecular interface between cell cycle and redox regulation | 2016 |
| 349 | DYNA-MIC | Deep non-invasive imaging via scattered-light acoustically-mediated computational microscopy | 2016 |
| 350 | Liqbiopsens | Reliable Novel Liquid Biopsy technology for early detection of colorectal cancer | 2016 |
| 351 | PolyDrug Discovery | Discovery of anticancer polymeric drugs that mimic the action of TRAIL | 2016 |
| 352 | FourCmodelling | Conflict, Competition, Cooperation and Complexity: Using Evolutionary Game Theory to model realistic populations | 2016 |
| 353 | PrECISE | PERSONALIZED ENGINE FOR CANCER INTEGRATIVE STUDY AND EVALUATION | 2016 |
| 354 | MAINTRAC-Auto | MAINTRAC-Auto: Automatization and validation of a liquid biopsy assay “Maintrac-AUTO CTC-analyser” for predictive real time monitoring and success control of solid tumor cancer therapy | 2016 |
| 355 | GvHDCure | Understanding the dynamics of the immune system to cure graft-versus-host disease (GvHD). | 2016 |
| 356 | EDEN2020 | Enhanced Delivery Ecosystem for Neurosurgery in 2020 | 2016 |
| 357 | PEPTO1 | Feasibility study of a novel treatment for cancer based on a recombinant peptide therapy | 2016 |
| 358 | OptiQ-CanDo | Hybrid Optical Interferometry for Quantitative Cancer Cell Diagnosis | 2016 |
| 359 | NanoIntra | Multitasking Nanoparticles for Intracellular Bioimaging and Biosensing | 2017 |
| 360 | ICARO | Colloidal Inorganic Nanostructures for Radiotherapy and Chemotherapy | 2016 |
| 361 | TROJANANOHORSE | Hybrid immune-eluding nanocrystals as smart and active theranostic weapons against cancer | 2016 |
| 362 | LDC4PCaTher | BMX-targeted ligand-drug conjugates for prostate cancer therapy | 2016 |
| 363 | PRIMASE_NMR | Visualizing Primase Initiating DNA Replication using NMR Spectroscopy | 2016 |
| 364 | ThruBlood | Clinical validation of Trop-2 as a serum biomarker for monitoring of disease-course in patients affected by breast and colon cancer | 2016 |
| 365 | CMIL | Crosstalk of Metabolism and Inflammation | 2016 |
| 366 | EVI1inCancer | Overcoming the epigenetic and therapeutic barrier of EVI1-overexpressing cancers | 2016 |
| 367 | MetamorphChip | Dynamic Microfluidic Structures for Analysis of Single Cell Systems | 2016 |
| 368 | HOLDING-HANDS | Holding hands: cell-cell junctions in breast cancer metastasis and resistance to therapy | 2016 |
| 369 | ChemBioAP | Elucidation of autophagy using novel chemical probes | 2016 |
| 370 | DIALOY | Mosaic loss of chromosome Y (LOY) in blood cells - a new biomarker for risk of cancer and Alzheimer’s disease in men | 2016 |
| 371 | BARCODE DIAGNOSTICS | Next-Generation Personalized Diagnostic Nanotechnologies for Predicting Response to Cancer Medicine | 2016 |
| 372 | G-EDIT | Mechanisms of RNA-guided genome editing in eukaryotes | 2016 |
| 373 | PreventStoCan | Understanding microbe-induced stomach cancer – the key to a workable strategy for worldwide prevention | 2016 |
| 374 | TARG-SUP | Targeting TGF-β activation, likely the core mechanism of immunosuppression by human regulatory T cells. | 2016 |
| 375 | NoCanTher | Nanomedicine upscaling for early clinical phases of multimodal cancer therapy | 2016 |
| 376 | PRECIOUS | Scaling-up biodegradable nanomedicines for multimodal for multimodal precision cancer immunotherapy | 2016 |
| 377 | CanPathPro | Generation of the CanPath prototype - a platform for predictive cancer pathway modeling | 2016 |
| 378 | DEMETROPIS | Degradation of ozone-depleting methyl halides in the troposphere characterized by isotopes | 2016 |
| 379 | IMAGINE | Widefield Raman imaging probe for intraoperative margin assessment of cancers | 2016 |
| 380 | M6Abolic-RNA-duplex | Metabolic control of RNA-protein and RNA-RNA interactions in cellular transformation. | 2016 |
| 381 | microMAGNETOFLUIDICS | 3D-printed magnetic microfluidics for applications in life sciences | 2016 |
| 382 | G4-PTROs | Regulatory network of G-quadruplex dependent Post-Transcriptional mRNA Operons (PTROs) | 2016 |
| 383 | EPILIPRO | Elucidating the role of Arid1a in adult liver | 2016 |
| 384 | MCNTMTDC | Metabolic control on NF-κB activity during dendritic cells-mediated immune tolerance to tumours | 2017 |
| 385 | FORECAST | Fluorescence lifetime optical biopsy system | 2017 |
| 386 | MTUB-ANGIO | Microtubule Dynamics during angiogenesis | 2016 |
| 387 | iGEMMdev | Development and Characterisation of New Immunogenic GEMMs of Lung Cancer | 2017 |
| 388 | PrecTherLSCC | Precision Therapies in Lung Squamous Cell Carcinoma | 2016 |
| 389 | CAP-CANCER | Cold atmospheric plasma treatment for effective cancer cell apoptosis | 2016 |
| 390 | DynOMIS | Dynamic Origins of MHC class I Selector function | 2016 |
| 391 | MCNANO | “Multi-component nanoparticles as bimodal contrast agents for MRI and optical detection of tumors and for targeted photodynamic therapy” | 2016 |
| 392 | SmartCubes | An innovative class of nanoparticles (“SmartCubes”) for the targeted delivery of protein therapeutics | 2016 |
| 393 | PDA_TGFb | TGF-beta mediated crosstalk between cancer (stem) cells and tumor microenvironment in pancreatic cancer metastasis | 2017 |
| 394 | MIRNANO | Multifunctional miRNA-targeting nanodevices for pluripotent cancer theranostics | 2017 |
| 395 | RecInRep | Beyond double-strand break repair: specific mechanisms of homologous recombination at stressed replication forks. | 2016 |
| 396 | INTEGRISTEM | Functions of Integrins in Mammary Stem Cell Activity and Tumorigenesis | 2016 |
| 397 | DNA Pol III | How single DNA polymerases make decisions during proofreading | 2016 |
| 398 | MPSC | Membrane Potential and Stem Cell Potency in Normal and Malignant Tissues | 2016 |
| 399 | NuSiCC | Modelling the therapeutic potential of NUAK1 suppression in colorectal cancer | 2016 |
| 400 | INTO | Inorganic therapeutic nanoparticles for osteoporosis | 2016 |
| 401 | SMART-LANLIGHT | New Scanning nearfield Microscopy method bAsed on Radio-frequency Trap and LANthanide nanoprobe for LIGHT matter interaction. | 2016 |
| 402 | MolecularEVOLUTION | Molecular Evolution of the Primary Structure of Single Chain Polymer Nanoparticles via Dynamic Covalent Chemistry | 2016 |
| 403 | PepPtNPAntiCan | Peptide Coated Platinum Nanoparticles as Antitumor Agents | 2016 |
| 404 | PIM PROTEOMICS | Unravelling PIM kinase signal integration in the T cell response | 2017 |
| 405 | DISTRICT | DECIPHERING THE ROLE OF TRIB1 IN REGULATORY T CELLS | 2017 |
| 406 | AVITAG | Alphaviral Immunotherapy against Glioblastoma | 2016 |
| 407 | ADHERE | Aptamer nanostructures dual-targeted to the HER receptor family for cancer therapy | 2016 |
| 408 | PERICYTEStroma | Pericyte-derived tumor stroma – a target for cancer therapy | 2016 |
| 409 | MECHANOCHECK | ATR-mediated mechanotransduction and connections with the actin cytoskeleton | 2016 |
| 410 | ENVERESP | Crosstalk between nuclear envelope and DNA Damage Response: Role of nucleoporin TPR in the maintenance of genomic integrity | 2016 |
| 411 | NIR-BIO-FLU | Bio-conjugatable and Bio-responsive Near Infrared Fluorochromes | 2016 |
| 412 | RAC | Defining the Role of Antioxidants on Cancer progression and metastasis | 2016 |
| 413 | BiominAB-3D | Revealing the composition and formation mechanism of carcinogenic asbestos bodies in human lungs | 2016 |
| 414 | THERAGEL | Development of a chemotherapeutic gel for glioblastoma multiforme treatment | 2016 |
| 415 | HeartAtaK | Targeting the Anti-Target: From Structure to Drug in the heart Kv11.1 channel | 2016 |
| 416 | EXACT | Identifying biomarkers of Exposure leading to Lung Cancer with Adductomics | 2016 |
| 417 | POL2-TFIID | The impact of TFIID on the transcription initiation machinery – a structural perspective. | 2016 |
| 418 | HeteroCancerInvasion | Effect of heterogeneity of cancer cells on collective invasion | 2016 |
| 419 | BiOp-FibEnd | Biopsy equivalent Optical Fiber multifunctional Endoscope | 2016 |
| 420 | Lipid and Polarity | The diffusion and nanoclustering of a polarity module in the lipid environment | 2016 |
| 421 | EC GNG metabolism | Endothelial Gluconeogenesis: a novel target for tumor anti-angiogenesis? | 2017 |
| 422 | t-Clinic | An innovative medical device for early diagnosis based on a disruptive body temperature monitoring and analysis scheme-t-Clinic | 2016 |
| 423 | OMIS | Feasibility study on Opto-Magnetic Imaging Spectroscopy for cancer screening | 2016 |
| 424 | CORNposite | Valorisation of corn processing by-products into plastic bio-composites | 2016 |
| 425 | ProstaPalp | Feasibility study to evaluate a novel prostate cancer diagnostic | 2016 |
| 426 | TBIA | Next generation breast and colorectal cancer screening through simple and accurate blood testing. | 2016 |
| 427 | NEBU-ONE | NEBU-ONE : A revolutionary method for anatomic pathology slides staining | 2016 |
| 428 | iBILD | iBILD: Imaging Biomarker for Intelligent Lung Cancer Detection | 2016 |
| 429 | LDMBI | Low dose Molecular Breast Imaging for improved cancer detection in dense breast tissue. | 2016 |
| 430 | OSTEOMET | Clinical Validation of a Novel Biomarker for the Prediction of Bone Metastasis in Early Stage Breast and Prostate Cancer | 2016 |
| 431 | MRCKa in cancer | Targeting Cancer Cell Invasion and Metastasis by Inhibition of the Serine Kinase MRCKa | 2016 |
| 432 | ChondUb | Identification and characterisation of novel WWP2 substrates and their role in chondrogenesis and osteoarthritis | 2016 |
| 433 | NanoPorous DNA-array | Ultra-high density three dimentional DNA arrays for biosensing | 2016 |
| 434 | OPTIM | Optimized drug combinations for effective cancer treatment: a personalised approach. | 2016 |
| 435 | SYNVIA | Synthetic viability of homologous recombination-deficient cancers | 2016 |
| 436 | TSGPs-of-CFSs | Role of Tumour Suppressor Gene Products of Common Fragile Sites in Human Diseases | 2016 |
| 437 | NanoPokers | Deciphering cell heterogeneity in tumors using arrays of nanowires to controllably poke single cells in longitudinal studies | 2016 |
| 438 | ONCOINTRABODY | Targeting common oncogenes with intracellular monobodies | 2016 |
| 439 | IdrSeq | Discovery and characterization of functional disordered regions and the genes involved in their regulation through next generation sequencing | 2016 |
| 440 | DECODE | Allele-specific Deconvolution of Tumour DNA Methylation and Expression Data toReveal Underlying Cell Populations | 2016 |
| 441 | Wnt and CRC | Therapeutic inhibition of the oncogenic Wnt/beta-catenin pathway in mismatch repair deficient hypermutant tumors | 2017 |
| 442 | FLUORODRUGS | Smart Theranostic Agents for the Tumour Microenvironment | 2017 |
| 443 | WntELECT | Wnt Enhancer LandscapE CharacTerization | 2016 |
| 444 | DLL4-LVN | Targeting the (pre)metastatic lympho-vascular niche: molecular mechanisms and therapeutic implications in melanoma | 2017 |
| 445 | MESO-JBIR-102 | Development of the aza-Prins reaction; synthesis and biological evaluation of JBIR-102 | 2016 |
| 446 | TRISCPOL | The role of the iron-sulpur cluster in human DNA polymerase delta | 2016 |
| 447 | ANGIO-IMAGE | ANGIO-tracer for immuno-PET imaging: a stratification and monitoring tool for anti-angiogenesis treatment | 2016 |
| 448 | Immune Regulation | How Infection History Shapes the Immune System: Pathogen-induced Changes in Regulatory T Cells | 2016 |
| 449 | KILLCANCER | Nanobody-targeted photodynamic therapy to kill cancer | 2016 |
| 450 | Ubl-Code | Revealing the ubiquitin and ubiquitin-like modification landscape in health and disease | 2016 |
| 451 | EpigenomeProgramming | An experimental and bioinformatic toolbox for functional epigenomics and its application to epigenetically making and breaking a cancer cell | 2016 |
| 452 | CELLFUSION | Molecular dissection of the mechanisms of cell-cell fusion in the fission yeast | 2016 |
| 453 | GUIDESIGINT | Competitive assembly dynamics of the DCC receptor with its guidance cues integrates signals for cellular steering | 2017 |
| 454 | HEAL-BY-MIRNA | microRNA replacement therapy for mature B cell neoplasias | 2016 |
| 455 | nextDART | Next-generation Detection of Antigen Responsive T-cells | 2016 |
| 456 | CentSatRegFunc | Dissecting the function and regulation of centriolar satellites: key regulators of the centrosome/cilium complex | 2016 |
| 457 | CLONCELLBREAST | CLONAL AND CELLULAR HETEROGENEITY OF BREAST CANCER AND ITS DYNAMIC EVOLUTION WITH TREATMENT | 2017 |
| 458 | CoSMaS | Developing an interdisciplinary Collaborative Self-Management Support model: behavioural and communication tools for integrated care | 2017 |
| 459 | AMECRYS | Revolutionising Downstream Processing of Monoclonal Antibodies by Continuous Template-Assisted Membrane Crystallization | 2016 |
| 460 | cryo-bacteria-reactor | Development of the flow through bioreactor of 3D-structured bacteria for biodegradation of aromatic chloroderivatives from contaminated water | 2016 |
| 461 | FIBROCAN | Defining the immunological interplay between fibroblastic reticular cells and anti-tumour T cells | 2016 |
| 462 | NANOTER | Development of Ultra-Sensitive Nanotherapeutic Anticancer Agents for Boron Neutron CaptureTherapy | 2016 |
| 463 | EpiTarget | Epigenome-targeted therapy for cholangiocarcinoma. | 2017 |
| 464 | NEURAM | Visual genetics: establishment of a new discipline to visualize neuronal nuclear functions in real-time in intact nervous system by 4D Raman spectroscopy | 2016 |
| 465 | IMCIS | Individualised medicine in chronic inflammatory skin diseases | 2016 |
| 466 | NanoSCAN | Developing multi-modality nanomedicines for targeted annotation of oncogenic signaling pathways | 2016 |
| 467 | PeptiCrad | Personalized oncolytic vaccines for cancer immunotherapy | 2016 |
| 468 | TiDrugArchitectures | Highly Competent and Safe Titanium(IV) Therapeutic Frameworks that are Cancer Targeted based on Complex 1, 2, and 3D Chemical Architectures | 2016 |
| 469 | CIL2015 | Dissecting the cellular mechanics of contact inhibition of locomotion | 2016 |
| 470 | iCARE | MobIle health-Care system for monitoring toxicity and symptoms in cAncer patients ReceivingdiseasE-oriented therapy | 2016 |
| 471 | iGOLDD | Commercialising MR-HIFU: an Image-Guided Local Drug-Delivery Platform | 2016 |
| 472 | OWISE4EU | OWise for Europe - A feasibility study of a pan-European mobile app providing people with cancer with useful tools and treatment information in one easily accessible place. | 2016 |
| 473 | BloodStemPLUS | Commercial feasibility study of a technology that multiplies blood stem cells to increase the success of transplants for cancer treatment | 2016 |
| 474 | OPTIMIsE | Commercial feasibility of the Novio-PlainGel: a novel synthetic, reversible thermosensitive, biomimetic hydrogel for organoid-based precision medicine | 2016 |
| 475 | Tamed Cancer | Personalized Cancer Therapy by Model-based Optimal Robust Control Algorithm | 2016 |
| 476 | REPLICONSTRAINTS | Dissecting the constraints that define the eukaryotic DNA replication program | 2016 |
| 477 | CHEMCHECK | CHECKPOINTS IN CHECK: Novel Chemical Toolbox for Local Cancer Immunotherapy | 2016 |
| 478 | MitoVin | Mechanism and Consequences of the Interplay between Mitosis and Human Papillomavirus Initial Infection | 2016 |
| 479 | HepatoMetaboPath | Cellular and molecular mechanisms of metabolic immune activation triggering non-alcoholic steatohepatitis (NASH) and HCC | 2016 |
| 480 | Immune-senescence | Dual targeting of senescence and tumor immunity for cancer therapy | 2016 |
| 481 | pocL-CI | A lab-on-chip platform for blood cell counting and identification at the point-of-care | 2016 |
| 482 | STEM-BCPC | Signal Transduction and Epigenetic Mechanisms of Breast Cell Plasticity and Cancer | 2016 |
| 483 | PCFENCM | Pan-cancer functional evaluation of non-coding DNA mutations | 2017 |
| 484 | TagIt | A Minimal-Tag Bioorthogonal Labelling Approach to Protein Uptake, Traffic and Delivery | 2016 |
| 485 | DrugSynergy | DrugSynergy: A data-driven systems biology approach to optimize drug combination strategies | 2016 |
| 486 | LeukaemiaTargeted | Selecting genetic lesions with essential function for patients' leukaemia in vivo as targets for precision medicine | 2016 |
| 487 | TENSION | Targeting replication stress recovery pathways in oncology | 2016 |
| 488 | PLEIO-RANK | Pleiotropic treatment of cancer: RANK inhibitors targeting cancer stem cells and immunity | 2016 |
| 489 | PERMIDES | Personsalised Medicine Innovation through Digital Enterprise Solutions | 2016 |
| 490 | GeCo | Data-Driven Genomic Computing | 2016 |
| 491 | CDK6-DrugOpp | CDK6 in transcription - turning a foe in a friend | 2016 |
| 492 | ZMOD | Blood Vessel Development and Homeostasis: Identification and Functional Analysis of Genetic Modifiers | 2016 |
| 493 | TNT-TUMORS | Therapeutic approaches to enhance innate immunity against Tumors | 2016 |
| 494 | SIDSCA | Defective DNA Damage Responses in Dominant Neurodegenerative Diseases | 2016 |
| 495 | RespeCT | Respiratory Disease Screening with Dark-Field Computed Tomography | 2016 |
| 496 | TAROX | Targeting oxidative repair proteins for treatment of cancer and inflammation | 2016 |
| 497 | GBM-CPP | Developing an anti-Myc cell-penetrating peptide for cancer treatment | 2016 |
| 498 | AngioResist | Coordinated Development of Inhibitors and Biomarkers for Resistance to Antiangiogenics in Cancer - AngioResist | 2016 |
| 499 | GlioDx | GlioDx - Blood platelet-based monitoring and treatment optimisation for glioblastoma patients | 2016 |
| 500 | PFKFBLOCK | Translating fundamental insights in endothelial metabolism: PFKFB3 drug discovery and development | 2016 |
| 501 | INTHER | Clinical validation and commercialization of innovative immunostimulating Interstitial Laser Thermotherapy | 2016 |
| 502 | LASER-HISTO | In vivo histology using femtosecond laser multiphoton tomograph for the early diagnosis of skin cancer and corneal diseases while simultaneously reducing Europe’s health care costs | 2016 |
| 503 | OMiProbe | Bio-optical probe technology for safe, fast and non-destructive cancer diagnosis | 2016 |
| 504 | Project ACT | Automated autologous cell therapy system | 2016 |
| 505 | NO-META | Feasibility study of a NOvel METAbolic liquid biopsy for cancer therapy monitoring | 2016 |
| 506 | MY FISH CURE | Zebrafish avatar as a real-time in vivo platform for personalized cancer therapeutics | 2016 |
| 507 | Quality2Cells | TimeLapseReader for Quality Control of Immune Cells used for Cell-Based Therapies | 2016 |
| 508 | Syndivia | Next generation drug conjugates for cancer treatment | 2016 |
| 509 | RIGVIR | Feasibility study for registration of medicine RIGVIR with the European Medicine Agency | 2016 |
| 510 | tagMDR | Identification of Multidrug Resistance for Chemotherapy Guidance in Cancer Using a Lab-on-a-chip Platform | 2016 |
| 511 | NanoSil4Cancer | Smart Multifunctional silica-based Nanoparticles for Targeted Therapy | 2016 |
| 512 | PDZnet | Unraveling Principles of PDZ-mediated Cell Signaling | 2016 |
| 513 | FAT NKT | Targeting iNKT cell and adipocyte crosstalk for control of metabolism and body weight | 2016 |
| 514 | MYELOMANEXT | Integrated next-generation flow cytometry and sequencing to uncover the pathway of curability in multiple myeloma | 2016 |
| 515 | ASSIMILES | Advanced Spectroscopy and Spectrometry for Imaging Metabolism using Isotopically-Labeled Endogenous Substrates | 2016 |
| 516 | MATRICAN | Matrix during cancer progression | 2016 |
| 517 | PolyP-FXII in cancer | The polyphosphate/factor-XII pathway in cancer-driven thrombosis and tumor growth | 2017 |
| 518 | CoCa | Collagen in Cancer: from the regulatory fibril forming function of collagen V in development to its implication in tumor progression | 2016 |
| 519 | MIMICS | MicroRNA Isoforms for Molecular Interception of Cervical cancer using Self-samples | 2016 |
| 520 | REDOXDRUGS | Discovery and commercialisation of novel compounds targeting redox proteins | 2016 |
| 521 | VERDI | polyValent mEsopoRous nanosystem for bone DIseases | 2016 |
| 522 | HOXA9 degradome | Deciphering the machinery involved in stability of the transcription factor HOXA9. | 2016 |
| 523 | FluoroDendriNostic | Combined fluorinated polymer and poly-L-lysine dendrimer as new potential contrast agents for magnetic resonance imaging 19F | 2016 |
| 524 | BRCANCER | A novel approach for modeling development of breast cancer | 2016 |
| 525 | ADC | Next-Generation Antibody-Drug Conjugates for safer and more effective cancer therapies | 2016 |
| 526 | HiPerNav | High Performance Soft-tissue Navigation | 2016 |
| 527 | TRANSMIT | TRANSlating the role of Mitochondria in Tumorigenesis | 2017 |
| 528 | SYNTRAIN | Targeting SYNthetic lethal interactions for new cancer treatments TRAINing network | 2016 |
| 529 | TRACT | Training in Cancer Mechanisms and Therapeutics | 2016 |
| 530 | EN_ACTI2NG | European Network on Anti-Cancer Immuno-Therapy Improvement by modification of CAR and TCR Interactions and Nanoscale Geometry | 2017 |
| 531 | PAIN-Net | Molecule-to-man pain network | 2017 |
| 532 | CATCH | Cancer: Activating Technology for Connected Health | 2016 |
| 533 | TransPot | Translational Research Network in Prostate Cancer | 2017 |
| 534 | PROTECTED | PROTECTion against Endocrine Disruptors; Detection, mixtures, health effects, risk assessment and communication. | 2017 |
| 535 | BioCapture | Smart capture phases for proteomics, glycomics and biomarker assays | 2016 |
| 536 | circRTrain | circular RNA Biology Training Network: from biogenesis to biomarkers | 2017 |
| 537 | TRAIN | Tribbles Research and Innovation Network | 2016 |
| 538 | GlySign | Exploitation of Glycosylation Signatures for Precision Medicine | 2016 |
| 539 | GameofGates | Solute carrier proteins as the gates managing chemical access to cells | 2016 |
| 540 | KIRANDIS | NK receptors and disease | 2016 |
| 541 | BSSTD | Bioelectrochemical Sensing of Sexually Transmitted Diseases | 2016 |
| 542 | TaGFrag | Stabilising Protein-Protein Interactions: A Target-Guided Fragment-Based Approach | 2016 |
| 543 | TRANSBIO | Cellular BIOtechnology for prognosis and monitoring in renal TRANSplantation | 2017 |
| 544 | PhotoMedMet | Towards Novel Inert (Photo-)toxic Ru(II) Polypyridyl Complexes | 2016 |
| 545 | EPIPHARM | Development of a ncRNA DNA Methylation Kit for Treatment Guidance in Cancer of Unknown Primary | 2017 |
| 546 | EMbRACe | Effective Multidrug Cocktails for Cancer | 2016 |
| 547 | HALODRUGSYN | Innovative Strategies towards Halogenated Organic Molecules: From Reaction Design to Application in Drug Synthesis | 2017 |
| 548 | DeNovoImmunoDesign | Computational Design of Novel Functional Proteins for Immunoengineering | 2017 |
| 549 | TiMaScan | Recirculated tissue macrophages (TiMa) in blood: Novel approach to early diagnosis and treatment monitoring in oncology | 2016 |
| 550 | BITCAT | Blocking Inhibition of T-cell Co-stimulation for Anti-tumour Therapy | 2017 |
| 551 | ACCENT | Unravelling the architecture and the cartography of the human centriole | 2017 |
| 552 | BIOCDx | A miniature Bio-photonics Companion Diagnostics platform for reliable cancer diagnosis and treatment monitoring. | 2017 |
| 553 | PAMMOTH | Photoacoustic/Ultrasound Mammoscopy for evaluating screening-detected abnormalities in the breast | 2017 |
| 554 | HypoSens | Nano-confined photonic system for detection of breast cancer spread to the lymph nodes | 2016 |
| 555 | MMpredict | Validation of a personalised medicine tool for Multiple Myeloma that predicts treatment effectiveness in patients | 2016 |
| 556 | DeeBMED | Deep learning and Bayesian inference for medical imaging | 2016 |
| 557 | ESOMAVOD | Enantioselective Synthesis of Madangamine Alkaloids via Organocatalytic Desymmetrization | 2016 |
| 558 | TERPENECAT | Bridging the gap between supramolecular chemistry and current synthetic challenges: Developing artificial catalysts for the tail-to-head terpene cyclization | 2016 |
| 559 | EnteroBariatric | Investigating Host-Microbial Interactions after Bariatric Surgery | 2017 |
| 560 | DPC_REPAIR | Mechanism of DNA-protein cross-link repair in S phase | 2017 |
| 561 | SOLUS | Smart optical and ultrasound diagnostics of breast cancer | 2016 |
| 562 | ESOTRAC | Hybrid optical and optoacoustic endoscope for esophageal tracking. | 2017 |
| 563 | INSPIRED | Targeting IRE1 in disease | 2017 |
| 564 | MNR4SCell | Micro/Nano Robotics for Single Cancer Cells | 2017 |
| 565 | EnvJustice | A GLOBAL MOVEMENT FOR ENVIRONMENTAL JUSTICE: The EJAtlas | 2016 |
| 566 | THERACAN | Novel therapeutic strategies to treat pancreatic and lung cancer | 2017 |
| 567 | MULTIFUNSOME | Anti-EGFR Monoclonal Antibody Conjugated Thermoresponsive Liposome for Triple Negative Breast Cancer Thermo-Chemotherapy | 2017 |
| 568 | Diet-namic | From fast food to healthy diet: Addressing the dynamic molecular mechanism of sequential diet switch-induced T cell plasticity for the purpose of developing new treatments for immuno-mediated diseases | 2016 |
| 569 | PICCOLO | Multimodal highly-sensitive PhotonICs endoscope for improved in-vivo COLOn Cancer diagnosis and clinical decision support | 2017 |
| 570 | 3D NEONET | Drug Discovery and Delivery NEtwork for ONcology and Eye Therapeutics | 2017 |
| 571 | BREATH | BREATH: Biomarkers for Respiratory diseases detected in Exhaled Air through a new Technological instrument for research and Healthcare markets. | 2016 |
| 572 | PANDA | Production of Advanced Nano Diamond Additives (PANDA) for various industries, science and medicine | 2016 |
| 573 | H-CCAT | Solid Catalysts for activation of aromatic C-H bonds | 2017 |
| 574 | TILC | Targeting Innate Lymphoid Cells | 2017 |
| 575 | DiVineGenoMe | Decoding cell-to-cell variation in genome integrity maintenance | 2017 |
| 576 | HiChemSynPro | High-throughput combinatorial chemical protein synthesis as a novel research technology platform for chemical and synthetic biology | 2017 |
| 577 | McHAP | Entrapment of Hypoxic Cancer by Macrophages Loaded with HAP | 2017 |
| 578 | VISGEN | Transcribing the processes of life: Visual Genetics | 2017 |
| 579 | STAR | SAFE, TRANSPARENT, ACTIVE AND RELIABLE MINERAL BASED SUNSCREEN INGREDIENT TECHNOLOGY | 2016 |
| 580 | SkinXCare | Integral cell-biology platform for the development of the first effective treatment of radiodermatitis. | 2016 |
| 581 | ICPerMed Secretariat | Secretariat for the International Consortium for Personalised Medicine (IC PerMed) | 2016 |
| 582 | NONCODRIVERS | Finding noncoding cancer drivers | 2016 |
| 583 | HYPOXIMMUNO | Tackling the Achilles Heel of Immunotherapy: Validating imaging biomarkers and targeting the immunological niche of tumour hypoxia | 2016 |
| 584 | MitoMethylome | Mitochondrial methylation and its role in health and disease | 2017 |
| 585 | OptoBETA | Multicellular regulation of insulin secretion from pancreatic islets | 2017 |
| 586 | SweetAim | Selective glycoimmuno-targeting for cancer therapy | 2016 |
| 587 | TKI resistance | Resistance mechanisms to tyrosine kinase inhibitors in solid tumors | 2016 |
| 588 | GlycoImaging | Imaging and detection of tumor-associated glycan structures on tumor cells | 2017 |
| 589 | MECHANO-CONTROL | Mechanical control of biological function | 2017 |
| 590 | NanoMed | Nanoporous and Nanostructured Materials for Medical Applications | 2017 |
| 591 | LungCARD | Blood test for clinical therapy guidance of non-small cell lung cancer patients | 2017 |
| 592 | MAGNAMED | Novel magnetic nanostructures for medical applications | 2017 |
| 593 | Oncosmart | ONCOlogic patient profiling and personalized treatment through SMART bedside diagnostics | 2016 |
| 594 | OVOMATIC | IN-OVO AUTOMATION FOR CANCER DRUG DISCOVERY | 2017 |
| 595 | CM | Prevention of Cosmetic-Induced Non-Communicable Diseases and Micro Plastics entering Food Chains with the CosmEthics- Health App | 2016 |
| 596 | HoloCyt | A rapid, low-cost, cervical cancer screening platform | 2017 |
| 597 | 3DCC | Ready-to-use 3D Cell Cultures for early de-risking in drug development | 2016 |
| 598 | HarmonicSS | HARMONIzation and integrative analysis of regional, national and international Cohorts on primary Sjögren’s Syndrome (pSS) towards improved stratification, treatment and health policy making | 2017 |
| 599 | EURE-CART | EURopean Endeavour for Chimeric Antigen Receptor Therapies | 2017 |
| 600 | SUMCASTEC | Semiconductor-based Ultrawideband Micromanipulation of CAncer STEm Cells | 2017 |
| 601 | Laser-Bioprint | Laser-Based Bioprinter | 2016 |
| 602 | ChemEpigen | The chemical understanding of biomolecular recognition in epigenetics | 2017 |
| 603 | IMMUNOSABR | Clinical proof of concept through a randomised phase II study: a combination of immunotherapy and stereotactic ablative radiotherapy as a curative treatment for limited metastatic lung cancer | 2017 |
| 604 | VAHVISTUS | Integrative development of smart drug-vector nanostructures for adaptive delivery to target cells | 2017 |
| 605 | 3D-REPAIR | Spatial organization of DNA repair within the nucleus | 2017 |
| 606 | SLaMM | Magnetic Solid Lipid Nanoparticles as a Multifunctional Platform against Glioblastoma Multiforme | 2017 |
| 607 | SCUBA CANCERS | Finding the genetic causes of contagious metastases under the sea | 2017 |
| 608 | ADJUV-ANT VACCINES | Elucidating the Molecular Mechanisms of Synthetic Saponin Adjuvants and Development of Novel Self-Adjuvanting Vaccines | 2017 |
| 609 | chromo-SUMMIT | Decoding dynamic chromatin signaling by single-molecule multiplex detection | 2017 |
| 610 | EVOLVE | Extracellular Vesicle-Internalizing Receptors (EVIRs) for Cancer ImmunoGeneTherapy | 2017 |
| 611 | ONCOCHECK | A simple blood test for prognosis and monitoring of patients undergoing cancer therapy. | 2017 |
| 612 | SmartGuide | Smart Biopsy Tool for Real-Time Cancerous Cell Characterization at the Tip of the Needle | 2017 |
| 613 | SynchroSelf | Harnessing reversibility of peptide Self-Assembly processes to Synchronise Extracellular Matrix substitutes with cellular driven tissue reconstruction | 2016 |
| 614 | SUPRACELL_COMMUN_CCT | Supracellular contractility dynamics and cell communication during collective chemotaxis. | 2016 |
| 615 | FANCODRUG | Reactivation of the Fanconi anemia-BRCA pathway in cells carrying patient-derived missense mutations: finding a drug to cure Fanconi anemia | 2017 |
| 616 | MONONANOCHEM | In vivo engineering of monocytes loaded with nano-chemotherapeutic formulations: a novel live-cell mediated drug delivery system for the treatment of cancer | 2017 |
| 617 | NinZA | Theranostic molecular zipper based switchable nanomedicine for overcoming drug resistance | 2017 |
| 618 | TSuNAMI | Trans-Spin NanoArchitectures: from birth to functionalities in magnetic field | 2017 |
| 619 | MetResistance | The role of tumour microenvironment in metastatic hormone-refractory prostate cancer | 2017 |
| 620 | MECHANICS | Mechanics of cells: the role of intermediate filaments | 2017 |
| 621 | STIMUNITY | Preclinical validation of a novel immunogenic composition to stimulate innate immunity | 2017 |
| 622 | SpheroPredict | A 3D advanced test for prediction of drug response in secondary liver cancer | 2017 |
| 623 | PDClungSME1 | A therapeutic vaccine candidate for lung cancer based on an exclusive cell line of Plasmacytoid Dendritic Cells (PDC*line) | 2016 |
| 624 | VIVAVE | Viral Vaccine Vectors in Personalized Medicine | 2017 |
| 625 | NANO-GROWTH | An innovative, non-invasive and de-risked system to enable the transdermal delivery of fragile therapeutic compounds for a better management of painful diseases | 2017 |
| 626 | CryoBiopsy | CryoBiopsy: a bi-modal temperature sample preservation device for standardized breast cancer biopsy | 2017 |
| 627 | METAdiag | METAdiag: Diagnose to Cure | 2017 |
| 628 | INNOBCT | Innovative combination therapy against bladder cancer | 2017 |
| 629 | RELEASE | Nanofiber based drug delivery for surgical therapy of adult and paediatric solid tumours | 2017 |
| 630 | CancerFluxome | Cancer Cellular Metabolism across Space and Time | 2017 |
| 631 | QuantSURG | Quantitative Surgical Guidance for Colorectal Surgery using Endogenous Molecular Contrast | 2017 |
| 632 | COLGENES | Defining novel mechanisms critical for colorectal tumourigenesis | 2017 |
| 633 | POLYBOOST | POLYBOOST: Renovating the Polyclonal Immunotherapy | 2016 |
| 634 | Curtana | Patented small molecule therapeutics that target cancer stem cells for the treatment of glioblastoma and other brain cancers | 2017 |
| 635 | THUNDER | Development of the Cyclin-Dependent Kinase Inhibitor VS2-370 to Target HIV-associated Malignancies and to Purge Viral Reservoir | 2017 |
| 636 | CG-100 | A next generation medical device that enhances patient care and treatment following colorectal surgery | 2017 |
| 637 | BGCI | Bacterial Ghost Cancer Immunotherapy - A new standard in tumour therapy based on the bacterial ghost platform technology | 2017 |
| 638 | PANTREAT | Pancreatic cancer as a treatment target of Dwarfbody-Therapeutics | 2017 |
| 639 | TEDCIP | Targeting epigenetic demethylases: development of covalent inhibitors and PROTACs (Proteolysis Targeting Chimeras). | 2017 |
| 640 | LIGER | Identification of novel substrates for ubiquitin ligases involved in cell cycle and cell migration | 2017 |
| 641 | Anticancer-PAM | Anticancer activity of plasma activated medium and its underlying mechanisms: Combined experimental and computational study | 2017 |
| 642 | BRECASTEM | Functional and Molecular Characterisation of Breast Cancer Stem Cells | 2017 |
| 643 | Stress Imaging | Nanoscale Stress Imaging with Imperfect Diamonds | 2017 |
| 644 | Mitomorphosis | Metabolic regulation of mitochondrial morphology | 2017 |
| 645 | INVESTIGERFE | Investigating the regulation of iron homeostasis by erythroferrone and therapeutic applications | 2017 |
| 646 | TRPLigDrugConj | TRPV1-targeted ligand-drug conjugates to treat prostate cancer | 2017 |
| 647 | ChroSoDSB | Chromatin Study of DNA Double Strand Breaks | 2017 |
| 648 | LEUKEMIC-TEs | Unveiling the signature of transposable elements-derived transcripts – the transposcriptome – as a biomarker in human acute myeloid leukemia | 2017 |
| 649 | LamelliActin | Mechanical Adaptation of Lamellipodial Actin Networks in Migrating Cells | 2017 |
| 650 | GlycoModels | 3D glyco-engineered models to address the role of glycosylation in gastric cancer clinical management | 2017 |
| 651 | eWAD | Unbalanced Wnt signalling in AD: a DNA methylation effect | 2017 |
| 652 | GD TCR LIGAND | Identification of the ligand of a human public anti-HCMV/cancer γδ T cell receptor | 2017 |
| 653 | CANCERSCREEN | Screening for cancer in the post-genomic era: diagnostic innovation and biomedicalisation in comparative perspective | 2017 |
| 654 | Survive | Surviving metabolism: acid handling and signalling | 2017 |
| 655 | ONCOmetENHANCERS | Elucidating the Role of Enhancer Methylation Variation in Cancer and Developing Enhancer-based Markers and Targets for Precision Medicine | 2017 |
| 656 | POLYAMACHINES | The polyA machinery: Elucidating the molecular mechanisms of mRNA polyadenylation, deadenylation and RNA recognition | 2017 |
| 657 | CHROMONUMBER | Chromosome number variations in vivo: probing mechanisms of genesis and elimination | 2017 |
| 658 | 3DPD | PhD position in commercial environment: cancer immunotherapy drug screening in 3D | 2017 |
| 659 | TheranOMICS | Integration of high resolution -OMICS datasets towards personalized therapy in bladder cancer | 2017 |
| 660 | MULTIDET | Multiplex qPCR detection and chemical analysis towards multifunctional diagnosis | 2017 |
| 661 | CMI2T IA | Harmless Clostridium bacteria as a highly targeted, continuous delivery system for immunomodulatory anti-cancer drugs | 2017 |
| 662 | CTFMAUTOMATION | Automation of Correlative Optical Tweezers-Fluorescence Microscopy Experiments | 2017 |
| 663 | LTPAM | Low Temperature Plasma for Applications in Medicine | 2017 |
| 664 | RepliStressTiming | Impact of replicative stress on DNA replication timing control | 2017 |
| 665 | BCSC-ST | Breast cancer stem-like cells specific vulnerabilities: focus in HER2 over-expression and protein glycosylation | 2017 |
| 666 | ZINCLAPS | Light-addressable potentiometric sensors (LAPS) for zinc imaging with high spatiotemporal resolution for elucidating the role of zinc in age related macular degeneration. | 2017 |
| 667 | OMICS | Origami-based Microfluidic Interface for Cell Signalling | 2017 |
| 668 | UBIMAPS | Ubiquitin-dependent regulation of the microtubule cytoskeleton | 2017 |
| 669 | BRAINHIB | Integrated drug discovery approach to generate brain-penetrant inhibitors of glioblastoma cell proliferation | 2018 |
| 670 | ExoSensor | A Nano-photoelectric Exosome Biosensor for Point-of-care Diagnosis of Early-stage Cancer | 2017 |
| 671 | TSPO METALLODRUGS | Novel, highly effective and selective anticancer metallodrugs | 2018 |
| 672 | APOLLO | Assessing population health from exposure to tobacco-specific carcinogens in Belgium using an innovative wastewater-based epidemiology approach | 2017 |
| 673 | ReXeG | Deciphering molecular mechanisms that resolve mutagenic DNA G-quadruplex structures | 2017 |
| 674 | CRISTONE | Targeting CRISPR-based HDAC inhibitors to histones: a new tool for assessing mechanisms of class I HDAC inhibitors and developing chemical probes. | 2017 |
| 675 | EXCITING-CT | Excellent lung cancer imaging and tumour identification using next generation computed tomography | 2017 |
| 676 | IMMUNO_CRC | Microbiota-immune interaction in colorectal cancer | 2017 |
| 677 | EpiMethFly | Study of the role of m6A RNA methylation in the nervous system of Drosophila melanogaster: an in-vivo model to dissect the impact of epitranscriptome reprogramming in physiology and cancer | 2017 |
| 678 | DrugSearchTool | Innovative FRET-based toolkit for screening of drugs to fight miRNA-related diseases and its use in the development of cancer treatment with miRNA-96 as a therapeutic target | 2018 |
| 679 | PRIMASKOTI | PReparing Introduction to MArket of SKOTI (PRIMASKOTI) - a breakthrough solution for real-time studies of cytoskeletal motors at single-molecule resolution | 2017 |
| 680 | LIFEOMEGA | Innovative highly concentrated Omega-3 Specialized Nutrition Product | 2017 |
| 681 | PHYSBIOHSC | Understanding the physical biology of adult blood stem cells | 2017 |
| 682 | GRADIENTSENSING | Cellular navigation along spatial gradients | 2017 |
| 683 | Monomark | A comparative clinical study of a stool-based versus a blood-based screening test for earlydetection of CRC | 2017 |
| 684 | MicroMechCell | Precision micromechanical lever for next-generation cell culture systems | 2017 |
| 685 | DREMATURE | DNA repair mechanisms and therapy resistance of BRCA2-deficient cancers | 2018 |
| 686 | QSB | Quantum Sensing for Biology | 2017 |
| 687 | SCALTIE | Single cell analysis of the lung tumour-immune ecosystem: Developing new tools for effective immunotherapy | 2017 |
| 688 | PhoRAu | Photochemistry and radiolabelling of gold(III) anticancer prodrugs | 2018 |
| 689 | QAPs | G-Quadruplex-associated proteins (QAPs) and their role in transcriptional regulation | 2017 |
| 690 | ThromboForce | Platelet tractions through the Glycoprotein (GP) GPIb receptor as a potential marker for platelet reactivity | 2017 |
| 691 | TRIBBLES | Characterizing the clinical relevance and the mechanism underlying TRIB2-mediated drug resistance to MEK inhibitiors in the context of melanoma | 2018 |
| 692 | ENDOCAM | TARGETING ENDOTHELIAL CELL AND CANCER AMOEBOID MOVEMENT TO OVERCOME RESISTANCE TO ANTI-VEGF AND ANTI-PROTEASE THERAPIES | 2017 |
| 693 | SHAPPI | Scaffold hybridization approach targeting PPIs | 2017 |
| 694 | DNAmethAML | Investigation of aberrant DNA methylation in malignant haematopoiesis | 2018 |
| 695 | HIPPOCRATE | Hybrid Imaging of PET and PrOmpt gamma for preCision RAnge- and biological- guidance in proton ThErapy | 2017 |
| 696 | MSCFate | Fate of mammary stem cells during tumorigenesis and clinical implications | 2017 |
| 697 | OPN-Can | Investigating the role of OPN-CD44 in mechanosensitive tumour invasion using biomimetic models | 2017 |
| 698 | BioMedBC | Molecular profiling of Bladder Cancer to support personalized medicine | 2017 |
| 699 | DevoSignGammaDelta | Tracking γδ T cell development and TCRγδ proximal signalling | 2018 |
| 700 | GlimS | Patient-specific tumour growth model for quantification of mechanical 'markers' in malignant gliomas: Implications for treatment outcomes. | 2017 |
| 701 | APACHE | Atmospheric Pressure plAsma meets biomaterials for bone Cancer HEaling | 2017 |
| 702 | AppSAM | A Flexible Platform for the Application of SAM-dependent enzymes | 2017 |
| 703 | SIRFUNCT | Chemical Tools for Unravelling Sirtuin Function | 2017 |
| 704 | MiRCHOL | Mechanistic and therapeutic implications of microRNA deregulation for drug resistance in bile duct cancer | 2017 |
| 705 | DeciTrustNET | Trust based Decision Support Systems for Social Networks with Uncertain Knowledge | 2017 |
| 706 | ChromoDrive | Investigating how anaphase chromosomal motion is generated during mitosis and meiosis | 2017 |
| 707 | OUTNANO | Out-of-equilibrium nanophotonics | 2017 |
| 708 | RNAatHD | Development of a high-resolution method to monitor structural changes of regulatory RNAs and therapeutic oligo-nucleotides directly in-cell. | 2017 |
| 709 | AttoDNA | AttoDNA: how electronic motions affect the photostability of the genomic material | 2018 |
| 710 | SIOMICS | SIngle-cell multi-OMICs approach to study intra-tumour heterogeneity of soft tissue Sarcomas | 2017 |
| 711 | TeloChromatin | Dissecting the chromatin dynamics at telomeres during mouse pre-implantation development. | 2017 |
| 712 | Glyco-Platforms | Novel smart glyco-nanomaterials as targeted therapeutics. | 2017 |
| 713 | IVORIaN | RAS/C-RAF interaction: A new pharmacological target in Kras-driven lung cancer. | 2017 |
| 714 | DesProtDNA | Computational design of proteins binding nucleosomal DNA with specificity for therapeutic applications | 2017 |
| 715 | EwiSarc | A novel in vivo platform to study and target undruggable Ewing onco-chimera. | 2017 |
| 716 | umCryofix | A microfluidic cryofixation method for time-resolved correlative microscopy | 2017 |
| 717 | MetEpiClock | Circadian Control of Histone Methylation Dynamics through the Fine-tuning of Methionine Metabolic Flux | 2017 |
| 718 | MIDxPRO | Microwave Diagnosis of Breast Cancer with Open Ended Contact Probes | 2017 |
| 719 | RTKPalm | Modulating and Profiling Receptor Tyrosine Kinase S-palmitoylation in Breast Cancer | 2017 |
| 720 | Immunometabolomics | CD8+ T cell metabolism in anti-tumor response | 2017 |
| 721 | SAS6-Cep135-CPAP | Towards a molecular understanding of the centriole assembly process | 2017 |
| 722 | pureCTC | A LAB-ON-A-CHIP DEVICE FOR PURE CIRCULATING TUMOR CELL ISOLATION FROM WHOLE BLOOD FOR CANCER THERAPY | 2017 |
| 723 | SPLICANCER | Regulation and reprogramming of alternative splicing in cellular transformation | 2017 |
| 724 | AcTaferon | Revitalizing the clinical potential of type I IFNs in fighting influenza A virus infections with AcTaferon. | 2017 |
| 725 | ONCOPHAGY | Novel Atg4B-inhibitors and dual [Atg4B-carbonic anhydrase]inhibitors for interfering with cytoprotective mechanisms of cancercells in the acidic tumor micro-environment. | 2017 |
| 726 | METMEL | Long range-acting drivers of premetastatic niches in melanoma | 2017 |
| 727 | mPOWER | Mobile platform to empower cancer patients with fatigue | 2017 |
| 728 | IB4SD-TRISTAN | Imaging Biomarkers (IBs) for Safer Drugs: Validation of Translational Imaging Methods in Drug Safety Assessment - Sofia ref.: 116106 | 2017 |
| 729 | UbiArchitect | Understanding the complexity and architecture in protein ubiquitination | 2017 |
| 730 | Prolifimeter | Growth detection and quantification (GDQ) | 2017 |
| 731 | CD4CRISPR | A quorum sensing mechanism regulating CD4 T cell proliferation | 2017 |
| 732 | DUALITY | An Integrated Computational and Experimental Approach to Rapid Synthesis of Highly Selective Dual-Targeted HDAC/CK2, MMP2/CK2 Inhibitors | 2018 |
| 733 | CINK | Advancing cancer immunotherapy using natural killer cells for hematological and metastatic cancers | 2018 |
| 734 | Rep. Fork Restart | Restart of blocked replication fork at replication fork barrier | 2017 |
| 735 | METCLL | Discovery and validation of ‘epidrivers’ of cancer evolution and resistance to therapy | 2018 |
| 736 | RoNDBioCan | NLRP3 in cancer: Deciphering the role of NLRP3 in the DNA Damage response pathway | 2018 |
| 737 | ESCRT model | A biophysical model for ESCRT-III mediated membrane scission | 2017 |
| 738 | IC_IL_EC_2017 | Investigating the effects of immunogenic chemoradiation in shaping the immune landscape of esophageal cancers | 2018 |
| 739 | THAT IS HUNT | Triggering Haematological Adoptive T-cell Immunotherapy Strategies by HUnting Novel T-cellreceptors | 2018 |
| 740 | PlateletLiquidBiopsy | Exploring the cellular heterogeneity underlying 'tumor-educated' platelets | 2017 |
| 741 | DSMT16 | Deciphering causes and consequences of inflammation in subtypes of sporadic intestinal cancer | 2018 |
| 742 | WHOLENICHE | Hold it or let it go: a niche decision on cancer growth | 2017 |
| 743 | UVdynamicsProtection | Aligning pigmentation and repair: a holistic approach for UV protection dynamics | 2017 |
| 744 | IASIS | Integration and analysis of heterogeneous big data for precision medicine and suggested treatments for different types of patients | 2017 |
| 745 | PHRD | The development of Personalised Host Response Diagnostic kit | 2017 |
| 746 | ILMET | Metabolic characterization of ILCs under homeostatic or stress conditions. | 2017 |
| 747 | HEGEMONIC | HEpatocellular carcinoma GErmline MutatiONs ImpaCt (HEGEMONIC) | 2017 |
| 748 | ONCOGENEVOL | The evolutionary history of oncogenic and non-oncogenic papillomaviruses | 2017 |
| 749 | STARFISH DNA | Stalling the Replication Fork via the Impedimental Stabilization of Higher-order DNAs | 2017 |
| 750 | TANTUMorNEUVACCINE | Neutrophil subtypes: distinct cellular targets for therapeutic intervention | 2017 |
| 751 | QUSMI | Translating quantum sensing into cost-effective molecular imaging | 2017 |
| 752 | iAML-lncTARGET | Targeting the transcriptional landscape in infant AML | 2017 |
| 753 | BEAT | The functional interaction of EGFR and beta-catenin signalling in colorectal cancer: Genetics, mechanisms, and therapeutic potential. | 2017 |
| 754 | ESCAPE_COPD | Elimination of Senescent Cells Approach for treatment of COPD | 2017 |
| 755 | ENDODEP | Molecular mechanisms of endosome departure from the spindle in asymmetric cell division | 2017 |
| 756 | CanFaster | The Translational Cancer Faster Forward doctoral programme – CanFaster | 2017 |
| 757 | CTCapture_2.0 | Advanced platform for profiling of therapeutic targets and functional analysis of circulating tumour cells in cancer patients | 2017 |
| 758 | LUMABS | Therapeutic antibody drug monitoring using bioluminescent sensors proteins and a smartphone | 2017 |
| 759 | EPICODE | Programmable Readers, Writers, and Erasers of the Epigenetic Cytosine Code | 2017 |
| 760 | NEST | Nanoengineering of radioactive seeds for cancer therapy and diagnosis | 2017 |
| 761 | NanoMOFdeli | Design of NanoMOFs Capsules for Drug Delivery and Bioimaging. | 2017 |
| 762 | META-DORM | Mechanobiology of METAstatic and DORMant cancer cells in bone marrow lesions | 2018 |
| 763 | altEJrepair | Characterisation of DNA Double-Strand Break Repair by Alternative End-Joining: Potential Targets for Cancer Therapy | 2017 |
| 764 | DrugComb | Informatics approaches for the rational selection of personalized cancer drug combinations | 2017 |
| 765 | INTUMORX | Elucidation of intratumoral heterogeneity in Kras-driven cancers | 2017 |
| 766 | CellTrack | Cellular Position Tracking Using DNA Origami Barcodes | 2017 |
| 767 | DeShield | Hide and Seek with Cancer Drugs | 2017 |
| 768 | FLUINEMS | Suspended Fluidic nanochannels as optomechanical sensors for single molecules | 2017 |
| 769 | TIGITtherapy | TIGIT therapy for cancer treatment | 2017 |
| 770 | SIRMIO | Small animal proton Irradiator for Research in Molecular Image-guided radiation-Oncology | 2017 |
| 771 | NAFLDcure | A novel pharmaceutical treatment for nonalcoholic fatty liver disease | 2017 |
| 772 | EPiR | The Chemical Basis of RNA Epigenetics | 2017 |
| 773 | gdTCR-Ligand | Investigating the recognition of a novel ligand by gamma-delta T cells and the translation of this interaction into molecules for future cancer immunotherapy | 2017 |
| 774 | ImPRESS | International Interdisciplinary PhD studies in Biomedical Research and Biostatistics. Supporting the career and training in omic-based research and biostatistics by inter-national and-sectoral mobility | 2018 |
| 775 | MetaboMARKER | A metabolism-based prognostic biomarker for prostate cancer | 2017 |
| 776 | ACTICELL | Precision confiner for mechanical cell activation | 2017 |
| 777 | PRELICAN | Treatment of liver disease and cancer prevention | 2017 |
| 778 | BrachyDOSE | Developing a feasibility study for the future commercialization of BranchyDOSE – an innovative accurate and simple brachytherapy measurements tool | 2017 |
| 779 | MEDIVAC | Machine learning software to design personalized neoantigen vaccines tailored to specific vaccine delivery systems | 2017 |
| 780 | ITCC-P4 | ITCC Pediatric Preclinical POC Platform – Sofia ref.: 116064 | 2017 |
| 781 | cis-CONTROL | Decoding and controlling cell-state switching: A bottom-up approach based on enhancer logic | 2017 |
| 782 | PROMINENT | Personalised Medicine in Diabetic Chronic Disease Management | 2017 |
| 783 | NanoScreen | Disruptive portable device for pre-screening of Persistent Organic Pollutants –POPs- in food products and water | 2017 |
| 784 | Secret Surface | The cell surface tetraspanin web drives tumour development and alters metabolic signalling | 2017 |
| 785 | FATE | Functional Biology of Hepatic CD8+ T cells | 2017 |
| 786 | DissectPcG | Dissecting the Function of Multiple Polycomb Group Complexes in Establishing Transcriptional Identity | 2017 |
| 787 | OVO-GROWTH | Oogenesis spotlighted: making mature human oocytes | 2017 |
| 788 | StressGene | The Genetics of Morbidity and Survival in Response to Significant Life Stressors | 2017 |
| 789 | CATCH-U-DNA | Capturing non-Amplified Tumor Circulating DNA with Ultrasound Hydrodynamics | 2017 |
| 790 | CTC4BMP | Circulating tumor cells for tailoring BMP targeted therapies | 2017 |
| 791 | ENLIGHTEN | INTEGRATION AND PROPAGATION OF IMMUNOLOGICAL SIGNALS DURING CANCER AND INFECTION | 2018 |
| 792 | HoldCancerBack | What Holds Cancer Cells Back? | 2017 |
| 793 | ChAMPioN | Game-changing Precision Medicine for Curing All Myeloproliferative Neoplasms | 2018 |
| 794 | BRCA-ERC | Understanding cancer development in BRCA 1/2 mutation carriers for improved Early detection and Risk Control | 2017 |
| 795 | INTACt | ImmuNogenomics TArgeting Cancer | 2017 |
| 796 | REALTA | Challenging Hypertension Through Novel Medical Device Development | 2017 |
| 797 | HOTFLOW | A Photothermal Lateral Flow Test for Visual Point of Care Detection | 2017 |
| 798 | NOVITREP | Novel viral therapy through targeting DNA repair | 2017 |
| 799 | DynaCOMP | Assessing compounds targeting DNA replication licensing complexes as anti-tumor agents | 2017 |
| 800 | MEDIRAD | Implications of Medical Low Dose Radiation Exposure | 2017 |
| 801 | ColoFast | Developing a Non-Invasive Kit for Early Colorectal Cancer Detection | 2017 |
| 802 | ComFyt | The revolution of the Compression Therapy Market: an easy-to-wear and comfortable compression stocking based on Electro-Active Polymers technology. | 2017 |
| 803 | IPMT | Integrated Precision Medicine Technologies Research Centre of Excellence | 2017 |
| 804 | MammoWave | The first ultra-high sensitive breast imaging device based on non-ionizing safe microwave | 2017 |
| 805 | MECHADIAN | Mechanobiology of the cellular circadian clock | 2018 |
| 806 | Nano4 | Providing the New Generation of Nano-Based Molecular Technology for the Early Detection of Bacteria, Viruses and Cancer at the Point of Care | 2017 |
| 807 | NeurIMM | Neuroimmune activation as a novel therapeutic approach for IBD | 2017 |
| 808 | OR-HMC | Assay for cancer diagnostics by quantification of 5hmC | 2017 |
| 809 | SENSY | Restoring complete motor and sensory ability for natural walking of amputees | 2017 |
| 810 | STEPUP | Synthetic DCs for a T cEll ProdUction Platform | 2017 |
| 811 | STOPCa | The cryptic path of tumor-microenvironment interactions in prostate cancer | 2017 |
| 812 | TelMetab | Telomere metabolism in Genome Stability and Disease | 2017 |
| 813 | BioProbe-PIT | Local molecular profiling of tumor tissue sections: towards personalized immunotherapy | 2017 |
| 814 | Glowsome | Encapsulated eukaryotic ribosome assembly | 2017 |
| 815 | IBIS | Platform for label-free quantitative detection of single proteins and extracellular vesicles | 2017 |
| 816 | Clinnova | Centre of Excellence in Digital Health and Personalised Medicine | 2017 |
| 817 | CodeSphere | CodeSphere - Discovering Therapeutic Nanoparticles by Molecular Encoding | 2017 |
| 818 | Tumor-Treg-Targeting | Training Network for the education of the next generation scientist in targeting the supressive capacity of regulatory T-cells specifically within tumours | 2018 |
| 819 | u-PBeam | Microdosimetry study of a new radiation therapy method based on proton minibeams | 2017 |
| 820 | UbiCODE | European Research Training to Decipher The Ub Code : identification of potential biomarkers and drug targets | 2018 |
| 821 | ZEBRAONCOFISH | Zebrafish avatar as a real-time in vivo platform for personalized cancer therapeutics | 2017 |
| 822 | AMPHORA | ACOUSTIC MARKERS FOR ENHANCED REMOTE SENSING OF RADIATION DOSES | 2017 |
| 823 | BIOCUDET | Identify and detect key ocular biomarkers towards personal medicine | 2017 |
| 824 | CADENCE | Catalytic Dual-Function Devices Against Cancer | 2017 |
| 825 | DeAge | Deconstructing Ageing: from molecular mechanisms to intervention strategies | 2017 |
| 826 | FLASH | Far-infrared Lasers Assembled using Silicon Heterostructures | 2017 |
| 827 | IBEX QDR | IBEX QDR: A Ground-breaking Technological Upgrade based on Quantitative Digital Radiography to Exploit the Full Diagnostic Potential of Standard Digital X-Ray | 2017 |
| 828 | INDEX | Integrated nanoparticle isolation and detection system for complete on-chip analysis of exosomes | 2017 |
| 829 | META-CAN | Targeting the metabolism-immune system connections in Cancer | 2017 |
| 830 | microSPIRE | micro-crystals Single Photon InfraREd detectors | 2017 |
| 831 | Photoclin | Advanced clinical photoacoustic imaging systems based on optical microresonator detection | 2017 |
| 832 | PurinesDX | Interdisciplinary training network on the purinergic P2X7 receptor to control neuroinflammation and hyperexcitability in brain diseases. | 2017 |
| 833 | REACT | Optimising Radiomics for MRI-based personalised cancer treatment | 2017 |
| 834 | STARDUST | in vivo optogeneticS, elecTrophysiology and phArmacology with an ultRasonically-powered DUST for Parkinson's Disease | 2017 |
| 835 | SUDOCHIP | New antiperspirant efficacy evaluation techniques based on a disruptive microfluidic technology | 2017 |
| 836 | VDJtargeting | Engineering T cells and B cells for Immunotherapy using V(D)J recombination | 2017 |
| 837 | ELBA | European Liquid Biopsies Academy - Towards widespread clinical application of blood- based diagnostic tools | 2018 |
| 838 | CONTRA | Computational ONcology TRaining Alliance | 2018 |
| 839 | GLIOTRAIN | Exploiting GLIOblastoma intractability to address European research TRAINing needs in translational brain tumour research, cancer systems medicine and integrative multi-omics | 2017 |
| 840 | PREDICT | A new era in personalised medicine: Radiomics as decision support tool for diagnostics and theragnostics in oncology | 2017 |
| 841 | BioMagMat | Functional magnetic materials for biomedical applications | 2017 |
| 842 | onCOMBINE | Towards evidence-based combinations of approved and novel cancer drugs | 2017 |
| 843 | ESEMT | DETERMINING THE FUNCTIONAL CONSEQUENCES OF TRANSCRIPTIONAL ENHANCER ACTIVATION ON ALTERNATIVE SPLICING DURING EMT | 2017 |
| 844 | StroMaP | Stromal stress networks underlying phenotypic plasticity and tumor fitness | 2017 |
| 845 | ARMOR-T | Armoring multifunctional T cells for cancer therapy | 2018 |
| 846 | deFIBER | Dissecting the cellular and molecular dynamics of bone marrow fibrosis for improved diagnostics and treatment | 2018 |
| 847 | HYPER-INSIGHT | Hypermutated tumors: insight into genome maintenance and cancer vulnerabilities provided by an extreme burden of somatic mutations | 2018 |
| 848 | noRAG-TOR | Rag-independent regulation of mTOR by Amino Acids | 2018 |
| 849 | ORISPECIFICATION | Molecular and structural mechanisms for metazoan replication origin specification | 2018 |
| 850 | ImPRESS | Imaging Perfusion Restrictions from Extracellular Solid Stress | 2018 |
| 851 | MICRONEX | Microbioreactor platforms as in vivo-like systems to probe the role of Neuroblastoma-derived Exosomes in cancer dissemination | 2017 |
| 852 | TRIPLECON | Triple negative breast cancer control through synergistic inhibition of EGFR and CDK9 signaling | 2017 |
| 853 | HypoRuLight | Hypoxic Tumour Models for Photoactivatable Ruthenium-based Chemotherapy | 2017 |
| 854 | IMBIBE | Innovative technology solutions to explore effects of the microbiome on intestine and brain pathophysiology | 2017 |
| 855 | CSI-Fun | Chronic Systemic Inflammation: Functional organ cross-talk in inflammatory disease and cancer | 2018 |
| 856 | TECNEC | Preclinical concept validation of tumor endothelial cell metabolism for novel anti-angiogenic therapy | 2017 |
| 857 | SUGARSmart | SUGARSmart: Smart design of recombinant antibody fragments specific for carbohydrate molecules | 2018 |
| 858 | NANONC | Nanomaterials in Oncology: Exploiting the Intrinsic Cancer-Specific Toxicity of Nanoparticles. | 2018 |
| 859 | MisloQC | Dissecting Quality Control Mechanisms of Mislocalized Proteins | 2018 |
| 860 | X-TAM | Dissecting Cross-Regulatory Interplays in Tumor-Associated Macrophages | 2018 |
| 861 | CHANNELMAT | Microchannels for controlling cellular mechanotransduction | 2017 |
| 862 | BOUNCE | Predicting Effective Adaptation to Breast Cancer to Help Women to BOUNCE Back | 2017 |
| 863 | NEOSETAC | New Selenium-based Targeted Nanocapsules to treat Breast Cancer | 2018 |
| 864 | safenolaTiCancerDrug | Highly and Widely Effective, Water Stable, and Non Toxic Titanium-Phenolato-based Anticancer Chemotherapy | 2017 |
| 865 | ProteaseNter | Disseminating N-terminomics to Advance Protease Research | 2018 |
| 866 | DIDO-MS | Commercialization of a first in class multiple sclerosis drug | 2018 |
| 867 | JetCell | Microfluidic bubble JET flow CELL sorter for cell therapy | 2018 |
| 868 | EDIReX | EurOPDX Distributed Infrastructure for Research on patient-derived cancer Xenografts | 2018 |
| 869 | IMMUNISA | A Next Generation Immunotherapy for Human Papilloma Virus induced Cervical Cancer | 2017 |
| 870 | GeroProtect | Developing Geroprotectors to Prevent Polymorbidity | 2017 |
| 871 | SENSIT | Sensitivity of human tumors to T cell attack | 2017 |
| 872 | NanoBioMap | Nanoparticle Biointerface Mapping | 2018 |
| 873 | ORI NUMBER | Unravelling the effect of origin number on the success of genome replication | 2017 |
| 874 | EXOGENESIS | Syntenin-phosphatidic acid interaction in exosome biogenesis and cell-cell communication: a structure-function based approach | 2018 |
| 875 | CylcoRu4PACT | Cyclometallated ruthenium complexes for photo-activated chemotherapy | 2018 |
| 876 | NANOCARGO | Photo/magnetic stimulated nanocargos for superior cancer treatments | 2018 |
| 877 | MESI-STRAT | Systems Medicine of Metabolic-Signaling Networks: A New Concept for Breast Cancer Patient Stratification | 2018 |
| 878 | COLOSSUS | Advancing a Precision Medicine Paradigm in metastatic Colorectal Cancer: Systems based patient stratification solutions | 2018 |
| 879 | CLINGLIO | A Clinical Phase IIB trial with 2OHOA in patients with newly-diagnosed malignant glioma. | 2017 |
| 880 | INSITUMUT | Direct detection of cancer-causing mutations in tumour specimens | 2018 |
| 881 | LIMA | Liquid biopsies and Imaging for improved cancer care | 2018 |
| 882 | MyPeBS | International Randomized Study Comparing personalized, Risk-Stratified to Standard Breast Cancer Screening In Women Aged 40-70 | 2018 |
| 883 | MTrix | Mechanical Targeting as an Integrative Approach for Personalized Nanomedicine | 2017 |
| 884 | PLASREVOLUTION | Understanding the evolution of plasmid-mediated antibiotic resistance in real life scenarios | 2018 |
| 885 | CHIPS | Effects of Prenatal Exposure to Acrylamide on Health: Prospective Biomarker-Based Studies | 2018 |
| 886 | ELIMINATE | Development of strategies to eliminate cancer cells from the bone marrow | 2018 |
| 887 | CANCER-DC | Dissecting Regulatory Networks That Mediate Dendritic Cell Suppression | 2018 |
| 888 | GlycoEdit | New Chemical Tools for Precision Glycotherapy | 2017 |
| 889 | ToMeTuM | Towards the Understanding a Metal-Tumour-Metabolism | 2018 |
| 890 | CombaTCancer | Rational combination therapies for metastatic cancer | 2018 |
| 891 | DualRP | Exploring cell interactions in the tumor microenvironment with dual ribosome profiling | 2018 |
| 892 | HoliFAB | Holistic digital-to-physical prototyping and production pilot for microfluidic MEMS | 2017 |
| 893 | CANCER | Personalised Postoperative Immunotherapy To Improving Cancer Outcome and improving quality of life | 2018 |
| 894 | Nano-OligoMed | Hybrid Nanostructured Oligonucleotide Platforms for Biomedical Applications | 2017 |
| 895 | CanBioSe | Novel 1D photonic metal oxide nanostructures for early stage cancer detection | 2018 |
| 896 | RESTORE | NEURONAL SELF-RENEWAL BY ANTIGEN-SPECIFIC TOLERIZATION IN MULTIPLE SCLEROSIS REINSTALLING THE BALANCE BETWEEN INFLAMMATION AND REGENERATION | 2018 |
| 897 | ITHACA | Immuno-targeting of human AML quiescent cells by a novel phage display approach. | 2018 |
| 898 | SiNBioSys | Luminescent silicon nanocrystals as bioimaging systems | 2017 |
| 899 | MATADOR | MAmmary chemoresistant Tumor deAth by Directed cell ORientation | 2018 |
| 900 | OMVCRC | Engineered bacterial Outer Membrane Vesicles (OMVs) for colorectal cancer immunotherapy | 2018 |
| 901 | DeepMiR | Innovative testing of microRNA from liquid biopsies using bistable molecular circuits | 2017 |
| 902 | OncoSeq | OncoSeq: an innovative single-cell system for immunomonitoring | 2017 |
| 903 | OmnImmune | Manufacturing and testing of an allogeneic gamma delta T cell therapy for the treatment of cancer | 2017 |
| 904 | OneRNA4Bladder | Non invasive Cell Based Liquid Biopsy Platform for Bladder Cancer | 2017 |
| 905 | SDS-OmiProbe | Revolutionary opto-biological methodology for aggressive HER2 cancer | 2017 |
| 906 | INNOPREFAT | Natural Food formulation for the prevention and treatment the Obesity and Metabolic Syndrome obtained with herbal extracts | 2017 |
| 907 | INTACT | Imaging NM: A Nanoparticulate Precision Medicine Approach to Target Cancer | 2017 |
| 908 | LymphoDrain | First subcutaneous implant to treat lymphedema. Definitive solution for chronic lymphedema | 2017 |
| 909 | SOFT | SOFT, the first camera-based colorectal cancer screening test to detect occult blood in faeces immediately and with no lab analysis. | 2017 |
| 910 | ImmuneHunter | Bioinformatics platform for profiling of health: allowing early and accurate detection of multiple diseases simultaneously | 2017 |
| 911 | PATHOLYTIX-GI | PATHOLYTIX: Using Artificial Intelligence to Transform Clinical Diagnostic Pathology | 2017 |
| 912 | EXACT-dna | EXtended Analysis of Circulating Tumour DNA to improve cancer management strategies | 2017 |
| 913 | Outsense Phase-1 | Toilet IoT sensor for medical monitoring and wellness tool | 2017 |
| 914 | HIL PT System | Revolutionary, cost effective, spatially efficient, proton therapy system for cancer treatment. | 2017 |
| 915 | NANOSTORM | Design of Nanomaterials for Targeted Therapies Guided by Super Resolution Imaging | 2018 |
| 916 | ProstOmics | 'Tissue is the issue': a multi-omics approach to improve prostate cancer diagnosis | 2018 |
| 917 | CTC-MAL | Isolation of rare circulating tumor cells | 2018 |
| 918 | MEL-Interactions | An integrative approach for the exploration of melanoma genetic and immunological interactions | 2018 |
| 919 | SysOrganoid | A systems biology approach to investigate cell fate switches in intestinal organoids | 2018 |
| 920 | PolarizeMe | Feeling Polarity: Integrating intracellular mechanics and forces for a biophysical understanding of epithelial polarity | 2018 |
| 921 | DEFEAT | DiseasE-FreE social life without Antibiotics resisTance | 2018 |
| 922 | NonChroRep | Investigating the role of the long noncoding transcriptome in chromatin replication | 2018 |
| 923 | CLLCLONE | Harnessing clonal evolution in chronic lymphocytic leukemia | 2018 |
| 924 | UFLNMR | Ultrafast Laplace NMR | 2018 |
| 925 | DiSect | The Tumour Stroma as a Driver of Clonal Selection | 2018 |
| 926 | SMART-DNA | Single Molecule Analytical Raman Tools based on DNA nanostructures | 2018 |
| 927 | GlycoSkin | Dissection of Glycan Function by Engineered Tissue Models | 2018 |
| 928 | MicroCaT | Micro-tumor Guided Cancer Therapy Selection MicroCaT | 2018 |
| 929 | ExoSonic | A microfluidic chip for non-invasive, early detection of pancreatic cancer – liquid biopsy | 2018 |
| 930 | P-ViTAL | The Precompetitive Steps of Virtual Transparency and Augmented Laparoscopy | 2018 |
| 931 | MicroBone | Novel 3D platforms to engineer bone microtissues for in vitro disease models | 2018 |
| 932 | TARASOL | TARASÓL - The pioneering bio-marine liposomal Sunscreen released to the skin upon sunlight exposure | 2018 |
| 933 | HepaCheC | HepaCheC - an in vitro diagnostic assay for the early detection of liver cancer | 2018 |
| 934 | NextGen-O2k | Next Generation instrument for in-depth mitochondrial status analyses | 2018 |
| 935 | DifMATRIX | Ground breaking 3D cell culture platform to eliminate animal testing in pharmaceuticals | 2018 |
| 936 | MetaRegulation | Metabolic regulation of metastatic growth | 2018 |
| 937 | METACELL | Metabolism of a cell pictured by single-cell approach | 2018 |
| 938 | ImmunoFit | Harnessing tumor metabolism to overcome immunosupression | 2018 |
| 939 | UBIQUITON | Development of a tool kit to investigate protein ubiquitylation in biomedical research | 2018 |
| 940 | SI | Structural and functional characterization of the ICOS/ICOSL immune complex | 2018 |
| 941 | GrowthControl | Mechanical and systemic control of growth during Drosophila abdominal development | 2018 |
| 942 | iaFRET | An amplified signal imaging software for prognosis of cancer enabling the evaluation of clinicalefficiency of personalised cancer treatments to an unprecedented level. | 2018 |
| 943 | EDROMA | Novel nanomedicine for the treatment of glioma | 2018 |
| 944 | SaveHER | The inhibition of sorting proteins as a therapeutic avenue in HER2 positive breast cancer | 2018 |
| 945 | inhibitAUTO | Towards a New Frontier in Autophagy Inhibition: The Development of a Novel Class of ChemicalProbes and Identification of Their Associated Biological Target | 2018 |
| 946 | ThermOutOfEq | Thermalization of out-of-equilibrium quantum matter | 2018 |
| 947 | TET2rec | Mechanisms of TET2 DNA demethylase recruitment to specific genomic regions | 2018 |
| 948 | SmallDrugRheuma | Discovery of Immune Therapeutic Targets and Immunomodulators for the Development of Novel Therapies in Rheumatoid Arthritis. | 2018 |
| 949 | IMMUNOMARK | Omics integration for precision cancer immunotherapy | 2018 |
| 950 | POLYTHEA | Design and photo-optimization of Photosensitizer for Human Health and Food security applications or “how light can save lives” | 2018 |
| 951 | AutoClean | Cell-free reconstitution of autophagy to dissect molecular mechanisms | 2018 |
| 952 | NIRCOThera | Spatiotemporal, near-infrared light controlled carbon monoxide delivery for cancer immunotherapy | 2018 |
| 953 | DREAMY | Disrupting Aberrant Protein–Protein Interactions with Conformationally Constrained Hydrocarbon α-Helical Mimetics | 2018 |
| 954 | REMIX | Effects of rewiring microexons (REMIX) on tissue-specific signaling networks | 2018 |
| 955 | IRONAGE | Iron as a driver of fibrosis and regeneration | 2018 |
| 956 | CaLecLig | Calcium-dependent Lectins in Human Pathogenic Infections: From Atomistic Understanding to Ligand Design | 2018 |
| 957 | SoftNanoHybrid | Polymer-Nanoparticle co-assembly for drug targeting and release kinetics: Investigation on Structure, Morphology, Responsiveness, and Nanoparticle distribution | 2018 |
| 958 | MaGMa | Applying Metabolomics to Unveil follow-up treatment biomarkers and Identify Novel TherapeuticTargets in Glioblastoma | 2018 |
| 959 | OE Scan | A next generation diagnostic device that effectively screens for breast cancer in all tissue types, without the use of ionising radiation | 2018 |
| 960 | CellularNanoMachines | Development of Stimuli-Responsive Nanoparticle-carrying T lymphocytes in the Fight against Cancer | 2019 |
| 961 | CENTR-ALL | Clarifying role of the CENTROSOME in abnormal mitotic processes featuring the most commonchildhood malignancy: paediatric High Hyperdiploid Acute Lymphoblastic Leukaemia (HHDpALL) | 2019 |
| 962 | ChemRAS | Chemical probing of transcriptional RAS effectors | 2019 |
| 963 | CheSSTaG | Chemotactic Super-Selective Targeting of Gliomas | 2018 |
| 964 | CHROMABOLISM | Chromatin-localized central metabolism regulating gene expression and cell identity | 2018 |
| 965 | COLONINFO | Improving COLOrectal cancer screening: Novel INverse and FOrward algorithms for a new real-time microwave endoscopy | 2018 |
| 966 | DNAProteinCrossRep | Identification of DNA-Protein-Crosslink Repair Factors | 2018 |
| 967 | DYNAFLUORS | Dynamic Activatable Fluorophores | 2018 |
| 968 | EMBRACE | Elucidating Mechanisms of Bladder Cancer Metastasis | 2018 |
| 969 | LASER OPTIMAL | Laser Ablation: SElectivity and monitoRing for OPTImal tuMor removAL | 2018 |
| 970 | PhenoSwitch | Phenotype switching: plasticity and/or differentiation of stromal cells and their progenitors within the tumour microenvironment regulate tumour fate. | 2018 |
| 971 | NoMePaCa | Novel Metabolic Pathways in Cancer | 2018 |
| 972 | TRECEPTORS | Transport and Receptor Mechanisms of Human Solute Carriers | 2018 |
| 973 | VENUSCANCER | Women’s cancers: do variations in patterns of care explain the world-wide inequalities in survival and avoidable premature deaths? | 2018 |
| 974 | MicroC | Agent-Based Modelling of Gene Networks to model clonal selection in the tumour microenvironment and predict therapeutic resistance | 2018 |
| 975 | MOSAIC | Relationship of Somatic Structural Variation Mosaicism to Aging and Disease Phenotypes | 2019 |
| 976 | Sialoglycan Array | Generation of a Cell-Based Sialoglycan Array to Decipher Biological Interactions and Functions of the Human Sialome | 2018 |
| 977 | ATG9_SOLVES_IT | In vitro high resolution reconstitution of autophagosome nucleation and expansion catalyzed byATG9 | 2018 |
| 978 | REPROGRAMIT | Control of T cell differentiation and plasticity through mitochondrial reprogramming | 2019 |
| 979 | Nanozymes POC | Nanozymes POC | 2018 |
| 980 | VALSL | Valorisation of splice-switching oligonucleotides for lung cancer therapy | 2018 |
| 981 | SenPET | Innovative cancer management: First in human senescence imaging | 2018 |
| 982 | UTILIUM | Unraveling The Immune Landscape In Uveal Melanoma | 2018 |
| 983 | RadonACCURACY | Accuracy assessment of the annual average indoor radon concentration based on measurements of different duration | 2018 |
| 984 | SPeNTa-Brain | Synthetic Peptidic Nanovesicles for Targeting Paediatric Brain tumours | 2019 |
| 985 | Tracer-T | Analysis of the effect of the tumour microenvironment on T cell functional phenotype | 2018 |
| 986 | NanoFEITH | Nanoparticles for Fluorescence-Enhanced Imaging and Therapy of Breast Cancer | 2018 |
| 987 | ORTHOCAT | Bioorthogonal Photocatalytic Activation of Metal-Based Prodrugs | 2018 |
| 988 | MITIG | Addressing MITochondrial Import by Glioblastoma cells to rewire respiratory metabolism | 2019 |
| 989 | SHINE | Self-Healthcare for breast cancer detection using an INtegrated paper-based Electrochemical device | 2019 |
| 990 | GAE | Genomics of Ageing in Elephants: Genomic architecture of senescence in a long-lived mammal | 2018 |
| 991 | METLINK | METLINK: Identification of links between cancer cell growth and metabolism genes. | 2018 |
| 992 | TRIANGLE | A novel integrative strategy to prevent colorectal cancer within the diet-host-microbiota triangle: from organoids to human in vivo reality | 2018 |
| 993 | TFs-HSCs | The identification of the Combinatorial Transcription Factor network exerting different roles in Hematopoietic Stem Cells. | 2019 |
| 994 | OESOPHAGEAL FATE | Epithelial/Mesenchymal Cross-talk in response to injury and early tumorigenesis; a spatiotemporal perspective | 2019 |
| 995 | TOLKEDA | Modulating brain structural plasticity versus neurodegeneration via a novel mechanism involving neurotrophins and dopamine, Tolls and Kek truncated-Trk-like receptors in Drosophila. | 2018 |
| 996 | VIAR | Virus-induced autophagy restriction | 2018 |
| 997 | SinMolTermination | Single-molecule visualisation of eukaryotic DNA replication termination to uncover novel mechanisms of replication stress | 2019 |
| 998 | O6-alkylguanines | Characterisation and quantification of O6-alkylguanine DNA adducts derived from nitrosated amino acids: Risk factors in colorectal cancer. | 2019 |
| 999 | ONCOTHERANOSTICS | Advanced Theranostic Nanomedicines for Oncology. Development of new combinatorial therapies for primary and metastatic Breast Cancer. | 2019 |
| 1000 | GLYCANLIPO | Selective glycan recognition using molecularly imprinted liposomes | 2018 |
| 1001 | Proteasome in cancer | Identification of the proteasome machinery targets in human cancer | 2018 |
| 1002 | SOCELL | Self-organized biomolecular gradients for controlling cellular behaviour in cell culture | 2018 |
| 1003 | Gal3-BrainMets | A novel immunotherapy against brain metastasis: Anti-Galectin-3 | 2019 |
| 1004 | MTOAC | Multi-compartmental Tumor-on-a-Chip | 2018 |
| 1005 | InTheMLLrBALL | Innovative Therapeutic Strategies for Mixed Lineage Leukemia-rearranged B-cell Acute Lymphoblastic Leukemia | 2018 |
| 1006 | rDNAstress | Novel insights into DNA damage and stress responses in the nucleolus: Mechanisms and relevance for genomic (in)stability and cancer | 2019 |
| 1007 | VitC | Structural studies of the full-length human Vitamin C transporters: unravelling Vitamin C transport across the membrane | 2018 |
| 1008 | HYPTEMPCELL | Local hyperthermia cancer treatment studies using a new temperature-imaging-hyperthermia-microscopy instrument | 2018 |
| 1009 | MECoCaM | Human gut Microbiome, gene Expression and Colorectal Cancer: Assigning causal roles from a novel Mendelian randomization perspective. | 2018 |
| 1010 | SquaMem | Interaction of squalene-based anti-cancer and neuroprotective drugs with cell membranes: in silico study | 2018 |
| 1011 | Spectro-Metrics | Advanced Data Mining Procedures Applied to Raman Spectroscopy Investigations of Interactions between Drugs and Cells. | 2018 |
| 1012 | LEUKEYOLK | Uncovering the origin and mechanisms of Down syndrome-associated leukaemia through human induced pluripotent stem cell-derived haemopoiesis | 2019 |
| 1013 | INMARE | Injectable hydrogels for magnetically-activated, remote-controlled drug delivery | 2019 |
| 1014 | COHEMEX | Molecular mechanisms controlling exit from mitosis | 2018 |
| 1015 | OPTOLEADER | Optogenetic control of leader cell mechanobiology during collective cell migration | 2019 |
| 1016 | MELANCHOR | Understanding the Role of Motors in Subcellular Mechanics of Organelles by Controlling Myo6-Cargo Interactions in situ | 2018 |
| 1017 | MDCRC | Metabolic Dynamics in Colorectal Cancer | 2018 |
| 1018 | MECHANOIDS | Probing and controlling the three-dimensional organoid mechanobiology | 2019 |
| 1019 | PNECtumor | Mechanisms regulating pulmonary neuroendocrine cell (PNEC) growth and tumorigenesis | 2019 |
| 1020 | ProCenDecl | Synthesis and validation of chemical Probes for Centrosome Declustering: development of potent and selective anti-cancer agents. | 2019 |
| 1021 | COLOVOC | Reliable and specific urinary biomarkers for colorectal cancer | 2019 |
| 1022 | UPDWMI | Ultra-low Power Digital circuits for Wireless Medical Implants | 2018 |
| 1023 | MECHANOSITY | Mechanical regulation of cellular behaviour in 3D viscoelastic materials | 2019 |
| 1024 | YAP MECHANO | Elucidating the mechanism of mechanotransduction through YAP and TAZ | 2019 |
| 1025 | RE-IMMUNE | Intelligent Nano-encapsuled siRNA for Restoring Immune Cell Response to Cancer | 2019 |
| 1026 | VulneraBAP1 | Mechanism and vulnerability of BAP1 loss in tumor metastasis | 2018 |
| 1027 | UNNAMEd-2 | Unraveling the conceptional novel ADAM17 regulation by PP2A in metastasis formation. | 2019 |
| 1028 | IN-3D-CAN | Instrumented 3D-Printed Miniature Muscles for Cardiotoxicity Screens of Cancer Therapies | 2018 |
| 1029 | MAGNET-CELLPATCH | Multimodal magnetic cellular-patches with synergistic effects for high performance theranostics | 2019 |
| 1030 | PROMPT | New generation of porphyrinoids for mitochondria-targeted photodynamic therapy | 2019 |
| 1031 | M-Lysosomes | Identification of a novel function of lysosomes in mitosis for cancer therapy | 2019 |
| 1032 | KILNEV | Killing Senescent Cells as a Novel Method to Eliminate Nevi | 2018 |
| 1033 | EpiTFeb | Deciphering the Transcriptional Logic of TFEB activation in cell identity and cancer | 2018 |
| 1034 | HiMIN | Histone H3.3 oncogenic mutations: a role in genome instability through altered DNA repair and replication fork stability? | 2018 |
| 1035 | HDAC6_GEMM | Development of a novel genetically engineered mouse model to study the role of HDAC6 in oncogenesis and metastasis of non-small cell lung cancer. | 2018 |
| 1036 | SKin SCiENCE | Skin Keratinocyte Stem CEll proliferatioN in field CancErisation | 2018 |
| 1037 | NANOBOTS | Tumor-Targeting Nanoengineered Bioorthogonal Technologies to Fight Metastatic Cancers | 2018 |
| 1038 | FUCTURE | Fucosylated Clusterin: a novel mechanism of tumor escape from immune response | 2018 |
| 1039 | PCaProTreat | Multi-omics molecular treatment targets for Prostate Cancer | 2018 |
| 1040 | GDCOLCA | Understanding gamma delta T cells in colon cancer metastasis | 2018 |
| 1041 | ProMeta | Non-histone protein acetylation targets of KAT2A in AML | 2018 |
| 1042 | METHYVIREVOL | Virocellular hybrids and epigenomic changes as driving factors of infection driven cancers. | 2019 |
| 1043 | iCARE-2 | International Cancer Research Fellowships - 2 | 2018 |
| 1044 | MEDISS | MEDical Imaging with Superconducting Sensors | 2018 |
| 1045 | PROCHIP | Chromatin organization PROfiling with high-throughput super-resolution microscopy on a CHIP | 2018 |
| 1046 | SEQURE | Targeted complete next-generation sequencing for companion diagnostics and personalized treatment of cancer | 2018 |
| 1047 | EuroXpand | EUROpean clinical validation of a new ex vivo eXpanded stem cell theraPy for cArdiac regeNeration after acute myocarDial infarction: EUROXPAND | 2018 |
| 1048 | TRANSREG | Dissecting the role of Translational Regulation in Tumorigenesis | 2018 |
| 1049 | QuanTII | Quantitative T cell Immunology and Immunotherapy | 2018 |
| 1050 | MATURE-NK | MAnufacturing of TUmour-REactive Natural Killer cells | 2018 |
| 1051 | THERACAT | Bio-orthogonal catalysis for cancer therapy | 2018 |
| 1052 | PhaseControl | How cellular suicide programmes control phase transitions in fatty liver disease and liver cancer | 2018 |
| 1053 | PIONEER | Prostate Cancer DIagnOsis and TreatmeNt Enhancement through the Power of Big Data in EuRope | 2018 |
| 1054 | mitozippers | Mitochondrial membrane-targeted compounds for cancer therapy | 2018 |
| 1055 | GLIOGUIDE | Commercialising a novel glioblastoma targeted therapy and a companion diagnostic compound | 2018 |
| 1056 | POLICE | The PIDDosome in Centrosome and Ploidy-Surveillance | 2018 |
| 1057 | 4DBIOSERS | Four-Dimensional Monitoring of Tumour Growth by Surface Enhanced Raman Scattering | 2018 |
| 1058 | MedPlant | Harnessing the Molecules of Medicinal Plants | 2018 |
| 1059 | RadioClick | A versatile ultrafast Click platform for antibody based radio diagnostics | 2018 |
| 1060 | AUTO NERVE | Tracers for targeting nerves in the autonomic nervous system | 2018 |
| 1061 | pBioStrat-for-PDA | Use of PAP as a biomarker and stratifier of pancreatic cancer to improve patient management | 2018 |
| 1062 | mTORmorS | Role of mTOR signaling dysregulation in the tumor suppressor networks in hepatocellular carcinoma | 2019 |
| 1063 | AlloGPCR | Allosteric modulation of G-protein Coupled Receptors conformational landscape | 2018 |
| 1064 | Pan3DP | 3D bioprinting of pancreatic tissue for biomedical research | 2018 |
| 1065 | EVO-NANO | Evolvable platform for programmable nanoparticle-based cancer therapies | 2018 |
| 1066 | NICI | Non-Invasive Chemistry Imaging in the whole human body | 2018 |
| 1067 | EDIT | Novel precision technological platforms to promote non-invasive early diagnosis, eradication and prevention of cancer relapse: proof of concept in the bladder carcinoma. | 2018 |
| 1068 | TALVIN | Inhibiting mechanotransduction for the treatment of pancreatic cancer | 2018 |
| 1069 | B2B | Modeling spontaneous Breast cancer metastasis TO the Bone with a first-of-its-kind 3D device that recapitulates physiological tissue-level complexity. | 2018 |
| 1070 | NanoTBTech | Nanoparticles-based 2D thermal bioimaging technologies | 2018 |
| 1071 | SENSITIVE | Early Detection of cancer onset based on sensing field cancerization at the organ level | 2018 |
| 1072 | QuantOCancer | Leveraging the unique organismic approach to health and disease of the Champalimaud Foundation through the inception of a quantitative biomedicine research programme focused on cancer | 2018 |
| 1073 | HOPE | Host Protective Engineering of Cancer Immunity by Targeting the Intracellular Immune Checkpoint NR2F6 | 2018 |
| 1074 | LIPOMET | Dietary Influences on Metastasis: How, When, and Why | 2018 |
| 1075 | SelectiveTGFb-inhib | Pro-tumorigenic effects of TGFb - elucidation of mechanisms and development of selective inhibitors | 2018 |
| 1076 | SENCAN | Senescence therapy for cancer | 2018 |
| 1077 | AGRISCENTS | Scents and sensibility in agriculture: exploiting specificity in herbivore- and pathogen-induced plant volatiles for real-time crop monitoring | 2018 |
| 1078 | REPLICHROMA | Eukaryotic DNA replication: a single-molecule approach to the study of yeast replication on chromatin | 2018 |
| 1079 | REPLISTRESS | DNA Replication: From Physiology to Replication Stress in Human Cancer | 2018 |
| 1080 | SUMMIT | Stepping Up mRNA Mutanome Immunotherapy | 2018 |
| 1081 | DISCOVER | Death receptor signalling in tumour immune editing | 2018 |
| 1082 | RV001 | RV001: An anti-metastatic cancer vaccine | 2018 |
| 1083 | GI-BCT | Disruptive imaging technology for accurate and painless breast cancer diagnosis | 2018 |
| 1084 | SOLUPORE | Solupore® - Enabling the Manufacture of Affordable New Treatments to Cure Cancer | 2018 |
| 1085 | REGENERA | Helping cancer survivors restoring their natural breast with resorbable implants inducing selfâ€tissue regeneration | 2018 |
| 1086 | NovaTests | The first predictive test for radio-sensitivity. A step towards an improved and personalised radiation therapy cancer treatment. | 2018 |
| 1087 | LEAD | Miniature colon spectral scanner that gives real-time automatic alerts for pathological findings. | 2018 |
| 1088 | HyperCollar3D | Improving the Treatment of Head and Neck Cancer without Additional Side Effects | 2018 |
| 1089 | EpiGlioT | Epigenetic Glioblastoma Therapeutics | 2018 |
| 1090 | SCOPIO | High-resolution, all-digital microscope that applies computational methods to bring revolutionary benefits of digital microscopy to small and medium sized laboratories | 2018 |
| 1091 | SMARTRIOX | Disruptive targeted drug delivery system via synergistic combination of intelligent DNA molecular machines and gated mesoporous nanoparticles | 2018 |
| 1092 | GRUNDIUM | The world´s first portable and smart digital microscope scanner for clinical and research use | 2018 |
| 1093 | MINAPATH | MINAPATH: A novel and unique method to diagnose and prevent diseases that are caused by exposure and accumulation of inorganic mineral dusts. | 2018 |
| 1094 | MOOD | Feasibility Study for the introduction into pre-clinical study domain of the first-of-a-kind Multi Organ On Device (MOOD) technology | 2018 |
| 1095 | QTrobot | QTrobot Autism Therapy Store | 2018 |
| 1096 | KERMA | A NEW VERIFICATION SYSTEM FOR COMPLEX RADIOTHERAPY TREATMENTS | 2018 |
| 1097 | Materialize.X | Smart Bio Adhesives for the Wood Industry Powered by Machine Learning | 2018 |
| 1098 | C-TCS | A Disruptive Treatment Control Software for Particle Therapy Centers | 2018 |
| 1099 | ExitAplasia | Reg-X310: new disruptive medicine for faster exit from aplasia afetr agressive chemotherapy of hematologic malignancies | 2018 |
| 1100 | Olfactomics | Bringing Surgery to the 21st Century: Feasibility Verification of Real-time Tissue Analysis During Surgery | 2018 |
| 1101 | HepatoPredict | A decision tool for Liver Transplantation based on molecular signature | 2018 |
| 1102 | ONCORED | An unrivalled medical device based on red- light photo biomodulation to prevent, improve and remove oral mucositis and dermatitis chemo radio induced as a side effect of cancer treatment | 2018 |
| 1103 | HistologTM Scanner | Intra-operative microscope for tumor margin assessment | 2018 |
| 1104 | SenolT | Fast and effective diagnostic test for the early detection of residual tumours to prevent cancer recurrence | 2018 |
| 1105 | Rosalind | Scale-up for Next Generation Enzymatic DNA Synthesis | 2018 |
| 1106 | HPV OncoPredict | A Groundbreaking Stand-Alone Diagnostic Kit to Predict Human Papilloma Virus Infections Evolving into Cervical Cancer | 2018 |
| 1107 | TARGETSS | Targeting SWI/SNF complex function in cancer | 2019 |
| 1108 | MEsHH | DNA MEthylation for HPV-related disease among women living with HIV | 2018 |
| 1109 | SRIMEM | Super-Resolution Imaging and Mapping of Epigenetic Modifications | 2018 |
| 1110 | AbCURE_COPD | Antibody mediated clearance of senescent cells for treatment of COPD | 2018 |
| 1111 | THERMONANO | Nanoassemblies for the subcutaneous self-administration of anticancer drugs | 2018 |
| 1112 | HIPShot | HBV GenetIc and Proteomic Screen | 2019 |
| 1113 | PCAPIP | Towards understanding non-canonical phosphatidylinositol kinases in the maintenance of prostate metabolism. | 2018 |
| 1114 | TETHIS-SBS-CTC | TETHIS-SBS-CTC: An innovative diagnostic testing platform to identify and characterize circulating tumour cells (CTCs) in blood samples. | 2018 |
| 1115 | ONCOscanner | ONCOscanner – oncological probe for intra-operative identification of cancerous tissues during surgical treatment for breast cancer | 2018 |
| 1116 | Simecos | A New Adjuvant Nutraceutical from the North Atlantic Ocean for Breast, Lung and Pancreatic Cancer Patients | 2018 |
| 1117 | Oncarin | A scientifically proven Microbiome immunotherapy for the treatment of colorectal cancer | 2018 |
| 1118 | Biopsy X | Endodrill® Model X - a new endoscopic biopsy instrument taking multiple cancer samples of varying depth in one single session | 2018 |
| 1119 | ColonScan | A simple to use, accurate and cost-effective blood test for large-scale colon cancer screening | 2018 |
| 1120 | SWIRL | Short, weakly interacting RNA ligands for the development of high-concentration monoclonal antibody therapeutics | 2018 |
| 1121 | UNLEASHAD | Unleashing the curative potential of cancer immunotherapy | 2018 |
| 1122 | Milis | Milis, a novel sweet protein for use as flavouring in the food and beverage industry | 2018 |
| 1123 | SYST-iMYC | Development of an effective and safe systemic Myc inhibitor for the treatment of multiple cancer types. | 2018 |
| 1124 | SMIMS | Single Molecule Imaging Mass Spectrometry | 2018 |
| 1125 | PaSION | A longitudinal assessment of treatment experience, symptoms and potential associations with biomarkers in cancer patients undergoing immune checkpoint inhibitor therapy | 2018 |
| 1126 | LapIt | Making AML treatment a clinical reality: A novel anti-IL7 receptor antibody to deliver Lap to 5LO positive cells | 2019 |
| 1127 | ONCOSMART | ONCOlogic patient profiling and personalized treatment through SMART bedside diagnostics | 2018 |
| 1128 | SECReTE | Enhancing biological drug production through protein secretion | 2018 |
| 1129 | 2shRNA | 2shRNA branched nanobinders as promising therapeutic tools for combined cancer therapy | 2019 |
| 1130 | vAMRes | Vaccines as a remedy for antimicrobial resistant bacterial infections | 2018 |
| 1131 | SIRIUS | Simulations for Inertial Particle Microfluidics | 2019 |
| 1132 | TRIM-NET | Training network in drug discovery targeting TRIM Ubiquitin ligases in disease | 2019 |
| 1133 | UNBRACE | Investigating the Role of the Unfolded Protein Response as a Novel Targetable Pathway in BRAF Mutant Colorectal Cancer | 2019 |
| 1134 | DELIVER | DELIVERy of advanced therapies for diabetes training network | 2019 |
| 1135 | IT4B-ALL | Therapeutic immunotherapy targeting NG2 and CD22 antigens for MLL-rearranged and MLL-germline B-cell Acute Lymphoblastic Leukemia | 2019 |
| 1136 | ElectroPros | Training research pioneers by utilizing and validating the promise of electroporation for minimal invasive oncological treatments. | 2019 |
| 1137 | PML-THERAPY | HARNESSING PML NUCLEAR BODIES FOR LEUKAEMIA THERAPY | 2019 |
| 1138 | DYMOCHRO | Dynamics of modified chromatin domains | 2019 |
| 1139 | CL-IO | Commercial feasibility of non-pathogenic Clostridium-Mediated Cancer Immunotherapy: leveraging the presence of tumour hypoxia & necrosis | 2018 |
| 1140 | COCLICAN | COllaborative Consortium for the early detection of LIver CANcer | 2018 |
| 1141 | RNADIAGON | Excellence in research and development of non-coding RNA DIAGnostics in ONcology | 2019 |
| 1142 | STARNEL | supracellular contractility of myofibroblasts in gut homeostasis and cancer invasion | 2018 |
| 1143 | IROCSIM | Integrated high-resolution on-chip structured illumination microscopy | 2019 |
| 1144 | STOP | STop Obesity Platform | 2019 |
| 1145 | CytoPro | A breakthrough cancer diagnostic instrument to save 3000 years of human lives annually and up | 2018 |
| 1146 | Lung EpiCheck | Blood Samples and DNA-an Innovative Technique for Lung Cancer Diagnostics | 2018 |
| 1147 | OXIGENATED | Hemoglobin based Protein Nanocarriers for Tumour Oxygenation and a more effective Photodynamic Therapy | 2019 |
| 1148 | CoPs | Continuous hazardous water Pollutants sensing in the environment | 2018 |
| 1149 | REACT | REsponsive theranostic nanosystems for Advanced Cancer Treatment | 2019 |
| 1150 | aDDRess | Joint Training and Research Program on Chromatin Dynamics and the DNA Damage Response | 2019 |
| 1151 | EPIC | Enabling Precision Immuno-oncology in Colorectal cancer | 2018 |
| 1152 | BiopSense | Proof of concept and pre-commercialisation of personalised liquid biopsies in cancer therapy | 2018 |
| 1153 | BonePainII | A European Training Network to Combat Bone Pain | 2019 |
| 1154 | I-DireCT | Immune DIREcted and Cancer-selective immunoTherapy | 2019 |
| 1155 | MOAB | Miniaturised optically accessible bioreactor for drug discovery and biological research | 2018 |
| 1156 | EPI-X4Health | Therapeutic potential of optimized derivatives of an endogenous CXCR4 antagonist for the treatment of cancers and inflammatory diseases | 2018 |
| 1157 | RxmiRcanceR | Tumor suppressive microRNAs for cancer therapy | 2018 |
| 1158 | FunDiT | Functional Diversity of T cells | 2019 |
| 1159 | STIMUNO | Searching for novel strategies improving cancer immunotherapy | 2019 |
| 1160 | INTEGRATA | Integrating chemical and biological approaches to target NAD production and signaling in cancer | 2018 |
| 1161 | pHioniC | pH and Ion Transport in Pancreatic Cancer | 2018 |
| 1162 | MammoWave | Cutting edge microwave imaging device for safe and accurate breast cancer screening | 2018 |
| 1163 | PROTEIN | PeRsOnalized nutriTion for hEalthy livINg | 2018 |
| 1164 | VIRUSES AND RNA | RNA regulation during viral infection | 2019 |
| 1165 | COR1-TCELL | Analysis of the role for coronin 1-dependent cell density signalling in T-cell homeostasis | 2019 |
| 1166 | Meiotic telomere | Study of telomere function in germ cells, relevant to the regulations of homologous recombination and telomere length maintenance across generations | 2019 |
| 1167 | SCIPER | Studying Cancer Individuality by Personal and Predictive Drug Screening and Differential OMICs | 2018 |
| 1168 | MechanoIMM | Mechanical Immunoengineering for Enhanced T-cell Immunotherapy | 2018 |
| 1169 | LIGHTPORT | From light-stimulated anion receptors to transmembrane carriers and pumps | 2019 |
| 1170 | CANCER INVASION | Deciphering and targeting the invasive nature of Diffuse Intrinsic Pontine Glioma | 2019 |
| 1171 | PCSCT | Photon Counting Spectral Computed Tomography | 2018 |
| 1172 | MitoGuide | Integration and adaptation of impaired mitochondrial fitness in orchestrating T cell dysfunction in the tumor microenvironment | 2019 |
| 1173 | ImmunoCode | Digital Single Cell Immunology: Decoding Cellular Interactions for Improved Immunotherapy | 2018 |
| 1174 | FunHoMic | Deciphering the fungus-host-microbiota interplay to improve the management of fungal infections | 2019 |
| 1175 | DNAProteinCrosslinks | DNA-protein crosslinks: endogenous origins and cellular responses. | 2019 |
| 1176 | NextGen IO | Exploiting the hypoxia response in T cells for Next-Generation Immuno-Oncology | 2019 |
| 1177 | INFORE | Interactive Extreme-Scale Analytics and Forecasting | 2019 |
| 1178 | FIBROHALT | Advancing a novel peptide-based therapeutic for pancreatic cancer | 2018 |
| 1179 | PanCaVax | Personalised Pancreatic Cancer Vaccination Therapy derived from Autologous Tumor Cells and Neoantigens | 2018 |
| 1180 | MarginGuide | The MarginGuide: a medical device to improve the results of cancer surgery | 2018 |
| 1181 | DCDP | Digital Cancer Diagnosis Platform | 2018 |
| 1182 | p38_InTh | Innovative therapeutic tools to ameliorate chemotherapy-induced cardiotoxicity | 2018 |
| 1183 | PRIMAGE | PRedictive In-silico Multiscale Analytics to support cancer personalized diaGnosis and prognosis, Empowered by imaging biomarkers | 2018 |
| 1184 | CONQR | Translation and Commercialization of a QSOX1-inhibitory Antibody Targeting the Tumor Microenvironment in Breast Cancer | 2018 |
| 1185 | IMPACCT | Improved Patient Care by Combinatorial Treatment | 2019 |
| 1186 | Andrea | A Novel Detection protocols for REliable prostate cancer Assays | 2018 |
| 1187 | HERMES | Hybrid Enhanced Regenerative Medicine Systems | 2019 |
| 1188 | VeCare | Selective retention of VEGF for cancer and retinopathies therapeutics | 2019 |
| 1189 | SM-Epigen | Revealing the Epigenetic Regulatory Network with Single-Molecule Precision | 2018 |
| 1190 | TUMOURPRINT | High Throughput Bioprinting of Tumour Models for Drug Development and Oncology Research | 2018 |
| 1191 | LUMAX | Innovative Laser and Fiber System for Non-Toxic, Efficient and Cost-Effective Treatment of Cancer | 2018 |
| 1192 | PD_Pal | Palliative care in Parkinson’s disease | 2019 |
| 1193 | DDRMac | DNA Damage Response-instructed Macrophage Differentiation in Granulomatous Diseases | 2019 |
| 1194 | Nevada | Diagnostics device for rapid testing of prostate cancer at Point-of-care | 2018 |
| 1195 | ONCOBIOME | Gut OncoMicrobiome Signatures (GOMS) associated with cancer incidence, prognosis and prediction of treatment response. | 2019 |
| 1196 | CancerQR | Next generation cancer therapies targeting cancer networks | 2019 |
| 1197 | ELEVATE | Early detection of cervical cancer in hard-to-reach populations of women through portable and point-of-care HPV testing | 2019 |
| 1198 | FURTHER | Focused Ultrasound and RadioTHERapy for Noninvasive Palliative Pain Treatment in Patients with Bone Metastasis | 2019 |
| 1199 | LEGACy | CeLac and European consortium for a personalized medicine approach to Gastric Cancer | 2019 |
| 1200 | POLYMMUNE | Off-the-Shelf Polypeptide-based Immunotherapy for Advanced Melanoma Treatment | 2019 |
| 1201 | CLOSER | Childhood Leukemia: Overcoming distance between South America and Europe Regions | 2019 |
| 1202 | MIAMi | Refactoring monoterpenoid indole alkaloid production in microbial cell factories | 2019 |
| 1203 | VOGAS | Screening of Gastric Cancer via Breath volatile organic compounds by Hybrid Sensing Approach | 2019 |
| 1204 | ESCALON | European-Latin American network for the assessment of biomarkers to predict and diagnose hepatobiliary malignancies and characterization of risk factors for cancer development | 2019 |
| 1205 | SELNET | Sarcoma as a model to improve diagnosis and clinical care of rare tumors through a European and Latin American multidisciplinary network | 2019 |
| 1206 | TIL-FIT | Increasing the fitness of tumor-infiltrating T cells for cellular immunotherapy | 2019 |
| 1207 | REALNANO | 3D Structure of Nanomaterials under Realistic Conditions | 2019 |
| 1208 | CRYOREP | Chromosome Replication Visualised by Cryo-EM | 2019 |
| 1209 | MycoVAP | Bacterial chassis for treating ventilator-associated pneumonia (VAP) | 2019 |
| 1210 | SENSOFT | SMART SENSING FOR RAPID RESPONSE TO CHEMICAL THREATS ON SOFT TARGETS | 2019 |
| 1211 | AI-MICADIS | Artificial Intelligence System for Multi-Cancer Detection Support | 2019 |
| 1212 | IVD4Sepsis | Novel ultrasensitive detection device for early Sepsis diagnosis | 2019 |
| 1213 | Mercurius Connect | Mercurius Connect | 2019 |
| 1214 | MAMSCAN | New Method for Early Stage Breast Cancer Detection | 2019 |
| 1215 | MAMMO1 | Deep learning for mammography: Improving accuracy and productivity in breast cancer diagnosis. | 2019 |
| 1216 | PalliativeSedation | The use of proportional palliative sedation for the relief of refractory symptoms: an international multicenter study | 2019 |
| 1217 | METANICHE | Regulation of bone metastases by age-associated angiocrine signals | 2019 |
| 1218 | ENDOMICS | Raman Endoscopic Proteo-lipidomics of Bladder Cancer | 2019 |
| 1219 | EpiTune | Epigenetic fine-tuning of T cells for improved adoptive cell therapy | 2019 |
| 1220 | GRAHAM | Concepts of Graph Theory Applied to the Human Microbiome | 2018 |
| 1221 | BIOMORPHIC | Brain-Inspired Organic Modular Lab-on-a-Chip for Cell Classification | 2019 |
| 1222 | iNANOVAC4CANCER | BIOHYBRID AND BIODEGRADABLE NANOVACCINES FOR CANCER IMMUNOTHERAPY | 2019 |
| 1223 | FTHPC | Fault Tolerant High Performance Computing | 2019 |
| 1224 | BARINAFLD | Using Bariatric Surgery to Discover Weight-Loss Independent Mechanisms Leading to the Reversal of Fatty Liver Disease | 2018 |
| 1225 | TCRabX | Structural basis for the therapeutic efficiency of optimal-affinity T cell receptors | 2019 |
| 1226 | HYPROTIN | Hyperpolarized Nuclear Magnetic Resonance Spectroscopy for Time-Resolved Monitoring of Interactions of Intrinsically Disordered Breast-Cancer Proteins | 2019 |
| 1227 | 3D-nanoMorph | Label-free 3D morphological nanoscopy for studying sub-cellular dynamics in live cancer cells with high spatio-temporal resolution | 2019 |
| 1228 | ProteoNE_dynamics | Surveillance mechanisms regulating nuclear envelope architecture and homeostasis | 2019 |
| 1229 | MagentiqEye | Automatic Polyp Detection System | 2019 |
| 1230 | 3DLT | 3D Living Tissues | 2019 |
| 1231 | GLADIATOR | Next-generation theranostics of brain pathologies with autonomous externally controllable nanonetworks: a trans-disciplinary approach with bio-nanodevice interfaces | 2019 |
| 1232 | CANCER SCAN | A Body Scan for Cancer Detection using Quantum Technology | 2019 |
| 1233 | FRINGE | Fluorescence and Reactive oxygen Intermediates by Neutron Generated electronic Excitation as a foundation for radically new cancer therapies | 2019 |
| 1234 | SEPSCAV | SCAVENGING ON SEPSIS. DEVELOPMENT OF SEPSIS SPECIFIC DRUGS FROM HUMAN SCAVENGER RECEPTORS | 2019 |
| 1235 | GlyCan | Innovative Glycan-based analysis for Cancer diagnostics | 2019 |
| 1236 | ReSpire | Respirable Advanced Therapeutics for Cystic Fibrosis & other Lung Diseases | 2019 |
| 1237 | Vezics | Highly efficient, scalable chromatography platform for high-quality exosome isolation | 2019 |
| 1238 | CANCEREVO | Deciphering and predicting the evolution of cancer cell populations | 2019 |
| 1239 | FanCY | Flow and Deformation of Cancer tumours near Yielding | 2019 |
| 1240 | SUMMIT | Site-specific Ultrasensitive Magnetic resonance of Mixtures for Isotopic Tracking | 2019 |
| 1241 | MultiplexGenomics | Exploring the Epigenome by Multiplexed Physical Mapping of Individual Chromosomes | 2019 |
| 1242 | PROTONMBRT | Spatial fractionation of the dose in proton therapy: a novel therapeutic approach | 2019 |
| 1243 | bECOMiNG | spontaneous Evolution and Clonal heterOgeneity in MoNoclonal Gammopathies: from mechanisms of progression to clinical management | 2019 |
| 1244 | ImmunoBioSynth | Synergistic engineering of anti-tumor immunity by synthetic biomaterials | 2019 |
| 1245 | STEP 2 | Spatiotemporal regulation of T-cell Priming | 2019 |
| 1246 | ONCOFUM | Integrating the tissue-specificity and chronology of hereditary renal cancer predisposition | 2019 |
| 1247 | PanCareFollowUp | PanCareFollowUp: Novel, patient-centred survivorship care to improve care quality, effectiveness, cost-effectiveness and accessibility for survivors and caregivers | 2019 |
| 1248 | PREFERABLE | Project on Exercise for Fatigue Eradication in Advanced Breast cancer to improve quality of life | 2019 |
| 1249 | DIAdIC | Evaluation of Dyadic Psychoeducational Interventions for People with Advanced Cancer and their Informal Caregivers (DIAdIC): An international randomized controlled trial | 2019 |
| 1250 | HEADSpAcE | Translational studies of HEAD and neck cancer in South America and Europe | 2019 |
| 1251 | MyPal | MyPal: Fostering Palliative Care of Adults and Children with Cancer through Advanced Patient Reported Outcome Systems | 2019 |
| 1252 | AURORAX | Advancing cancer detection through metabolism-based diagnostics | 2019 |
| 1253 | Lakhesys | Lakhesys: building the machine to make the medicines of tomorrow | 2019 |
| 1254 | Metachip | A pan-cancer diagnostic platform based on nanobiotechnology and machine learning for simple and accessible early cancer detection | 2019 |
| 1255 | BioLyco | Biologic Lycopene from Tomatoes | 2019 |
| 1256 | MP-101 | a novel drug for prevention and treatment peripheral neuropathy symptoms | 2019 |
| 1257 | SAFE-N-MEDTECH | SAFETY TESTING IN THE LIFE CYCLE OF NANOTECHNOLOGY-ENABLED MEDICAL TECHNOLOGIES FOR HEALTH. | 2019 |
| 1258 | iPC | individualizedPaediatricCure: Cloud-based virtual-patient models for precision paediatric oncology | 2019 |
| 1259 | CancerFingerPrints | Identification of nano-mechanical fingerprints as a biomarker for cancer treatment prognosis | 2019 |
| 1260 | POCON | Proof-of-Concept of a nanobody targeting Osteopontin to inhibit colorectal cancer development | 2019 |
| 1261 | Olfactomics Surgery | BRINGING SURGERY TO THE 21ST CENTURY: REAL-TIME TISSUE ANALYSIS DURING CANCER SURGERY. Improving Patient Safety, Quality and Cost-Effectiveness | 2019 |
| 1262 | SECRETE-HF | SECRETED FACTORS IN CARDIAC REMODELING PROVOKE TUMORIGENESIS AND END ORGAN DAMAGE IN HEART FAILURE | 2019 |
| 1263 | Cluster-Buster | Development of small molecule inhibitors of circulating tumor cell clusters | 2019 |
| 1264 | mitoUPR | Cellular modulation by the mitochondrial unfolded protein response | 2019 |
| 1265 | IntratumoralNiche | Defining heterocellular signalling within the intratumoral stem cell niche of colorectal cancer | 2019 |
| 1266 | CRC-MTOs | Colorectal Cancer Mouse Tumor Organoids as Pre-clinical Models for Therapeutical Testing | 2018 |
| 1267 | RAPID | RAPID MIGRAINE RELIEF WITH ALGINATE-BASED THIN FILM | 2018 |
| 1268 | DermoSafe 2.0 | An Integral Platform for the Early Diagnosis of Skin Cancer | 2018 |
| 1269 | VESSEL CO-COPTION | Vessel co-option and radioresistance in glioblastoma | 2019 |
| 1270 | SUPRAVACC | Supramolecular engineering of glycan-decorated peptides as synthetic vaccines | 2019 |
| 1271 | iReceptor Plus | ARCHITECTURE AND TOOLS FOR THE QUERY OF ANTIBODY AND T-CELL RECEPTOR SEQUENCING DATA REPOSITORIES FOR ENABLING IMPROVED PERSONALIZED MEDICINE AND IMMUNOTHERAPY | 2019 |
| 1272 | EUCANCan | EUCANCan: a federated network of aligned and interoperable infrastructures for the homogeneous analysis, management and sharing of genomic oncology data for Personalized Medicine. | 2019 |
| 1273 | 20SInhibitor | Selective 20S proteasome inhibition for multiple myeloma therapy | 2019 |
| 1274 | Facer | The First Cell Culture Platform that Enables Affordable Cell Therapies at a Large Scale | 2019 |
| 1275 | HyPPOCRATES | Medical Hyperspectral Image and Video Processing and Interpretation via Constrained Matrix and Tensor Factorization | 2019 |
| 1276 | Visual Proteomics | Biomarker discovery by AI-guided, image based single-cell isolation proteomics | 2019 |
| 1277 | IMaP | Imaging tumor vessels as a marker for p53 mutation status in cancer | 2020 |
| 1278 | Biosensor Design | Engineering Chemotactic Biosensors for a Diverse Spectrum of Metastatic Markers | 2020 |
| 1279 | INHuMAN | Intra-tumoral heterogeneity in NRAS-driven metastatic melanoma | 2019 |
| 1280 | PICModForPCa | Personalised Image-based Computational Modelling Framework to Forecast Prostate Cancer | 2020 |
| 1281 | IRF4 Degradation | Using a novel protein degradation approach to uncover IRF4-regulated genes in plasma cells | 2019 |
| 1282 | scTALLmap | Single-cell map of the composition and evolution of T-cell acute lymphoblastic leukemia | 2019 |
| 1283 | SYNKIT | Synthetic Natural Killer Cells for Immunotherapy | 2020 |
| 1284 | Oncogenic PI3-kinase | New biology of oncogenic PI 3-kinase | 2019 |
| 1285 | Kinaddict | Vulnerability of esophageal cancer to their addiction to kinase activities: evaluation and prediction of eSCC tumors responsiveness to kinase inhibitors. | 2019 |
| 1286 | RESIST3D | Targeting drug resistance in ovarian cancer through large-scale drug-response profiling in physiologically relevant cancer organoids | 2020 |
| 1287 | BrEXo-Apt | Non-invasive and accurate diagnosis and treatment of breast cancer. | 2019 |
| 1288 | GlyCANswer | Decoding the Cancer Glycoproteome Driven Immune Response | 2019 |
| 1289 | REAP | Repair of DNA lesions induced by platinum drugs | 2019 |
| 1290 | GPCR-MS | Molecular Details of Membrane Protein Receptor Dynamics | 2019 |
| 1291 | Centromere Stability | Mechanisms that maintain centromere DNA repeats stability in human cells. | 2020 |
| 1292 | TRACERxTME | Constructing an evolutionary atlas of the immune landscape in lung cancer | 2019 |
| 1293 | CApaCITy | CAncer Stem Cell Imunoreceptors as potential Targets for skin Squamous cell carcinoma | 2019 |
| 1294 | THERMOGUIDE | Optimizing delivery and effectiveness of chemotherapy in breast cancer patients using thermotherapy under image-guidance | 2019 |
| 1295 | EOBRECA | Differential Roles of Estrogens in Obesity-mediated ER+ Breast Cancer Development | 2019 |
| 1296 | EVOMET | The rise and fall of metastatic clones under immune attack | 2019 |
| 1297 | Neu-i-Gut | Neural regulation of the immune system in the Gut | 2020 |
| 1298 | PCinBC | Plasma cell heterogeneity and dynamics in patient tumors | 2019 |
| 1299 | INTEGRIN REGULATION | Functional analysis of the kinome and phosphatome as determinants of integrin phosphorylation in cancer | 2019 |
| 1300 | BCLLatlas | Single-cell genomics to comprehensively understand healthy B-cell maturation and transformation to chronic lymphocytic leukemia | 2019 |
| 1301 | DC Metabolism | Metabolic Regulation of Conventional Dendritic Cell Development and Function | 2020 |
| 1302 | MacrophInt | Targeting integrin signaling in tumour-associated macrophages to combat cancer progression and resistance | 2019 |
| 1303 | ImmunoMECH | High-performance biomechanical model of combined immunotherapy and anti-angiogenic cancer treatment | 2019 |
| 1304 | INTERACT | Phylogenetic association mapping and its application to secondary metabolite variation in Brassicaceae species | 2019 |
| 1305 | Need2immune | Personalized liposomal cancer vaccines within days by rapid formulation screening | 2019 |
| 1306 | EndoPos | Endosome positioning in tumour-stroma interactions | 2019 |
| 1307 | BispecificsThatClick | Combinatorial Antibody Synthesis for the Discovery of New Anti-Tumour Immunomodulators | 2019 |
| 1308 | AR-DDR | Co-targeting androgen receptor signalling and DNA damage repair for precision therapy in advanced prostate cancer | 2019 |
| 1309 | PB_dormancy | Insertional mutagenesis to identify molecular mechanisms of breast cancer dormancy and metastasis | 2020 |
| 1310 | TorsionAtLamina | TWISTING THE BOUNDARIES: ROLE OF TOPOISOMERASE 1 AT THE NUCLEAR LAMINA | 2020 |
| 1311 | PI3K MODULATORS | Identification and characterisation of new class of PI3K modulators in oncology | 2019 |
| 1312 | TRIDOS | Targeted Radiotherapy Internal Dosimetry: A platform for individualized patient dosimetry and radiobiological assessment | 2019 |
| 1313 | CentrosoTME | The role of extra centrosomes on the tumour microenvironment | 2019 |
| 1314 | Exh-Res-CART | Exhaustion-resistant CAR-T cells for the treatment of solid tumours | 2019 |
| 1315 | MetaTarGet | Targeting metabolic regulation in metastasis formation | 2019 |
| 1316 | IEOCCD | THE IMPACT OF THE ENVIRONMENT AND ONCOGENESIS ON CANCER CELL DIVISIONS | 2019 |
| 1317 | iRhomADAM | Uncovering the role of the iRhom2-ADAM17 interaction in inflammatory signalling | 2020 |
| 1318 | PanILC | Deciphering type 2 innate lymphoid cell/epithelial progenitor cell crosstalk in pancreas regeneration and neoplasia | 2019 |
| 1319 | MImETIC INDiRECT | MIcrovascularizED Tumour-on-chip for Cellular ImagiNg of Drug Response and Cell moTility | 2019 |
| 1320 | MGLycan | Targeting hMGL-GalNAc interactions to reverse immune suppression in cancer | 2019 |
| 1321 | UMMATR | Uncovering molecular mechanisms of active transcriptional repression. | 2020 |
| 1322 | BIOplasma | Use flexible Tube Micro Plasma (FµTP) for Lipidomics | 2019 |
| 1323 | NanoEnHanCeMent | Nanoparticle Enhanced Hadron-therapy: a Comprehensive Mechanistic description | 2020 |
| 1324 | MechTransition | Regulatory mechanisms controlling a new mechanical Epithelial to Mesenchymal Transition in zebrafish | 2020 |
| 1325 | PhotoStem | Photoswitching molecules for the spatiotemporal control of cancer stem cells with light | 2019 |
| 1326 | PDX-PC | Elucidation of tumour cell plasticity mechanisms associated to treatment in metastatic prostate cancer | 2019 |
| 1327 | META2 | METAbolism of bone METAstasis (META2): Metabolic interactions between disseminated breast cancer cells and osteoblast lineage cells drive bone metastases formation | 2019 |
| 1328 | ARGONAUT | ARGONAUT: from the synthesis of gAnglioside tumouR antiGens to a platfOrm for caNcer Active immUnoTherapy | 2019 |
| 1329 | PredAlgoBC | Machine learning prediction for breast cancer therapy | 2019 |
| 1330 | qCHROMDEK | Quantitative insight into chromatin nanoscale structure: sub-nuclear organisation of oncoprotein DEK | 2019 |
| 1331 | IDEAL | Inhibitor of DUX4-IGH to Erase Acute lymphoblastic Leukaemia | 2020 |
| 1332 | GOLDEN | Gold-Functionalized Devices and Engineered Nanoparticles: Bioorthogonal Tools for Unprecedented Biomedical Applications | 2019 |
| 1333 | RecPAIR | Genetic landscape of the homology search | 2019 |
| 1334 | INFORM | Innovative Electrochemical Multiplex Biosensor for Detection and Quantification of Clinically Relevant Circulating miRNAs | 2020 |
| 1335 | ICE-METs | Interstitium-on-a-chip to explore its role in cancer metastasis | 2019 |
| 1336 | POLAR STAR | Polymeric cyclodextrin-based nanoparticles for combination therapy of castrate-resistant prostate cancer | 2019 |
| 1337 | Adductomics | Novel DNA adductomics methodological developments for research in colon cancer | 2019 |
| 1338 | MINT | Multifunctional Immunocompatible NanoTheranostics to modulate tumor microenvironment and improve treatment monitoring: A double blow to pancreatic cancer | 2019 |
| 1339 | Tumor microbiome | The tumor microbial communities: Characterization, effects and translational opportunities | 2019 |
| 1340 | UreaCa | Deciphering the metabolic roles of the urea-cycle pathway in carcinogenesis for improving diagnosis and therapy | 2019 |
| 1341 | CancerADAPT | Targeting the adaptive capacity of prostate cancer through the manipulation of transcriptional and metabolic traits | 2019 |
| 1342 | MATRIX | Novel mitochondria-targeted therapies for cancer treatment-induced cardiotoxicity | 2019 |
| 1343 | BRAIN-MATCH | Matching CNS Lineage Maps with Molecular Brain Tumor Portraits for Translational Exploitation | 2019 |
| 1344 | METASPINE | Comprehensive experimental and computational mechanical characterisation of metastatic vertebrae | 2019 |
| 1345 | Biochip-images | A Breast Cancer Biomarker Point of CarePOCDiagnostic Platform Integrating Dual-Functionalized Nanoparticle for Magnetic Gradient Ranking and Electrochemical Sensing | 2019 |
| 1346 | NanoProt-ID | Proteome profiling using plasmonic nanopore sensors | 2019 |
| 1347 | RegulatioNFkB | Deciphering transcriptional regulation of NF-kB target genes using integrative omics approaches | 2019 |
| 1348 | FUNTRICAN | Functional analysis of thyroid hormone nuclear receptors TRs in human Intestinal Cancer stem cells | 2019 |
| 1349 | LYSOKIN | Architecture and regulation of PI3KC2β lipid kinase complex for nutrient signaling at the lysosome | 2020 |
| 1350 | MICROX | Microscopy of living cancer cells at physiological oxygen levels: the MICROX platform | 2019 |
| 1351 | RegADyn | In vivo characterization of novel actin dynamic regulators during cell migration | 2020 |
| 1352 | TargetDUBs | Targeting ubiquitin processing in cancer and fibrosis: novel probes for the Ubiquitin Carboxy-Terminal Hydrolases | 2019 |
| 1353 | SUPERBRAIN | Magneto-Plasmonic, Raman active Nanocapsules for Superior Pediatric Brain Cancer Therapy | 2020 |
| 1354 | MultiPan | A Multi-omics Approach To Decode Epigenetic Lesions In Pancreatic Cancer Development | 2019 |
| 1355 | MIMIC | Mapping and modulating integrin mediated interactions | 2020 |
| 1356 | MIMIC | Deciphering how microbiota modulate anti-tumor immune responses in checkpoint therapy | 2020 |
| 1357 | MONET | Merkel cell polyomavirus Oncogenic Network | 2019 |
| 1358 | PulsatERK | Intracellular ERK signalling dynamics mediated epidermal stem cell fate control | 2019 |
| 1359 | TargetGBM | Generating a targeted, brain-permeable and stable polymeric nanoparticle for systemic gene delivery to glioblastoma | 2019 |
| 1360 | BITFORM | Multiplexed biosensing and tissue-on-a-chip integrated platform for breast cancer biomarkers monitoring | 2019 |
| 1361 | H. Pylori-Scopy | Biophotonic Spectroscopic tool for Helicobacter Pylori diagnosis - a pathway for low cost clinical robotic device | 2019 |
| 1362 | ICL CHROM | DNA interstrand crosslink repair and chromatin remodelling | 2020 |
| 1363 | OCTAV | A novel approach to non-invasive and personalized skin cancer diagnosis | 2019 |
| 1364 | MIRACLE | Metabolic Imaging with RF Antennas to predict Chemotherapy Efficacy | 2019 |
| 1365 | CB-103 | First effective targeted therapy for T-cell acute lymphoblastic leukemia (T-ALL) and other NOTCH pathway driven cancers | 2019 |
| 1366 | Geme.io | Utilizing Urban Tech to Power Smarter Cities | 2019 |
| 1367 | TARGLIO | Improved glioblastoma treatment through targeted, local drug delivery | 2019 |
| 1368 | Hyalcis | Hyaluronic-Cisplatin Film for Implant in Malignant Mesothelioma Recurrence | 2019 |
| 1369 | MS-INFINITE | MASS SPECTROMETRY WITHOUT LIMITS: Pioneer MS equipment and Automated Sample Preparation unit to boost New Therapies Development | 2019 |
| 1370 | INTRA | The first ultrasound-compatible cranial prosthesis enabling diagnostic and therapeutic use of ultrasound in brain pathologies | 2019 |
| 1371 | IBL-302 | Inflection Bioscience unique dual mechanism, small molecule, orally available therapeutic targeting major unmet medical needs in breast cancer | 2019 |
| 1372 | QuiescStemGBM | Studying the role of Quiescent Cancer Stem Cells in GBM development using a novel in vivo cell cycle-based approach | 2020 |
| 1373 | ActiveMatter | Active Matter: From Fundamental Science to Technological Applications | 2019 |
| 1374 | SynProAtCell | Delivery and On-Demand Activation of Chemically Synthesized and Uniquely Modified Proteins in Living Cells | 2019 |
| 1375 | HealthierWomen | A woman's reproductive experience: Long-term implications for chronic disease and death | 2019 |
| 1376 | CAN-IT-BARRIERS | Disruption of systemic and microenvironmental barriers to immunotherapy of antigenic tumors | 2020 |
| 1377 | PROTEUS | Predicting Routes Of Tumour Evolution driven by Unstable genomes and Selection | 2019 |
| 1378 | EPICAN | Inhibiting tumor cell plasticity by targeting the epigenome in breast cancer | 2020 |
| 1379 | ISAC | International Study on Age-related disparity in Cancer patient survival | 2019 |
| 1380 | Mitobetes | The role of Von Willebrand Domain-containing Protein 8 in mitochondrial physiology | 2020 |
| 1381 | CHyMERA | Monitoring cancer heterogeneity based on the dynamic assessment of the Warburg effect under metabolic perturbation | 2019 |
| 1382 | GlycoMabs | Chemoenzymatic glyco-engineering of therapeutic monoclonal antibodies | 2019 |
| 1383 | HARMONIC | Health effects of cArdiac fluoRoscopy and MOderN radIotherapy in paediatriCs | 2019 |
| 1384 | EuReCa | Institut Curie EuReCa PhD Programme | 2020 |
| 1385 | BodyDMI | Development of deuterium metabolic imaging to map body biochemistry with MRI | 2019 |
| 1386 | SCANRESIST | Reversal of anti-cancer drug resistance | 2019 |
| 1387 | ONCOTECT | Early detection of tumor DNA in liquid biopsies as a biomarker of cancer recurrence | 2019 |
| 1388 | PEAR | Plasmonic Electronically Addressable super-Resolution: Accelerating the in-depth understanding of biomedical processes at the nanoscale via a novel real-time, optical limit-breaking imaging technology | 2019 |
| 1389 | GAIA-Health | GAIA-Health: microbiome suite for personalized medicine | 2019 |
| 1390 | SIMCARE | SImulation-assisted Minimally invasive CAncer tREatment using the gosmart environment | 2019 |
| 1391 | ONCO-BOOST | Boosting immuno-oncology strategies with innovative immuno-stimulants derived from bacteria, to be administrated in combination with therapeutic monoclonal antibodies | 2019 |
| 1392 | SCOPE | Schwann Cell Options for chronic Pain Eradication | 2019 |
| 1393 | SPLITVAC | Harnessing the innate and adaptive immune system with targeted neoantigen based cancer vaccines | 2019 |
| 1394 | Nadam-G | Nanocoating deposition of anti-fingerprint and fluorine free material on glass for optical lenses and solar panels industry | 2019 |
| 1395 | Breakborder | Breaking borders, Functional genetic screens of structural regulatory DNA elements | 2019 |
| 1396 | 3DBrainStrom | Brain metastases: Deciphering tumor-stroma interactions in three dimensions for the rational design of nanomedicines | 2019 |
| 1397 | 5G-HEART | 5G HEalth AquacultuRe and Transport validation trials | 2019 |
| 1398 | NGI | Next Generation Imaging | 2019 |
| 1399 | LOUISA 3D | Innovative 3-dimensional optoacoustic imaging for safe breast cancer screening | 2019 |
| 1400 | KINETICfinder | KINETICfinder: A disruptive method to determine kinetic profiles in drug discoveries | 2019 |
| 1401 | CTI | A novel, efficient and minimally invasive medical procedure to treat anastomotic leakage during colorectal cancer surgery. | 2019 |
| 1402 | RESTORE | RESTORE Health by Advanced Therapies (Advanced Therapy Medicinal Products and Biologized Medical Devices) – ALL for Advanced Therapies – with Passion – For Patients | 2019 |
| 1403 | Genetic Vaccine | Study the therapeutic and preventive potential of targeting oncogenic mutations with CRISPR-Cas9 technology | 2019 |
| 1404 | NETCONTROLOGY | Controllability of biological networks | 2020 |
| 1405 | EpiSeq | Single molecule sequencing and biophysical properties of oxidized genomic DNA using magnetic tweezers. | 2019 |
| 1406 | FRC BioEnergetics | Functional dissection of metabolic checkpoints in lymph node fibroblastic reticular cells | 2020 |
| 1407 | UNPACK PD-L1 | Molecular mechanism and inhibition of extracellular vesicle-mediated PD-L1 release in melanoma cells | 2020 |
| 1408 | AL4BIOCH | Assembly Lines for Biocombinatorial Chemistry | 2019 |
| 1409 | CLOCK | Characterization of the circadian chromatin landscape using a novel CRISPR/Cas9-guided proximity-labelling technique | 2020 |
| 1410 | RepDiff | Revealing novel molecular mechanisms linking DNA replication and cell fate decisions | 2020 |
| 1411 | SIMULTANEOUS DBTMI | Preclinical and Pilot Co-Clinical Evaluation of Simultaneous Digital Breast Tomosynthesis and Mechanical Imaging | 2019 |
| 1412 | MetEpiC | P53-dependent Metabolic and Epigenetic Reprogramming in Carcinogenesis | 2020 |
| 1413 | MS | Unravelling the molecular and cellular mechanism of metastasis | 2020 |
| 1414 | IMPACT | Improving DNA Analysis for Correct Healthcare | 2019 |
| 1415 | MECADISTEM | A new and innovative method to extract adipose Stromal Vascular Fraction: Application in post-prostatectomy erectile dysfunction | 2019 |
| 1416 | U-TURBT | A revolutionary shape memory alloy-based disposable device for bladder cancer removal | 2019 |
| 1417 | CareMin650 | An unrivalled medical device for severe cancer treatment complications:exact & easy red-LED photobiomodulation for mucositis and dermatitis | 2019 |
| 1418 | NextGen-O2k | Next Generation Instrument for In-Depth Analysis of Mitochondrial Fitness | 2019 |
| 1419 | MEDIVAC | Machine learning software to design personalized neoantigen vaccines tailored to specific vaccine delivery systems | 2019 |
| 1420 | ReSurg | Realistic, accessible, and affordable models for surgical education | 2019 |
| 1421 | NEXIM | A Next-generation targeted immuno-oncology therapy | 2019 |
| 1422 | VACCIBIOME | Cancer Vaccines and Gut Microbiome: a rational approach to optimize cancer immunotherapy | 2019 |
| 1423 | ARTimmune | Programmable ARTificial immune systems to fight cancer | 2019 |
| 1424 | Anti-L1CAM | Anti-L1CAM antibody: A novel efficacious immunotherapy for pancreatic and ovarian cancer patients | 2019 |
| 1425 | RASImmune | Targeting RAS driven tumour immune evasion | 2019 |
| 1426 | TOPAS | Exploiting the Tumor Proteome Activity Status for Future Cancer Therapies | 2019 |
| 1427 | APAC | Advanced Pain Control – An innovation in pain control for those suffering from secondary bone cancer | 2019 |
| 1428 | MitoCRISTAE | Mitochondrial Cristae Biogenesis | 2019 |
| 1429 | BiomStrip | Over-The-Counter Test Strip for Early-Stage Cancer Screening | 2019 |
| 1430 | PYRATEX | Natural, health-benefiting fabrics to protect our skin from external agents | 2019 |
| 1431 | SIMICA | Site-selective protein-modification chemistries for antibody-drug conjugates (ADCs) | 2019 |
| 1432 | MaNaCa | Magnetic Nanohybrids for Cancer Therapy | 2019 |
| 1433 | Chaperon | ERA Chair Position for Excellent Research in Oncology | 2019 |
| 1434 | EXPERT | EXpanding Platforms for Efficacious mRNA Therapeutics | 2019 |
| 1435 | MABIOS | The first microalgae platform for the production of anticancer biopharmaceuticals | 2019 |
| 1436 | GACD | Global Alliance for Chronic Diseases Secretariat | 2019 |
| 1437 | IMpaCT | Imaging life from Molecules to cells - building knowledge on Cryo-electron microscopy methodologies | 2019 |
| 1438 | VISION | Strategies to strengthen scientific excellence and innoVation capacIty for early diagnoSIs of gastrOintestinal caNcers | 2019 |
| 1439 | REMODEL | Research models in infection, cancer and regeneration: replacement and translation | 2019 |
| 1440 | Promitil | Promitil® - a new ‘smart’ nanomedicine for cancer chemo-radiotherapy. | 2019 |
| 1441 | TAcTIC | TArgeTed molecular Imaging and surgery for gastro-intestinal Cancer | 2019 |
| 1442 | INJURMET | Impact of tissue injury induced by diagnostic biopsies and surgery on cancer metastasis | 2019 |
| 1443 | CHRONO | Chronotype, health and family: The role of biology, socio- and natural environment and their interaction | 2019 |
| 1444 | COMBIVET | Setting up the ERA Chair of Comparative Medicine in the Institute of Veterinary Medicine and Animal Sciences of the Estonian University of Life Sciences | 2019 |
| 1445 | Angio-NYT | Investigating the crosstalk between Notch and YAP/TAZ in sprouting angiogenesis | 2020 |
| 1446 | TK-NEO | Personalized Cancer Immunotherapy through DNA-EP vaccines | 2019 |
| 1447 | ImmunoGrow | Making life-saving cancer therapies more widely available by simplifying production processes, reducing costs and enhancing patient safety through its patent-protected biomimicking mesh material. | 2019 |
| 1448 | WMT | A scalable, low cost solution for healthy mineralization of drinking water | 2019 |
| 1449 | VISIOCYT | VISIOCYT SCREENING: A DISRUPTIVE ARTIFICIAL INTELLIGENCE SOLUTION FOR BLADDER CANCER SCREENING | 2019 |
| 1450 | WineALaCarte | Commercial appliance for an on-demand & custom reduction of alcohol in wine | 2019 |
| 1451 | FRAME | FRAME - tumor genome-based personalized anti-cancer vaccines off-the-shelf | 2019 |
| 1452 | SCMS | ScreenCancer Mole Scanner - Easily accessible mole scanning service for early detection of skin cancer. | 2019 |
| 1453 | Salmino | Regaining health through Salmon discards | 2019 |
| 1454 | AstaFerm | A natural and high quality ingredient for dietary supplement derived from yeast fermentation to reduce oxidative stress and promote health and wellbeing | 2019 |
| 1455 | SYNPEP | Synthetic biology of non-ribosomal peptide synthetases to generate new peptides | 2019 |
| 1456 | IL7RsignaTHER | Antibody-based IL-7R targeted therapies | 2020 |
| 1457 | MechanoGPER | Development of GPER agonists as a novel therapeutic option for pancreatic cancer | 2019 |
| 1458 | Archimede | An Archimedes-inspired sit-to-stand desk to tackle workplace sedentarism | 2019 |
| 1459 | RASMAC | Regulatory Approved Software for Mutation Analysis in Cancer | 2019 |
| 1460 | IMMUNOTRAP | Diagnosis test for immuno-oncology therapies. | 2019 |
| 1461 | MERWIS | Melanoma Early Warning System | 2019 |
| 1462 | AntiHelix | DNA helicases in genome maintenance: from molecular and cellular mechanisms to specific inhibitors as potential drugs | 2019 |
| 1463 | ENHPATHY | Molecular basis of human enhanceropathies | 2020 |
| 1464 | SECRET | Exploitation of the SECRETory pathway for cancer therapy to address European research | 2019 |
| 1465 | THERADNET | International NETwork for training and innovations in THErapeutic RADiation | 2019 |
| 1466 | PROTON | Proton transport and proton-coupled transport | 2019 |
| 1467 | proEVLifeCycle | The life cycle of extracellular vesicles in prostate cancer: from biogenesis and homing, to functional relevance | 2019 |
| 1468 | INODE | INODE - Intelligent Open Data Exploration | 2019 |
| 1469 | HEPCAN | A Humanized Monoclonal Anti-Claudin1 Antibody (anti-CLDN1 mAb) for Treatment of Hepatocellular Carcinoma (HCC) | 2019 |
| 1470 | LymphoDrain | LymphoDrain: The definitive solution for chronic lymphedema | 2019 |
| 1471 | CANCERPREV | Innovative strategies for cancer prevention with focus on sex hormone signaling and chronic inflammation | 2019 |
| 1472 | EULAT Eradicate GBC | Establishment and Exploitation of a European-Latin American Research Consortium towards Eradication of Preventable Gallbladder Cancer | 2019 |
| 1473 | HeatNMof | Heating triggered drug release from nanometric inorganic-metal organic framework composites | 2020 |
| 1474 | PRECODE | PancREatic Cancer OrganoiDs rEsearch Network | 2019 |
| 1475 | BeMAGIC | Magnetoelectrics Beyond 2020: A Training Programme on Energy-Efficient Magnetoelectric Nanomaterials for Advanced Information and Healthcare Technologies | 2019 |
| 1476 | 3DCanPredict | Predicting clinical response to anticancer drugs using 3D-bioprinted tumor models for personalized therapy | 2019 |
| 1477 | LIVELMIA | Innovative assay for microRNAs analysis | 2019 |
| 1478 | ONCORNET2.0 | ONCOgenic Receptor Network of Excellence and Training 2.0 | 2020 |
| 1479 | LycoSOL | Feasibility Analysis on the Extraction of Lycopene from Tomato Peel through Organic Synthesis | 2019 |
| 1480 | OSAvit-D | POINT OF CARE DEVICE FOR VITAMIN D DEFICIENCY MONITORING | 2019 |
| 1481 | MYCure | Innovative cancer therapy through Myc inhibition: taking OMO-103 to market | 2019 |
| 1482 | NeutroCure | Development of “smart” amplifiers of reactive oxygen species specific to aberrant polymorphonuclear neutrophils for treatment of inflammatory and autoimmune diseases, cancer and myeloablation. | 2020 |
| 1483 | mRNA NanoDeli | Application of RNA nanotechnology for delivery of mRNA therapeutics | 2019 |
| 1484 | PHOTOPARS | Development of a prototype clinical photoacoustic scanner for use in plastic and reconstructive surgery | 2020 |
| 1485 | CAST | Active Monitoring of Cancer As An Alternative To Surgery | 2019 |
| 1486 | Cell2Cell | What makes a successfull pathogen? Understanding the impact of cell-to-cell heterogeneity in chromatin structure on infection and adaptation | 2019 |
| 1487 | StaphIMPACT | SA.100: Next-generation targeted antibacterial product entering European market | 2019 |
| 1488 | PAVE | A nanovaccine Approach for the treatment of Pancreatic Cancer | 2019 |
| 1489 | Magicbullet Reloaded | Small-Molecule Drug Conjugates for Targeted Delivery in Tumor Therapy | 2019 |
| 1490 | HIL PT System | A revolutionary, cost effective, ultra-compact proton therapy system for cancer treatment | 2019 |
| 1491 | MCBD | MCBD (MULTI-CORE BIOPSY DEVICE) INNOVATIVE BIOPSY TECHNOLOGY FOR THE NEW ERA OF TARGETED MEDICINE | 2019 |
| 1492 | SUNNRL | Novel Photoprotective Cosmetics: From Fundamental Science to Product | 2020 |
| 1493 | TERAmeasure | Non-contact millimeter and Terahertz frequency measurement paradigm for instrumentation and sensing applications unlocking metrology-grade results | 2019 |
| 1494 | RV001 | RV001: An anti-metastatic cancer vaccine | 2019 |
| 1495 | CSI AurkA-MYC | Conformational Shift Inducers (CSI): An atomistic level investigation of Aurora kinase A (AurkA)–MYC interaction and its distortion by CSI compounds | 2019 |
| 1496 | Immune-Image | Immune-Image: Specific Imaging of Immune Cell Dynamics Using Novel Tracer Strategies | 2019 |
| 1497 | CoEvolve | Deconstructing and rebuilding the evolution of cell and tissue mechanoadaptation | 2020 |
| 1498 | CanFaster-Postdoc | The Translational Cancer Faster Forward postdoctoral programme – CanFaster-ER | 2020 |
| 1499 | MABSTER | Monoclonal Antibodies with Binding Sensitive To Environmental Regulation | 2020 |
| 1500 | EPICAMENTE | At the epigenetics-cancer metabolism interface | 2019 |
| 1501 | TroyCAN | Redefining the esophageal stem cell niche – towards targeting of squamous cell carcinoma | 2020 |
| 1502 | GLYCOSWITCH | Probing the mysteries of sweet “on-off” switches of the human immune system: toward the development of novel glycomimetics against bacterial infections | 2020 |
| 1503 | SUMiDENTITY | Deconstructing the role of SUMO on chromatin in cell identity and tissue repair | 2020 |
| 1504 | GelGeneCircuit | Cancer heterogeneity and therapy profiling using bioresponsive nanohydrogels for the delivery of multicolor logic genetic circuits. | 2020 |
| 1505 | ConflictResolution | Transcription-replication conflicts in disease and development | 2020 |
| 1506 | Cenya | Ex vivo cell labelling for in vivo imaging applied to cell therapeutics | 2019 |
| 1507 | OrganometRuPDT | Cancer-Cell Specific Organometallic Ru(II) Complexes as Photosensitizers in Photodynamic Therapy | 2020 |
| 1508 | PROT-RESIST | Toward the Commercialization of a Proteolytically Resistant APPI Variant for Inhibiting Metastasis in Prostate and Pancreatic Cancer | 2019 |
| 1509 | QUALITOP | Monitoring multidimensional aspects of QUAlity of Life after cancer ImmunoTherapy - an Open smart digital Platform for personalized prevention and patient management | 2020 |
| 1510 | CAPABLE | CAncer PAtients Better Life Experience | 2020 |
| 1511 | NanoFUNC | Functionalisation of ultra-bright all organic nanoparticles for super resolution imaging in intact brain preparations | 2020 |
| 1512 | MitoRepairosome | Dissecting the mechanism of DNA repair in human mitochondria | 2020 |
| 1513 | MaxONCO | A cancer vaccine to boost body’s natural defences to fight chordoma and head and neck cancer | 2020 |
| 1514 | BioTrace | World's First Real-Time Monitoring System for Ablation Procedures | 2019 |
| 1515 | PROSCOPE | Point-of-care instrument for diagnosis and image-guided intervention of Colo-Rectal Cancer | 2020 |
| 1516 | ORIGIN | Optical Fibre Dose Imaging for Adaptive Brachytherapy | 2020 |
| 1517 | CLARIFY | Cancer Long Survivors Artificial Intelligence Follow Up | 2020 |
| 1518 | BD4QoL | Big Data Models and Intelligent tools for Quality of Life monitorinBig Data Models and Intelligent tools for Quality of Life monitoring and participatory empowerment of head and neck cancer survivors | 2020 |
| 1519 | PERSIST | Patients-centered SurvivorShIp care plan after Cancer treatments based on Big Data and Artificial Intelligence technologies | 2020 |
| 1520 | ONCORELIEF | A digital guardian angel enhancing cancer patient’s wellbeing and health status improvement following treatment. | 2020 |
| 1521 | LifeChamps | A Collective Intelligence Platform to Support Cancer Champions | 2019 |
| 1522 | AiforCancerDX | Deep learning AI in cancer diagnostics | 2019 |
| 1523 | Obsidian | Obsidian Anastomotic SafeGuard – A powerful and efficient tissue sealant method for reducing the anastomotic leak rate in colorectal surgery | 2019 |
| 1524 | ASCAPE | Artificial intelligence Supporting CAncer Patients across Europe | 2020 |
| 1525 | FAITH | a Federated Artificial Intelligence solution for moniToring mental Health status after cancer treatment | 2020 |
| 1526 | Miiskin | ML-powered app and platform to identify skin changes over time | 2019 |
| 1527 | CAESAR | Developing Therapeutic Antibodies for Pets | 2019 |
| 1528 | EARLYDETECT | Development of an accurate, early diagnostic tool for ovarian cancer | 2020 |
| 1529 | TrojanDC | TrojanDC | 2019 |
| 1530 | StrataGRT | An innovative topical drug delivery system for improving chronic wound healing | 2019 |
| 1531 | B6VitaStat | A diagnostic device for personalized determination of vitamin B6 status and health | 2019 |
| 1532 | CHROMREP | Dissecting the chromatin response to DNA damage in silenced heterochromatin regions | 2019 |
| 1533 | ONco-Energetics_OFF | Dissection of Bioenergetic Plasticity of Tumors | 2020 |
| 1534 | ImOPac | GemciTest: An innovative In Vitro Diagnostic for the decision-making process of pancreatic cancer treatment | 2019 |
| 1535 | REVERT | taRgeted thErapy for adVanced colorEctal canceR paTients | 2020 |
| 1536 | CANDY | Comorbid Analysis of Neurodevelopmental Disorders and Epilepsy | 2020 |
| 1537 | RESCUER | RESISTANCE UNDER COMBINATORIAL TREATMENT IN ER+ AND ER- BREAST CANCER. | 2020 |
| 1538 | TheraLymph | Gene Therapy to restore lymphatic flow lymphedema | 2020 |
| 1539 | RNPdynamics | Multivalent interactions driving RNP dynamics in development and disease | 2020 |
| 1540 | RhabdoEvo | Deciphering the cellular origin and evolution of malignant rhabdoid tumors | 2019 |
| 1541 | RARITY | RAtional design of canceR ImmunoTherapY: one size does not fit all | 2019 |
| 1542 | PRISAR2 | proactive monitoring of cancer as an alternative to surgery | 2020 |
| 1543 | Cancersensing | A multi-cancer screening platform for fast and accurate early stage cancer detection from urine samples | 2019 |
| 1544 | MEISi | Druggable Small Molecule Inhibitor of MEIS Proteins | 2019 |
| 1545 | STI-001 | Turn Cancer Immunotherapy Effective in Most Patients | 2019 |
| 1546 | PARPinhibit | A systems biology approach to tackle PARP-inhibitors resistance and identify novel therapeutic targets to overcome it | 2020 |
| 1547 | RISCC | RISK-BASED SCREENING FOR CERVICAL CANCER | 2020 |
| 1548 | MISTRAL | Microbiome-based stratification of individuals at risk of HIV-1 acquisition, chronic clinical complications,antimicrobial drug resistance,and unresponsiveness to therapeutic HIV-1 vaccination | 2020 |
| 1549 | 4-IN THE LUNG RUN | 4-IN THE LUNG RUN: towards INdividually tailored INvitations, screening INtervals, and INtegrated co-morbidity reducing strategies in lung cancer screening | 2020 |
| 1550 | NUCDDR | Nucleolar Responses to DNA Damage: rDNA, an emerging hub of genome instability | 2020 |
| 1551 | ExocyTher | Extracellular vesicle production and engineering by turbulence for fistula therapy in thermoreversible hydrogels | 2020 |
| 1552 | MonoComb | Monolithic frequency comb spectrometers | 2020 |
| 1553 | AMPLITUDE | Advanced Multimodal Photonics Laser Imaging Tool for Urothelial Diagnosis in Endoscopy | 2020 |
| 1554 | CUDI | Implementation of contrast-ultrasound dispersion imaging for better prostate cancer care | 2020 |
| 1555 | READY | Getting ready to treat human patients with nanobody-targeted photodynamic therapy | 2020 |
| 1556 | GenomtecTumor | MicroRNA-based tool for non-invasive early-stage cancer diagnosis | 2019 |
| 1557 | PROSKit | Prostate cancer urinary diagnostic kit based on RNA biomarkers | 2020 |
| 1558 | ENDOWAVE | ENDObronchial microWAVE Ablation for the minimally invasive treatment of lung cancer | 2019 |
| 1559 | oncNGS | NGS diagnostics in 21st century oncology: the best, for all, at all times | 2020 |
| 1560 | AGEMEC | Age-dependent mechanisms of sporadic Alzheimer’s Disease in patient-derived neurons | 2020 |
| 1561 | DDREAMM | Dna Damage REsponse: Actionabilities, Maps and Mechanisms | 2020 |
| 1562 | MATCH | Discovering a novel allergen immunotherapy in house dust mite allergy tolerance research | 2020 |
| 1563 | Meta-Targeting | Macro-Nanomedicine to Treat Metastatic Cancer | 2020 |
| 1564 | nbPTMs | A multifaceted platform for exploring nucleotide-based post-translational modifications | 2021 |
| 1565 | nanoDNArepair | Next Generation Nanofluidic Devices for Single Molecule Analysis of DNA Repair Dynamics | 2020 |
| 1566 | inhibiTOR | Novel selective mTORC1 inhibitors | 2020 |
| 1567 | M6AQuantKit | Development and commercialization of kit for quantitative interrogation of a key RNA modification | 2020 |
| 1568 | Glue2Degrade | Therapeutic hijacking of E3 Ligases | 2020 |
| 1569 | PHYRIST | Physiological roles of the Ribotoxic Stress Response | 2020 |
| 1570 | PROSTATOR | Reliable urinary test for the diagnosis of prostate cancer | 2020 |
| 1571 | PoreDetect | Bench-top system for detection and analysis of miRNA using solid-state nanopores | 2020 |
| 1572 | SILENT | Silent mutations in cancer | 2020 |
| 1573 | Controlling MAC | Structural basis of controlling the membrane attack complex | 2020 |
| 1574 | ICE_PACK | Polymer Materials for Cryogenic Storage and Distribution of Biologics | 2020 |
| 1575 | TrojanDC | Harnessing dendritic cell reprogramming for cancer immunotherapy | 2020 |
| 1576 | NIMBUS4CIP | Effective management of pregnant cancer patients through a cloud-based integrative and highly specialized advisory board platform | 2020 |
| 1577 | TACT | Targeted Anti-Cancer Therapies | 2020 |
| 1578 | LIGHTCAP | LIGHTCAP: Light, Cognition, Attention, Perception | 2020 |
| 1579 | NATURE-ETN | Nucleic Acids for Future Gene Editing, Immunotherapy and Epigenetic Sequence Modification | 2020 |
| 1580 | REpAIR | Spatio-Temporal Regulation of Inflammation and Tissue Regeneration: Studying the immune system - tissue - microbiota communication to develop targeted therapies for immune-mediated diseases and cancer | 2020 |
| 1581 | AuriMod | From pills to bio-electronics: a wearable neurostimulator for the personalised treatment of chronic pain | 2019 |
| 1582 | ALTER-brain | Metastasis-associated altered molecular patterns in the brain | 2020 |
| 1583 | KineTic | New Reagents for Quantifying the Routing and Kinetics of T-cell Activation | 2020 |
| 1584 | METABOLIGHT | Optical imaging platform to unravel metabolic reprogramming of cancer: a path for improved treatments | 2020 |
| 1585 | SURE | 3-D Super resolution Ultrasound Real time imaging of Erythrocytes | 2020 |
| 1586 | PreventALL | Prevention of childhood Acute Lymphoblastic Leukemia immunology links oncology | 2020 |
| 1587 | NanoBioMade | Bioinorganic intracellular synthesis of photo-responsive bio-camouflaged nanomedicines | 2021 |
| 1588 | Ru4EYE | Ruthenium-based photoactivated chemotherapy against eye cancer | 2020 |
| 1589 | ExploDProteins | Exploiting the DNA damage response to induce degradation of proteins | 2020 |
| 1590 | RECOBIN-PROTACs | Reversible Covalently Binding PROTACs Technology for Protein Degradation in Cancer Therapy | 2020 |
| 1591 | ClickandTreatCancer | Ligand Directed NIR-based Theranostic Prodrugs for Prostate Cancer | 2020 |
| 1592 | MelImmuneOrg | Deciphering the tumor-immune-microenvironment profile and organization within the tumors of melanoma patients undergoing immunotherapy | 2020 |
| 1593 | TESTIMONY | Tumor Endothelial Cells: Gatekeepers Of Anti-Tumor Immunity | 2020 |
| 1594 | LINKER | Elucidating transcriptional rewiring on hematological malignancies via computational methods | 2020 |
| 1595 | ADDITIVES | Exposure to ‘cocktails’ of food additives and chronic disease risk | 2020 |
| 1596 | SynWaiXen | Total Synthesis of Waixenicin A and Xenibellol A | 2020 |
| 1597 | BRCAstem | Monitoring cancer stem cell dynamics and therapeutic response in BRCA2-deficient breast tumour cells | 2020 |
| 1598 | BraINstorm | Engineered nanocarriers for simultaneous anticancer immune response and “switching” of tumor-associated macrophages for intranasal glioblastoma treatment | 2020 |
| 1599 | FBC predisposition | Unraveling novel Familial Breast Cancer (FBC) predisposition genes. | 2020 |
| 1600 | GrowthDevStability | Characterization of the developmental mechanisms ensuring a robust symmetrical growth in the bilateral model organism Drosophila melanogaster | 2020 |
| 1601 | cONCReTE | DevelOpmeNt of Cancer RNA TherapEutics | 2020 |
| 1602 | RNADOMAIN | Computational genomics of long noncoding RNA domains across metazoans | 2021 |
| 1603 | NetriCan | Characterization of the role of netrin-1 in the regulation of the Epithelial-to-Mesenchymal Transition during tumor progression. | 2020 |
| 1604 | StressRhomboid | Trapping intramembrane protease substrates in living cells: focus on RHBDL4 role in ERAD | 2020 |
| 1605 | HollidayTrack | Tracking the movement and dynamics of Holliday junctions | 2020 |
| 1606 | BESG | Bioengineered exosomes based approaches for the effective treatment of non-small cell lung cancer | 2020 |
| 1607 | GlioTarget | Inflaming the microenvironment of glioblastoma tumors by ADAR1 inhibition: a two-hit approach for the treatment of brain cancer. | 2021 |
| 1608 | STIMULATE | STING signalling modulation via the Electron Transport Chain | 2021 |
| 1609 | TGF-BTB | Transforming Growth Factor – Bench To Bedside. Towards a better understanding of TGF-β isoform specific signalling in health and disease | 2020 |
| 1610 | NANOCRISPR | NANODELIVERY OF SPECIFIC GENOME ENGINEERING TOOLS AS A NOVEL THERAPEUTIC APPROACH FOR AGGRESSIVE PROSTATE CANCERS | 2021 |
| 1611 | TARNEPC | Targeting treatment-induced neuroendocrine prostate cancer | 2021 |
| 1612 | BiCiCle | Biophysics of circulating tumor cells, from single molecule to cell clusters | 2020 |
| 1613 | MAMBO | Magnetic swArms for liver chemoeMBOlization | 2020 |
| 1614 | SPOT | SPOT - Synthesis of Pretargeted Oncology Theranostics | 2020 |
| 1615 | FluAttack | Validation of a novel antiviral drug candidate against influenza | 2020 |
| 1616 | AmpliFISH | Bright nanoparticle probes for amplified fluorescence in situ hybridization in cancer diagnostics | 2020 |
| 1617 | MANTARGET | Super resolution imaging of nanoPMOs for cancer drug delivery | 2021 |
| 1618 | miRanDa | microRNA assay system based on self-assembled nanoscale DNA origami arrays | 2021 |
| 1619 | RMAG | Rheology and Mechanics of Active Glasses | 2021 |
| 1620 | CATKERB | Total Syntheses of Catharanthine and Keramaphidin B by an Iridium-Catalyzed Reductive Cyclization Cascade | 2020 |
| 1621 | Irrev Fork Arrest | Deciphering the mechanism of irreversible replication fork arrest | 2020 |
| 1622 | RegARcis | Role of the SWI/SNF complex in the Androgen Receptor cistrome regulation | 2020 |
| 1623 | RabTarget4Metastasis | Targeting Rab27A with covalent inhibitors for the treatment of metastatic breast cancer | 2020 |
| 1624 | ONCO-VAX | A multifaceted cancer immunotherapy based on an immune checkpoint-modulating chimeric oncolytic virus vector in combination with a dendritic cell vaccine | 2020 |
| 1625 | Immuno-Predictor | Mechanical Biomarkers for Prediction of Cancer Immunotherapy | 2020 |
| 1626 | RCC_Evo | Modelling the Predictability and Repeatability of Tumour Evolution in Clear Cell Renal Cell Cancer | 2020 |
| 1627 | ICG68-PROG | Imaging of c-Met aberrant cancers with Gallium-68 chelators for positron emission tomography | 2020 |
| 1628 | DIM-CrIC | Decreasing Pancreatic Adenocarcinoma-related Inflammation using small molecule inhibitors of STING | 2020 |
| 1629 | ROSETTA | Deciphering the Role of aberrant glycOSylation in the rEsponse to Targeted TherApies for breast cancer | 2020 |
| 1630 | OPEN P-CAN | Dissecting the role of mitochondrial dynamics in pancreatic carcinogenesis | 2020 |
| 1631 | HypoCyclo | Multifunctional Polymeric Cyclodextrin Nanocarriers As Novel Triple-Negative Breast Cancer Treatment: A Versatile Photo-Chemotherapy Bypassing Hypoxic Conditions | 2020 |
| 1632 | NOSCAR | decipheriNg Oncogenic SIgnalling patterns to break CAncer drug Resistance | 2020 |
| 1633 | TETCOLON | Dissecting the role of the epigenetic regulator TET2 in colorectal cancer | 2020 |
| 1634 | MRTFSen | MRTF/SRF signalling in regulation of cell senescence and melanoma progression | 2020 |
| 1635 | COMMiT | Cancer Organoids Multiplexed Screening in Microfluidic Textile chips | 2020 |
| 1636 | CAPRI | Treating the Chronic Pain Patient earlier in the Pathway | 2020 |
| 1637 | ANEUPLOIDY | Molecular origins of aneuploidies in healthy and diseased human tissues | 2020 |
| 1638 | SecondCANCERinKIDS | What causes therapy-related malignancies in childhood cancer survivors? Dissecting the etiology of second cancers | 2020 |
| 1639 | COSMOS | The Conformation Of S-phase chroMOSomes | 2020 |
| 1640 | TARGETOF | Mass cytometry nanotools for intracellular target engagement. Towards precision medicine. | 2021 |
| 1641 | Catenin-Condensation | The effect of β-catenin condensation on the Wnt-pathway | 2020 |
| 1642 | RASATaC | Regulating RAS Activity to Target RAS-Driven Cancers | 2020 |
| 1643 | antiCSC | Targeting the cancer stem cell (CSC) metabolism with designed, reactive metal complexes | 2020 |